Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
precursor  ||| S:47 E:57 ||| NN
of  ||| S:57 E:60 ||| IN
heparin-binding  ||| S:60 E:76 ||| JJ
EGF-like  ||| S:76 E:85 ||| JJ
growth  ||| S:85 E:92 ||| NN
factor  ||| S:92 E:107 ||| NN
( ||| S:107 E:108 ||| -LRB-
proHB-EGF ||| S:108 E:117 ||| NNP
)  ||| S:117 E:119 ||| -RRB-
is  ||| S:119 E:122 ||| VBZ
found  ||| S:122 E:128 ||| VBN
on  ||| S:128 E:131 ||| IN
a  ||| S:131 E:133 ||| DT
wide  ||| S:133 E:138 ||| JJ
variety  ||| S:138 E:146 ||| NN
of  ||| S:146 E:149 ||| IN
cell  ||| S:149 E:154 ||| NN
surfaces  ||| S:154 E:163 ||| NNS
and  ||| S:163 E:175 ||| CC
is  ||| S:175 E:178 ||| VBZ
present  ||| S:178 E:186 ||| JJ
in  ||| S:186 E:189 ||| IN
numerous  ||| S:189 E:198 ||| JJ
tissue  ||| S:198 E:205 ||| NN
types  ||| S:205 E:211 ||| NNS
[  ||| S:211 E:213 ||| -LRB-
1  ||| S:213 E:215 ||| LS
]  ||| S:215 E:217 ||| -RRB-
.  ||| S:217 E:219 ||| .
Previously  ||| S:219 E:230 ||| RB
in  ||| S:230 E:241 ||| IN
our  ||| S:241 E:245 ||| PRP$
laboratory ||| S:245 E:255 ||| NN
,  ||| S:255 E:257 ||| ,
we  ||| S:257 E:260 ||| PRP
cloned  ||| S:260 E:267 ||| VBD
the  ||| S:267 E:271 ||| DT
cDNA  ||| S:271 E:276 ||| JJ
encoding  ||| S:276 E:285 ||| JJ
proHB-EGF  ||| S:285 E:295 ||| NN
from  ||| S:295 E:308 ||| IN
monkey  ||| S:308 E:315 ||| JJ
Vero  ||| S:315 E:320 ||| JJ
cells  ||| S:320 E:326 ||| NNS
and  ||| S:326 E:330 ||| CC
identified  ||| S:330 E:341 ||| VBN
this  ||| S:341 E:346 ||| DT
cell-surface  ||| S:346 E:359 ||| JJ
molecule  ||| S:359 E:376 ||| NN
as  ||| S:376 E:379 ||| IN
a  ||| S:379 E:381 ||| DT
receptor  ||| S:381 E:390 ||| NN
for  ||| S:390 E:394 ||| IN
diphtheria  ||| S:394 E:405 ||| JJ
toxin  ||| S:405 E:411 ||| NN
( ||| S:411 E:412 ||| -LRB-
DT ||| S:412 E:414 ||| NNP
)  ||| S:414 E:416 ||| -RRB-
[  ||| S:416 E:418 ||| -LRB-
2  ||| S:418 E:420 ||| LS
]  ||| S:420 E:422 ||| -RRB-
.  ||| S:422 E:424 ||| .
The  ||| S:424 E:436 ||| DT
predicted  ||| S:436 E:446 ||| VBN
amino  ||| S:446 E:452 ||| JJ
acid  ||| S:452 E:457 ||| NN
sequence  ||| S:457 E:466 ||| NN
was  ||| S:466 E:470 ||| VBD
shown  ||| S:470 E:476 ||| VBN
to  ||| S:476 E:479 ||| TO
be  ||| S:479 E:482 ||| VB
identical  ||| S:482 E:492 ||| JJ
to  ||| S:492 E:503 ||| TO
that  ||| S:503 E:508 ||| DT
of  ||| S:508 E:511 ||| IN
the  ||| S:511 E:515 ||| DT
cell  ||| S:515 E:520 ||| NN
surface-expressed  ||| S:520 E:538 ||| JJ
precursor  ||| S:538 E:548 ||| NN
of  ||| S:548 E:551 ||| IN
human  ||| S:551 E:565 ||| JJ
heparin-binding  ||| S:565 E:581 ||| JJ
EGF-like  ||| S:581 E:590 ||| JJ
growth  ||| S:590 E:597 ||| NN
factor  ||| S:597 E:604 ||| NN
( ||| S:604 E:605 ||| -LRB-
proHB-EGF ||| S:605 E:614 ||| NNP
)  ||| S:614 E:616 ||| -RRB-
[  ||| S:616 E:618 ||| -LRB-
3  ||| S:618 E:620 ||| CD
4  ||| S:620 E:622 ||| CD
]  ||| S:622 E:632 ||| -RRB-
.  ||| S:632 E:634 ||| .
The  ||| S:634 E:638 ||| DT
derived  ||| S:638 E:646 ||| FW
amino  ||| S:646 E:652 ||| FW
acid  ||| S:652 E:657 ||| FW
sequence  ||| S:657 E:666 ||| FW
revealed  ||| S:666 E:675 ||| FW
a  ||| S:675 E:677 ||| FW
signal  ||| S:677 E:692 ||| FW
sequence  ||| S:692 E:701 ||| FW
( ||| S:701 E:702 ||| -LRB-
residues  ||| S:702 E:711 ||| FW
1-23 ||| S:711 E:715 ||| FW
) ||| S:715 E:716 ||| -RRB-
,  ||| S:716 E:718 ||| ,
an  ||| S:718 E:721 ||| DT
extracellular  ||| S:721 E:735 ||| JJ
domain  ||| S:735 E:742 ||| NN
( ||| S:742 E:743 ||| -LRB-
residues  ||| S:743 E:760 ||| FW
24-159 ||| S:760 E:766 ||| FW
) ||| S:766 E:767 ||| -RRB-
,  ||| S:767 E:769 ||| ,
a  ||| S:769 E:771 ||| DT
transmembrane  ||| S:771 E:785 ||| JJ
domain  ||| S:785 E:792 ||| NN
( ||| S:792 E:793 ||| -LRB-
residues  ||| S:793 E:802 ||| FW
160-184 ||| S:802 E:809 ||| FW
) ||| S:809 E:810 ||| -RRB-
,  ||| S:810 E:812 ||| ,
and  ||| S:812 E:816 ||| CC
a  ||| S:816 E:826 ||| DT
carboxyl  ||| S:826 E:835 ||| FW
terminal  ||| S:835 E:844 ||| FW
cytoplasmic  ||| S:844 E:856 ||| FW
domain  ||| S:856 E:863 ||| FW
( ||| S:863 E:864 ||| -LRB-
residues  ||| S:864 E:873 ||| FW
185-208 ||| S:873 E:880 ||| FW
)  ||| S:880 E:882 ||| -RRB-
[  ||| S:882 E:884 ||| -LRB-
2  ||| S:884 E:894 ||| LS
]  ||| S:894 E:896 ||| -RRB-
.  ||| S:896 E:898 ||| .
Proteolytic  ||| S:898 E:910 ||| JJ
processing  ||| S:910 E:921 ||| NN
of  ||| S:921 E:924 ||| IN
the  ||| S:924 E:928 ||| DT
proHB-EGF  ||| S:928 E:938 ||| JJ
occurs  ||| S:938 E:945 ||| NN
on  ||| S:945 E:948 ||| IN
the  ||| S:948 E:960 ||| DT
cell  ||| S:960 E:965 ||| NN
surface  ||| S:965 E:973 ||| NN
and  ||| S:973 E:977 ||| CC
results  ||| S:977 E:985 ||| NNS
in  ||| S:985 E:988 ||| IN
the  ||| S:988 E:992 ||| DT
release  ||| S:992 E:1000 ||| NN
of  ||| S:1000 E:1003 ||| IN
mature  ||| S:1003 E:1010 ||| JJ
HB-EGF  ||| S:1010 E:1025 ||| NN
( ||| S:1025 E:1026 ||| -LRB-
mHB-EGF ||| S:1026 E:1033 ||| NNP
)  ||| S:1033 E:1035 ||| -RRB-
( ||| S:1035 E:1036 ||| -LRB-
residues  ||| S:1036 E:1045 ||| FW
63-148 ||| S:1045 E:1051 ||| FW
)  ||| S:1051 E:1053 ||| -RRB-
[  ||| S:1053 E:1055 ||| -LRB-
5  ||| S:1055 E:1057 ||| LS
]  ||| S:1057 E:1059 ||| -RRB-
.  ||| S:1059 E:1061 ||| .
The  ||| S:1061 E:1065 ||| DT
mature ||| S:1065 E:1071 ||| JJ
/ ||| S:1071 E:1072 ||| CD
soluble  ||| S:1072 E:1088 ||| JJ
HB-EGF  ||| S:1088 E:1095 ||| NN
is  ||| S:1095 E:1098 ||| VBZ
a  ||| S:1098 E:1100 ||| DT
member  ||| S:1100 E:1107 ||| NN
of  ||| S:1107 E:1110 ||| IN
the  ||| S:1110 E:1114 ||| DT
EGF  ||| S:1114 E:1118 ||| NNP
family  ||| S:1118 E:1125 ||| NN
of  ||| S:1125 E:1128 ||| IN
growth  ||| S:1128 E:1135 ||| NN
factors  ||| S:1135 E:1143 ||| NNS
that  ||| S:1143 E:1156 ||| WDT
includes  ||| S:1156 E:1165 ||| VBZ
amphiregulin ||| S:1165 E:1177 ||| VBN
,  ||| S:1177 E:1179 ||| ,
epidermal  ||| S:1179 E:1189 ||| JJ
growth  ||| S:1189 E:1196 ||| NN
factor ||| S:1196 E:1202 ||| NN
,  ||| S:1202 E:1204 ||| ,
and  ||| S:1204 E:1216 ||| CC
transforming  ||| S:1216 E:1229 ||| JJ
growth  ||| S:1229 E:1236 ||| NN
factor  ||| S:1236 E:1243 ||| NN
a  ||| S:1243 E:1245 ||| DT
[  ||| S:1245 E:1247 ||| -LRB-
6  ||| S:1247 E:1249 ||| CD
]  ||| S:1249 E:1251 ||| -RRB-
.  ||| S:1251 E:1253 ||| .
Mature  ||| S:1253 E:1260 ||| JJ
HB-EGF  ||| S:1260 E:1267 ||| NN
released  ||| S:1267 E:1284 ||| VBN
from  ||| S:1284 E:1289 ||| IN
the  ||| S:1289 E:1293 ||| DT
cell  ||| S:1293 E:1298 ||| NN
surface  ||| S:1298 E:1306 ||| NN
is  ||| S:1306 E:1309 ||| VBZ
mitogenic  ||| S:1309 E:1319 ||| VBN
and  ||| S:1319 E:1323 ||| CC
is  ||| S:1323 E:1326 ||| VBZ
able  ||| S:1326 E:1331 ||| JJ
to  ||| S:1331 E:1334 ||| TO
bind  ||| S:1334 E:1339 ||| VB
to  ||| S:1339 E:1350 ||| TO
the  ||| S:1350 E:1354 ||| DT
EGF  ||| S:1354 E:1358 ||| NNP
receptor  ||| S:1358 E:1367 ||| NN
[  ||| S:1367 E:1369 ||| -LRB-
3  ||| S:1369 E:1371 ||| LS
]  ||| S:1371 E:1373 ||| -RRB-
.  ||| S:1373 E:1375 ||| .
Membrane-bound  ||| S:1375 E:1390 ||| JJ
proHB-EGF  ||| S:1390 E:1400 ||| NN
has  ||| S:1400 E:1412 ||| VBZ
juxtacrine  ||| S:1412 E:1423 ||| JJ
growth  ||| S:1423 E:1430 ||| NN
factor  ||| S:1430 E:1437 ||| NN
activity  ||| S:1437 E:1446 ||| NN
[  ||| S:1446 E:1448 ||| -LRB-
7  ||| S:1448 E:1450 ||| CD
]  ||| S:1450 E:1452 ||| -RRB-
and  ||| S:1452 E:1456 ||| CC
also  ||| S:1456 E:1461 ||| RB
acts  ||| S:1461 E:1466 ||| VBZ
as  ||| S:1466 E:1469 ||| IN
a  ||| S:1469 E:1479 ||| DT
DT  ||| S:1479 E:1482 ||| NNP
receptor  ||| S:1482 E:1491 ||| NN
[  ||| S:1491 E:1493 ||| -LRB-
2  ||| S:1493 E:1495 ||| CD
8  ||| S:1495 E:1497 ||| CD
]  ||| S:1497 E:1499 ||| -RRB-
.  ||| S:1499 E:1509 ||| .
Previously  ||| S:1509 E:1520 ||| RB
we  ||| S:1520 E:1523 ||| PRP
have  ||| S:1523 E:1528 ||| VBP
described  ||| S:1528 E:1538 ||| VBN
the  ||| S:1538 E:1542 ||| DT
interaction  ||| S:1542 E:1554 ||| NN
of  ||| S:1554 E:1557 ||| IN
the  ||| S:1557 E:1569 ||| DT
extracellular  ||| S:1569 E:1583 ||| JJ
domain  ||| S:1583 E:1590 ||| NN
of  ||| S:1590 E:1593 ||| IN
proHB-EGF  ||| S:1593 E:1603 ||| JJ
with  ||| S:1603 E:1608 ||| IN
the  ||| S:1608 E:1612 ||| DT
second  ||| S:1612 E:1627 ||| JJ
extracellular  ||| S:1627 E:1641 ||| JJ
domain  ||| S:1641 E:1648 ||| NN
of  ||| S:1648 E:1651 ||| IN
the  ||| S:1651 E:1655 ||| DT
tetraspanin  ||| S:1655 E:1667 ||| JJ
protein ||| S:1667 E:1674 ||| NN
,  ||| S:1674 E:1676 ||| ,
monkey  ||| S:1676 E:1683 ||| FW
CD9  ||| S:1683 E:1695 ||| FW
[  ||| S:1695 E:1697 ||| -LRB-
9  ||| S:1697 E:1699 ||| CD
]  ||| S:1699 E:1701 ||| -RRB-
.  ||| S:1701 E:1703 ||| .
Tissue  ||| S:1703 E:1710 ||| NN
culture  ||| S:1710 E:1718 ||| NN
experiments  ||| S:1718 E:1730 ||| NNS
using  ||| S:1730 E:1736 ||| VBG
DT-sensitive  ||| S:1736 E:1757 ||| JJ
transfected  ||| S:1757 E:1769 ||| JJ
mouse  ||| S:1769 E:1775 ||| NN
fibroblast  ||| S:1775 E:1786 ||| NN
cell  ||| S:1786 E:1791 ||| NN
lines  ||| S:1791 E:1797 ||| NNS
expressing  ||| S:1797 E:1808 ||| VBG
on  ||| S:1808 E:1811 ||| IN
the  ||| S:1811 E:1823 ||| DT
cell  ||| S:1823 E:1828 ||| NN
surface  ||| S:1828 E:1836 ||| NN
both  ||| S:1836 E:1841 ||| CC
the  ||| S:1841 E:1845 ||| DT
monkey  ||| S:1845 E:1852 ||| JJ
DT  ||| S:1852 E:1855 ||| NNP
receptor  ||| S:1855 E:1864 ||| NN
and  ||| S:1864 E:1868 ||| CC
chimeric  ||| S:1868 E:1885 ||| JJ
mouse-monkey  ||| S:1885 E:1898 ||| JJ
CD9  ||| S:1898 E:1902 ||| CD
antigen  ||| S:1902 E:1910 ||| NN
showed  ||| S:1910 E:1917 ||| VBD
that  ||| S:1917 E:1922 ||| IN
the  ||| S:1922 E:1926 ||| DT
second  ||| S:1926 E:1941 ||| JJ
extracellular  ||| S:1941 E:1955 ||| JJ
domain  ||| S:1955 E:1962 ||| NN
of  ||| S:1962 E:1965 ||| IN
monkey  ||| S:1965 E:1972 ||| CD
CD9  ||| S:1972 E:1976 ||| CD
antigen  ||| S:1976 E:1984 ||| NN
is  ||| S:1984 E:1987 ||| VBZ
able  ||| S:1987 E:1992 ||| JJ
to  ||| S:1992 E:1995 ||| TO
act  ||| S:1995 E:2007 ||| VB
as  ||| S:2007 E:2010 ||| IN
a  ||| S:2010 E:2012 ||| DT
coreceptor  ||| S:2012 E:2023 ||| NN
for  ||| S:2023 E:2027 ||| IN
DT  ||| S:2027 E:2030 ||| NNP
and  ||| S:2030 E:2034 ||| CC
is  ||| S:2034 E:2037 ||| VBZ
also  ||| S:2037 E:2042 ||| RB
responsible  ||| S:2042 E:2054 ||| JJ
for  ||| S:2054 E:2058 ||| IN
the  ||| S:2058 E:2070 ||| DT
increased  ||| S:2070 E:2080 ||| JJ
DT-sensitivity  ||| S:2080 E:2095 ||| JJ
and  ||| S:2095 E:2099 ||| CC
affinity  ||| S:2099 E:2108 ||| NN
for  ||| S:2108 E:2112 ||| IN
DT  ||| S:2112 E:2115 ||| NNP
in  ||| S:2115 E:2118 ||| IN
these  ||| S:2118 E:2124 ||| DT
cell  ||| S:2124 E:2137 ||| NN
lines  ||| S:2137 E:2143 ||| NNS
[  ||| S:2143 E:2145 ||| -LRB-
9  ||| S:2145 E:2147 ||| CD
]  ||| S:2147 E:2149 ||| -RRB-
.  ||| S:2149 E:2151 ||| .
These  ||| S:2151 E:2157 ||| DT
observations  ||| S:2157 E:2170 ||| NNS
suggested  ||| S:2170 E:2180 ||| VBD
that  ||| S:2180 E:2185 ||| IN
the  ||| S:2185 E:2189 ||| DT
CD9  ||| S:2189 E:2201 ||| JJ
antigen  ||| S:2201 E:2209 ||| NN
and  ||| S:2209 E:2213 ||| CC
proHB-EGF  ||| S:2213 E:2223 ||| JJ
likely  ||| S:2223 E:2230 ||| JJ
interact  ||| S:2230 E:2239 ||| NNS
physically  ||| S:2239 E:2250 ||| RB
on  ||| S:2250 E:2253 ||| IN
the  ||| S:2253 E:2265 ||| DT
cell  ||| S:2265 E:2270 ||| NN
surface ||| S:2270 E:2277 ||| NN
.  ||| S:2277 E:2279 ||| .
Using  ||| S:2279 E:2285 ||| VBG
a  ||| S:2285 E:2287 ||| DT
yeast  ||| S:2287 E:2293 ||| NN
two-hybrid  ||| S:2293 E:2304 ||| JJ
system ||| S:2304 E:2310 ||| NN
,  ||| S:2310 E:2312 ||| ,
we  ||| S:2312 E:2315 ||| PRP
have  ||| S:2315 E:2328 ||| VBP
shown  ||| S:2328 E:2334 ||| VBN
that  ||| S:2334 E:2339 ||| IN
the  ||| S:2339 E:2343 ||| DT
extracellular  ||| S:2343 E:2357 ||| JJ
domain  ||| S:2357 E:2364 ||| NN
of  ||| S:2364 E:2367 ||| IN
proHB-EGF  ||| S:2367 E:2377 ||| JJ
and  ||| S:2377 E:2381 ||| CC
the  ||| S:2381 E:2393 ||| DT
second  ||| S:2393 E:2400 ||| JJ
extracellular  ||| S:2400 E:2414 ||| JJ
domain  ||| S:2414 E:2421 ||| NN
of  ||| S:2421 E:2424 ||| IN
monkey  ||| S:2424 E:2431 ||| JJ
CD9  ||| S:2431 E:2435 ||| NN
do  ||| S:2435 E:2438 ||| VBP
indeed  ||| S:2438 E:2453 ||| RB
interact  ||| S:2453 E:2462 ||| JJ
[  ||| S:2462 E:2464 ||| -LRB-
9  ||| S:2464 E:2466 ||| CD
]  ||| S:2466 E:2468 ||| -RRB-
.  ||| S:2468 E:2478 ||| .
The  ||| S:2478 E:2482 ||| DT
yeast  ||| S:2482 E:2488 ||| NN
two-hybrid  ||| S:2488 E:2499 ||| JJ
system  ||| S:2499 E:2506 ||| NN
strategy  ||| S:2506 E:2515 ||| NN
has  ||| S:2515 E:2519 ||| VBZ
been  ||| S:2519 E:2524 ||| VBN
used  ||| S:2524 E:2529 ||| VBN
to  ||| S:2529 E:2540 ||| TO
examine  ||| S:2540 E:2548 ||| VB
both  ||| S:2548 E:2553 ||| DT
intracellular  ||| S:2553 E:2567 ||| NN
and  ||| S:2567 E:2571 ||| CC
receptor-ligand  ||| S:2571 E:2595 ||| JJ
protein-protein  ||| S:2595 E:2611 ||| JJ
interactions ||| S:2611 E:2623 ||| NNS
.  ||| S:2623 E:2625 ||| .
The  ||| S:2625 E:2629 ||| DT
interaction  ||| S:2629 E:2641 ||| NN
of  ||| S:2641 E:2644 ||| IN
mammalian  ||| S:2644 E:2662 ||| JJ
growth  ||| S:2662 E:2669 ||| NN
hormone ||| S:2669 E:2676 ||| NN
,  ||| S:2676 E:2678 ||| ,
prolactin ||| S:2678 E:2687 ||| NN
,  ||| S:2687 E:2689 ||| ,
and  ||| S:2689 E:2693 ||| CC
vascular  ||| S:2693 E:2702 ||| JJ
endothelial  ||| S:2702 E:2714 ||| JJ
growth  ||| S:2714 E:2729 ||| NN
factor  ||| S:2729 E:2736 ||| NN
with  ||| S:2736 E:2741 ||| IN
their  ||| S:2741 E:2747 ||| PRP$
respective  ||| S:2747 E:2758 ||| JJ
extracellular  ||| S:2758 E:2772 ||| JJ
ligand-binding  ||| S:2772 E:2795 ||| JJ
proteins  ||| S:2795 E:2804 ||| NNS
have  ||| S:2804 E:2809 ||| VBP
been  ||| S:2809 E:2814 ||| VBN
observed  ||| S:2814 E:2823 ||| VBN
using  ||| S:2823 E:2829 ||| VBG
yeast  ||| S:2829 E:2835 ||| JJ
two-hybrid  ||| S:2835 E:2846 ||| JJ
sytems  ||| S:2846 E:2853 ||| NNS
[  ||| S:2853 E:2863 ||| -LRB-
10  ||| S:2863 E:2866 ||| CD
11  ||| S:2866 E:2869 ||| CD
12  ||| S:2869 E:2872 ||| CD
13  ||| S:2872 E:2875 ||| CD
]  ||| S:2875 E:2877 ||| -RRB-
.  ||| S:2877 E:2887 ||| .
The  ||| S:2887 E:2891 ||| DT
involvement  ||| S:2891 E:2903 ||| NN
of  ||| S:2903 E:2906 ||| IN
HB-EGF  ||| S:2906 E:2913 ||| JJ
in  ||| S:2913 E:2916 ||| IN
various  ||| S:2916 E:2924 ||| JJ
cellular  ||| S:2924 E:2933 ||| JJ
and  ||| S:2933 E:2937 ||| CC
tissue  ||| S:2937 E:2952 ||| NN
functions  ||| S:2952 E:2962 ||| NNS
and  ||| S:2962 E:2966 ||| CC
its  ||| S:2966 E:2970 ||| PRP$
presence  ||| S:2970 E:2979 ||| NN
in  ||| S:2979 E:2982 ||| IN
extracellular  ||| S:2982 E:2996 ||| JJ
matrices  ||| S:2996 E:3013 ||| NN
suggested  ||| S:3013 E:3023 ||| VBD
the  ||| S:3023 E:3027 ||| DT
possibility  ||| S:3027 E:3039 ||| NN
that  ||| S:3039 E:3044 ||| IN
it  ||| S:3044 E:3047 ||| PRP
may  ||| S:3047 E:3051 ||| MD
interact  ||| S:3051 E:3060 ||| VB
with  ||| S:3060 E:3065 ||| IN
other  ||| S:3065 E:3079 ||| JJ
extracellular  ||| S:3079 E:3093 ||| JJ
matrix  ||| S:3093 E:3100 ||| JJ
proteins ||| S:3100 E:3108 ||| NNS
.  ||| S:3108 E:3110 ||| .
To  ||| S:3110 E:3113 ||| TO
test  ||| S:3113 E:3118 ||| VB
this  ||| S:3118 E:3123 ||| DT
possiblity  ||| S:3123 E:3134 ||| NN
we  ||| S:3134 E:3145 ||| PRP
used  ||| S:3145 E:3150 ||| VBD
the  ||| S:3150 E:3154 ||| DT
extracellular  ||| S:3154 E:3168 ||| JJ
domain  ||| S:3168 E:3175 ||| NN
of  ||| S:3175 E:3178 ||| IN
proHB-EGF  ||| S:3178 E:3188 ||| JJ
in  ||| S:3188 E:3191 ||| IN
a  ||| S:3191 E:3193 ||| DT
yeast  ||| S:3193 E:3207 ||| NN
two-hybrid  ||| S:3207 E:3218 ||| JJ
system  ||| S:3218 E:3225 ||| NN
to  ||| S:3225 E:3228 ||| TO
screen  ||| S:3228 E:3235 ||| VB
a  ||| S:3235 E:3237 ||| DT
monkey  ||| S:3237 E:3244 ||| JJ
kidney  ||| S:3244 E:3251 ||| NN
cDNA  ||| S:3251 E:3256 ||| JJ
library ||| S:3256 E:3263 ||| NN
.  ||| S:3263 E:3273 ||| .
In  ||| S:3273 E:3276 ||| IN
the  ||| S:3276 E:3280 ||| DT
present  ||| S:3280 E:3288 ||| JJ
report ||| S:3288 E:3294 ||| NN
,  ||| S:3294 E:3296 ||| ,
we  ||| S:3296 E:3299 ||| PRP
have  ||| S:3299 E:3304 ||| VBP
identified  ||| S:3304 E:3315 ||| VBN
two  ||| S:3315 E:3319 ||| CD
novel  ||| S:3319 E:3333 ||| NN
extracellular  ||| S:3333 E:3347 ||| VBZ
matrix  ||| S:3347 E:3354 ||| JJ
proteins  ||| S:3354 E:3363 ||| NNS
latent  ||| S:3363 E:3370 ||| VBP
transforming  ||| S:3370 E:3383 ||| VBG
growth  ||| S:3383 E:3398 ||| NN
factor  ||| S:3398 E:3405 ||| NN
β-binding  ||| S:3405 E:3415 ||| JJ
protein  ||| S:3415 E:3423 ||| NN
3  ||| S:3423 E:3425 ||| CD
and  ||| S:3425 E:3429 ||| CC
fibulin-1C  ||| S:3429 E:3440 ||| CD
that  ||| S:3440 E:3445 ||| IN
interact  ||| S:3445 E:3462 ||| NN
with  ||| S:3462 E:3467 ||| IN
the  ||| S:3467 E:3471 ||| DT
extracellular  ||| S:3471 E:3485 ||| JJ
domain  ||| S:3485 E:3492 ||| NN
of  ||| S:3492 E:3495 ||| IN
proHB-EGF ||| S:3495 E:3504 ||| JJ
.  ||| S:3504 E:3528 ||| .
Results  ||| S:3528 E:3536 ||| NNS
and  ||| S:3536 E:3540 ||| CC
Discussion  ||| S:3540 E:3570 ||| NNP
Yeast  ||| S:3570 E:3576 ||| NNP
two-hybrid  ||| S:3576 E:3587 ||| JJ
screening  ||| S:3587 E:3597 ||| NN
of  ||| S:3597 E:3600 ||| IN
the  ||| S:3600 E:3604 ||| DT
monkey  ||| S:3604 E:3611 ||| JJ
cDNA  ||| S:3611 E:3626 ||| JJ
library  ||| S:3626 E:3634 ||| NN
using  ||| S:3634 E:3640 ||| VBG
the  ||| S:3640 E:3644 ||| DT
extracellular  ||| S:3644 E:3658 ||| JJ
domain  ||| S:3658 E:3665 ||| NN
of  ||| S:3665 E:3668 ||| IN
proHB-EGF  ||| S:3668 E:3678 ||| JJ
as  ||| S:3678 E:3691 ||| IN
the  ||| S:3691 E:3695 ||| DT
bait  ||| S:3695 E:3700 ||| JJ
fusion  ||| S:3700 E:3717 ||| NN
The  ||| S:3717 E:3721 ||| DT
initial  ||| S:3721 E:3729 ||| JJ
screening  ||| S:3729 E:3739 ||| NN
of  ||| S:3739 E:3742 ||| IN
≈  ||| S:3742 E:3744 ||| CD
3  ||| S:3744 E:3746 ||| CD
×  ||| S:3746 E:3748 ||| CD
10  ||| S:3748 E:3751 ||| CD
6clones  ||| S:3751 E:3759 ||| CD
of  ||| S:3759 E:3762 ||| IN
the  ||| S:3762 E:3776 ||| DT
monkey  ||| S:3776 E:3783 ||| JJ
cDNA  ||| S:3783 E:3788 ||| JJ
library  ||| S:3788 E:3796 ||| NN
with  ||| S:3796 E:3801 ||| IN
the  ||| S:3801 E:3805 ||| DT
bait  ||| S:3805 E:3810 ||| JJ
fusion  ||| S:3810 E:3817 ||| NN
of  ||| S:3817 E:3820 ||| IN
GAL4  ||| S:3820 E:3825 ||| CD
binding  ||| S:3825 E:3843 ||| JJ
domain  ||| S:3843 E:3850 ||| NN
fused  ||| S:3850 E:3856 ||| NN
to  ||| S:3856 E:3859 ||| TO
the  ||| S:3859 E:3863 ||| DT
extracellular  ||| S:3863 E:3877 ||| JJ
domain  ||| S:3877 E:3884 ||| NN
of  ||| S:3884 E:3887 ||| IN
proHB-EGF  ||| S:3887 E:3907 ||| NNP
yielded  ||| S:3907 E:3915 ||| VBD
294  ||| S:3915 E:3919 ||| CD
colonies  ||| S:3919 E:3928 ||| NNS
that  ||| S:3928 E:3933 ||| WDT
were  ||| S:3933 E:3938 ||| VBD
able  ||| S:3938 E:3943 ||| JJ
to  ||| S:3943 E:3946 ||| TO
grow  ||| S:3946 E:3951 ||| VB
on  ||| S:3951 E:3954 ||| IN
Trp  ||| S:3954 E:3958 ||| NNP
-His  ||| S:3958 E:3973 ||| NNP
-Leu  ||| S:3973 E:3978 ||| NNP
-media  ||| S:3978 E:3985 ||| NNP
and  ||| S:3985 E:3989 ||| CC
that  ||| S:3989 E:3994 ||| WDT
gave  ||| S:3994 E:3999 ||| VBD
positive  ||| S:3999 E:4008 ||| JJ
β-galactosidase  ||| S:4008 E:4034 ||| JJ
activity  ||| S:4034 E:4043 ||| NN
in  ||| S:4043 E:4046 ||| IN
the  ||| S:4046 E:4050 ||| DT
β-galactosidase  ||| S:4050 E:4066 ||| JJ
filter  ||| S:4066 E:4073 ||| JJ
paper  ||| S:4073 E:4079 ||| NN
assay ||| S:4079 E:4084 ||| NN
.  ||| S:4084 E:4086 ||| .
False  ||| S:4086 E:4102 ||| JJ
positives  ||| S:4102 E:4112 ||| NN
were  ||| S:4112 E:4117 ||| VBD
ruled  ||| S:4117 E:4123 ||| VBN
out  ||| S:4123 E:4127 ||| RP
by  ||| S:4127 E:4130 ||| IN
testing  ||| S:4130 E:4138 ||| VBG
the  ||| S:4138 E:4142 ||| DT
β-galactosidase  ||| S:4142 E:4168 ||| JJ
activity  ||| S:4168 E:4177 ||| NN
of  ||| S:4177 E:4180 ||| IN
the  ||| S:4180 E:4184 ||| DT
library  ||| S:4184 E:4192 ||| NN
clone  ||| S:4192 E:4198 ||| VBZ
alone  ||| S:4198 E:4204 ||| RB
or  ||| S:4204 E:4207 ||| CC
the  ||| S:4207 E:4211 ||| DT
library  ||| S:4211 E:4219 ||| NN
clone  ||| S:4219 E:4235 ||| NNS
and  ||| S:4235 E:4239 ||| CC
the  ||| S:4239 E:4243 ||| DT
GAL4  ||| S:4243 E:4248 ||| NNP
DNA  ||| S:4248 E:4252 ||| NNP
binding  ||| S:4252 E:4260 ||| JJ
domain  ||| S:4260 E:4267 ||| NN
plasmid  ||| S:4267 E:4275 ||| NNS
vector  ||| S:4275 E:4282 ||| VBP
together  ||| S:4282 E:4301 ||| RB
in  ||| S:4301 E:4304 ||| IN
the  ||| S:4304 E:4308 ||| DT
yeast  ||| S:4308 E:4314 ||| NN
host  ||| S:4314 E:4319 ||| NN
strain ||| S:4319 E:4325 ||| NN
.  ||| S:4325 E:4327 ||| .
False  ||| S:4327 E:4333 ||| JJ
positives  ||| S:4333 E:4343 ||| NN
were  ||| S:4343 E:4348 ||| VBD
also  ||| S:4348 E:4353 ||| RB
ruled  ||| S:4353 E:4369 ||| VBN
out  ||| S:4369 E:4373 ||| RP
by  ||| S:4373 E:4376 ||| IN
testing  ||| S:4376 E:4384 ||| VBG
the  ||| S:4384 E:4388 ||| DT
β-galactosidase  ||| S:4388 E:4404 ||| JJ
activity  ||| S:4404 E:4413 ||| NN
of  ||| S:4413 E:4416 ||| IN
the  ||| S:4416 E:4430 ||| DT
library  ||| S:4430 E:4438 ||| NN
clone  ||| S:4438 E:4444 ||| NN
with  ||| S:4444 E:4449 ||| IN
pVA3  ||| S:4449 E:4454 ||| NNP
( ||| S:4454 E:4455 ||| -LRB-
pGBT9  ||| S:4455 E:4461 ||| NNP
with  ||| S:4461 E:4466 ||| IN
a  ||| S:4466 E:4468 ||| DT
cloned  ||| S:4468 E:4475 ||| JJ
insert ||| S:4475 E:4481 ||| NN
) ||| S:4481 E:4482 ||| -RRB-
.  ||| S:4482 E:4484 ||| .
The  ||| S:4484 E:4498 ||| DT
elimination  ||| S:4498 E:4510 ||| NN
of  ||| S:4510 E:4513 ||| IN
these  ||| S:4513 E:4519 ||| DT
false  ||| S:4519 E:4525 ||| JJ
positive  ||| S:4525 E:4534 ||| JJ
colonies  ||| S:4534 E:4543 ||| NNS
from  ||| S:4543 E:4548 ||| IN
the  ||| S:4548 E:4562 ||| DT
initial  ||| S:4562 E:4570 ||| JJ
screening  ||| S:4570 E:4580 ||| NN
of  ||| S:4580 E:4583 ||| IN
the  ||| S:4583 E:4587 ||| DT
cDNA  ||| S:4587 E:4592 ||| JJ
library  ||| S:4592 E:4600 ||| NN
resulted  ||| S:4600 E:4609 ||| VBD
in  ||| S:4609 E:4612 ||| IN
a  ||| S:4612 E:4614 ||| DT
total  ||| S:4614 E:4630 ||| NN
of  ||| S:4630 E:4633 ||| IN
64  ||| S:4633 E:4636 ||| CD
colonies  ||| S:4636 E:4645 ||| NNS
whose  ||| S:4645 E:4651 ||| WP$
library  ||| S:4651 E:4659 ||| NN
clones  ||| S:4659 E:4666 ||| NNS
encoded  ||| S:4666 E:4674 ||| VBP
potentially  ||| S:4674 E:4696 ||| RB
true  ||| S:4696 E:4701 ||| JJ
interacting  ||| S:4701 E:4713 ||| JJ
proteins  ||| S:4713 E:4722 ||| NNS
with  ||| S:4722 E:4727 ||| IN
the  ||| S:4727 E:4731 ||| DT
extracellular  ||| S:4731 E:4745 ||| JJ
domain  ||| S:4745 E:4762 ||| NN
of  ||| S:4762 E:4765 ||| IN
proHB-EGF ||| S:4765 E:4774 ||| JJ
.  ||| S:4774 E:4776 ||| .
Some  ||| S:4776 E:4781 ||| DT
of  ||| S:4781 E:4784 ||| IN
these  ||| S:4784 E:4790 ||| DT
cDNA  ||| S:4790 E:4795 ||| JJ
library  ||| S:4795 E:4803 ||| NN
clones  ||| S:4803 E:4810 ||| NNS
were  ||| S:4810 E:4825 ||| VBD
transformed  ||| S:4825 E:4837 ||| VBN
into  ||| S:4837 E:4842 ||| IN
the  ||| S:4842 E:4846 ||| DT
other  ||| S:4846 E:4852 ||| JJ
yeast  ||| S:4852 E:4858 ||| NN
host  ||| S:4858 E:4863 ||| NN
strain ||| S:4863 E:4869 ||| NN
,  ||| S:4869 E:4871 ||| ,
Y187 ||| S:4871 E:4875 ||| NNP
,  ||| S:4875 E:4877 ||| ,
and  ||| S:4877 E:4891 ||| CC
tested  ||| S:4891 E:4898 ||| VBN
for  ||| S:4898 E:4902 ||| IN
β-galactosidase  ||| S:4902 E:4918 ||| JJ
activity  ||| S:4918 E:4927 ||| NN
as  ||| S:4927 E:4930 ||| IN
a  ||| S:4930 E:4932 ||| DT
further  ||| S:4932 E:4940 ||| JJ
check  ||| S:4940 E:4956 ||| NN
that  ||| S:4956 E:4961 ||| IN
these  ||| S:4961 E:4967 ||| DT
clones  ||| S:4967 E:4974 ||| NNS
did  ||| S:4974 E:4978 ||| VBD
indeed  ||| S:4978 E:4985 ||| RB
contain  ||| S:4985 E:4993 ||| VB
potential  ||| S:4993 E:5013 ||| JJ
protein-interacting  ||| S:5013 E:5033 ||| JJ
partners  ||| S:5033 E:5042 ||| NNS
for  ||| S:5042 E:5046 ||| IN
the  ||| S:5046 E:5050 ||| DT
extracellular  ||| S:5050 E:5064 ||| JJ
domain  ||| S:5064 E:5081 ||| NN
of  ||| S:5081 E:5084 ||| IN
proHB-EGF ||| S:5084 E:5093 ||| JJ
.  ||| S:5093 E:5123 ||| .
Detection  ||| S:5123 E:5133 ||| NNP
of  ||| S:5133 E:5136 ||| IN
the  ||| S:5136 E:5140 ||| DT
physical  ||| S:5140 E:5149 ||| JJ
interactions  ||| S:5149 E:5162 ||| NNS
of  ||| S:5162 E:5165 ||| IN
proHB-EGF  ||| S:5165 E:5185 ||| JJ
with  ||| S:5185 E:5190 ||| IN
CD9  ||| S:5190 E:5194 ||| NNP
antigens  ||| S:5194 E:5213 ||| VBD
The  ||| S:5213 E:5217 ||| DT
membrane-bound  ||| S:5217 E:5232 ||| JJ
precursor  ||| S:5232 E:5242 ||| NN
and  ||| S:5242 E:5246 ||| CC
soluble  ||| S:5246 E:5254 ||| JJ
forms  ||| S:5254 E:5260 ||| NNS
of  ||| S:5260 E:5273 ||| IN
heparin-binding  ||| S:5273 E:5289 ||| JJ
epidermal  ||| S:5289 E:5299 ||| JJ
growth  ||| S:5299 E:5306 ||| NN
factor-like  ||| S:5306 E:5318 ||| JJ
growth  ||| S:5318 E:5335 ||| NN
factor  ||| S:5335 E:5342 ||| NN
( ||| S:5342 E:5343 ||| -LRB-
HB-EGF ||| S:5343 E:5349 ||| NNP
)  ||| S:5349 E:5351 ||| -RRB-
contribute  ||| S:5351 E:5362 ||| VBP
to  ||| S:5362 E:5365 ||| TO
a  ||| S:5365 E:5367 ||| DT
variety  ||| S:5367 E:5375 ||| NN
of  ||| S:5375 E:5378 ||| IN
cellular  ||| S:5378 E:5397 ||| JJ
developmental  ||| S:5397 E:5411 ||| JJ
processes  ||| S:5411 E:5421 ||| NNS
[  ||| S:5421 E:5423 ||| -LRB-
1  ||| S:5423 E:5425 ||| LS
]  ||| S:5425 E:5427 ||| -RRB-
.  ||| S:5427 E:5429 ||| .
The  ||| S:5429 E:5433 ||| DT
observations  ||| S:5433 E:5446 ||| NNS
of  ||| S:5446 E:5459 ||| IN
HB-EGF  ||| S:5459 E:5466 ||| JJ
in  ||| S:5466 E:5469 ||| IN
cell  ||| S:5469 E:5474 ||| NN
and  ||| S:5474 E:5478 ||| CC
tissue  ||| S:5478 E:5485 ||| NN
types  ||| S:5485 E:5491 ||| NNS
have  ||| S:5491 E:5496 ||| VBP
suggested  ||| S:5496 E:5506 ||| VBN
roles  ||| S:5506 E:5512 ||| NNS
for  ||| S:5512 E:5526 ||| IN
HB-EGF  ||| S:5526 E:5533 ||| JJ
in  ||| S:5533 E:5536 ||| IN
numerous  ||| S:5536 E:5545 ||| JJ
cellular  ||| S:5545 E:5554 ||| JJ
and  ||| S:5554 E:5558 ||| CC
tissue  ||| S:5558 E:5565 ||| NN
events  ||| S:5565 E:5572 ||| NNS
such  ||| S:5572 E:5577 ||| JJ
as ||| S:5577 E:5579 ||| IN
:  ||| S:5579 E:5591 ||| :
cell  ||| S:5591 E:5596 ||| NN
movement ||| S:5596 E:5604 ||| NN
,  ||| S:5604 E:5606 ||| ,
extracellular  ||| S:5606 E:5620 ||| JJ
matrix  ||| S:5620 E:5627 ||| JJ
formation ||| S:5627 E:5636 ||| NN
,  ||| S:5636 E:5638 ||| ,
tumor  ||| S:5638 E:5654 ||| NN
formation  ||| S:5654 E:5664 ||| NN
and  ||| S:5664 E:5668 ||| CC
cell  ||| S:5668 E:5673 ||| NN
adherence  ||| S:5673 E:5683 ||| NNS
[  ||| S:5683 E:5685 ||| -LRB-
1  ||| S:5685 E:5687 ||| LS
]  ||| S:5687 E:5689 ||| -RRB-
.  ||| S:5689 E:5691 ||| .
As  ||| S:5691 E:5694 ||| RB
described  ||| S:5694 E:5704 ||| VBN
above ||| S:5704 E:5709 ||| IN
,  ||| S:5709 E:5721 ||| ,
the  ||| S:5721 E:5725 ||| DT
membrane-bound  ||| S:5725 E:5740 ||| JJ
precursor  ||| S:5740 E:5750 ||| NN
of  ||| S:5750 E:5753 ||| IN
HB-EGF  ||| S:5753 E:5760 ||| NNP
( ||| S:5760 E:5761 ||| -LRB-
proHB-EGF ||| S:5761 E:5770 ||| NNP
)  ||| S:5770 E:5772 ||| -RRB-
is  ||| S:5772 E:5785 ||| VBZ
also  ||| S:5785 E:5790 ||| RB
the  ||| S:5790 E:5794 ||| DT
cell-surface  ||| S:5794 E:5807 ||| JJ
receptor  ||| S:5807 E:5816 ||| NN
for  ||| S:5816 E:5820 ||| IN
diphtheria  ||| S:5820 E:5831 ||| JJ
toxin  ||| S:5831 E:5837 ||| NN
( ||| S:5837 E:5838 ||| -LRB-
DT ||| S:5838 E:5840 ||| NNP
)  ||| S:5840 E:5852 ||| -RRB-
in  ||| S:5852 E:5855 ||| IN
DT-sensitive  ||| S:5855 E:5868 ||| JJ
cells  ||| S:5868 E:5874 ||| NNS
[  ||| S:5874 E:5876 ||| -LRB-
2  ||| S:5876 E:5878 ||| LS
]  ||| S:5878 E:5880 ||| -RRB-
.  ||| S:5880 E:5892 ||| .
Previously  ||| S:5892 E:5903 ||| RB
we  ||| S:5903 E:5906 ||| PRP
have  ||| S:5906 E:5911 ||| VBP
examined  ||| S:5911 E:5920 ||| VBN
the  ||| S:5920 E:5924 ||| DT
protein-protein  ||| S:5924 E:5950 ||| JJ
interactions  ||| S:5950 E:5963 ||| NNS
of  ||| S:5963 E:5966 ||| IN
proHB-EGF  ||| S:5966 E:5976 ||| JJ
with  ||| S:5976 E:5981 ||| IN
the  ||| S:5981 E:5985 ||| DT
cell-surface  ||| S:5985 E:5998 ||| JJ
CD9  ||| S:5998 E:6012 ||| CD
antigen  ||| S:6012 E:6020 ||| NNS
[  ||| S:6020 E:6022 ||| -LRB-
9  ||| S:6022 E:6024 ||| CD
]  ||| S:6024 E:6026 ||| -RRB-
.  ||| S:6026 E:6028 ||| .
The  ||| S:6028 E:6032 ||| DT
CD9  ||| S:6032 E:6036 ||| JJ
antigen  ||| S:6036 E:6044 ||| NN
is  ||| S:6044 E:6047 ||| VBZ
found  ||| S:6047 E:6053 ||| VBN
on  ||| S:6053 E:6056 ||| IN
a  ||| S:6056 E:6058 ||| DT
wide  ||| S:6058 E:6073 ||| JJ
variety  ||| S:6073 E:6081 ||| NN
of  ||| S:6081 E:6084 ||| IN
tissue  ||| S:6084 E:6091 ||| NN
and  ||| S:6091 E:6095 ||| CC
cell  ||| S:6095 E:6100 ||| NN
types  ||| S:6100 E:6106 ||| NNS
and  ||| S:6106 E:6110 ||| CC
has  ||| S:6110 E:6114 ||| VBZ
been  ||| S:6114 E:6119 ||| VBN
reported  ||| S:6119 E:6128 ||| VBN
to  ||| S:6128 E:6141 ||| TO
be  ||| S:6141 E:6144 ||| VB
involved  ||| S:6144 E:6153 ||| VBN
in  ||| S:6153 E:6156 ||| IN
such  ||| S:6156 E:6161 ||| JJ
cellular  ||| S:6161 E:6170 ||| JJ
processes  ||| S:6170 E:6180 ||| NNS
as  ||| S:6180 E:6183 ||| IN
B-cell  ||| S:6183 E:6200 ||| JJ
development ||| S:6200 E:6211 ||| NN
,  ||| S:6211 E:6213 ||| ,
cell  ||| S:6213 E:6218 ||| NN
metastasis ||| S:6218 E:6228 ||| NN
,  ||| S:6228 E:6230 ||| ,
platelet  ||| S:6230 E:6239 ||| JJ
activation  ||| S:6239 E:6250 ||| NN
and  ||| S:6250 E:6264 ||| CC
adhesion ||| S:6264 E:6272 ||| NN
,  ||| S:6272 E:6274 ||| ,
and  ||| S:6274 E:6278 ||| CC
cell  ||| S:6278 E:6283 ||| NN
motility  ||| S:6283 E:6292 ||| NNS
[  ||| S:6292 E:6294 ||| -LRB-
14  ||| S:6294 E:6297 ||| CD
15  ||| S:6297 E:6300 ||| CD
]  ||| S:6300 E:6302 ||| -RRB-
.  ||| S:6302 E:6304 ||| .
CD9  ||| S:6304 E:6308 ||| NNP
antigen  ||| S:6308 E:6316 ||| NN
is  ||| S:6316 E:6319 ||| VBZ
a  ||| S:6319 E:6331 ||| DT
member  ||| S:6331 E:6338 ||| NN
of  ||| S:6338 E:6341 ||| IN
the  ||| S:6341 E:6345 ||| DT
tetraspanin  ||| S:6345 E:6357 ||| JJ
superfamily  ||| S:6357 E:6369 ||| NN
and  ||| S:6369 E:6373 ||| CC
consists  ||| S:6373 E:6382 ||| VBZ
of  ||| S:6382 E:6385 ||| IN
two  ||| S:6385 E:6399 ||| CD
extracellular  ||| S:6399 E:6413 ||| NNS
domains  ||| S:6413 E:6421 ||| VBP
sandwiched  ||| S:6421 E:6432 ||| VBN
between  ||| S:6432 E:6440 ||| IN
four  ||| S:6440 E:6455 ||| CD
highly-conserved  ||| S:6455 E:6472 ||| JJ
hydrophobic  ||| S:6472 E:6484 ||| FW
transmembrane  ||| S:6484 E:6498 ||| FW
domains  ||| S:6498 E:6506 ||| FW
[  ||| S:6506 E:6508 ||| -LRB-
14  ||| S:6508 E:6521 ||| CD
15  ||| S:6521 E:6524 ||| CD
]  ||| S:6524 E:6526 ||| -RRB-
.  ||| S:6526 E:6528 ||| .
The  ||| S:6528 E:6532 ||| DT
second  ||| S:6532 E:6539 ||| JJ
extracellular  ||| S:6539 E:6553 ||| JJ
domain  ||| S:6553 E:6560 ||| NN
( ||| S:6560 E:6561 ||| -LRB-
75-130  ||| S:6561 E:6568 ||| FW
amino  ||| S:6568 E:6584 ||| FW
acids ||| S:6584 E:6589 ||| FW
)  ||| S:6589 E:6591 ||| -RRB-
is  ||| S:6591 E:6594 ||| VBZ
larger  ||| S:6594 E:6601 ||| JJR
than  ||| S:6601 E:6606 ||| IN
the  ||| S:6606 E:6610 ||| DT
first  ||| S:6610 E:6616 ||| JJ
extracellular  ||| S:6616 E:6630 ||| JJ
domain  ||| S:6630 E:6647 ||| NN
( ||| S:6647 E:6648 ||| -LRB-
20-27  ||| S:6648 E:6654 ||| FW
amino  ||| S:6654 E:6660 ||| FW
acids ||| S:6660 E:6665 ||| FW
) ||| S:6665 E:6666 ||| -RRB-
.  ||| S:6666 E:6668 ||| .
Short  ||| S:6668 E:6674 ||| JJ
cytoplasmic  ||| S:6674 E:6686 ||| JJ
domains  ||| S:6686 E:6694 ||| NNS
( ||| S:6694 E:6695 ||| -LRB-
5-14  ||| S:6695 E:6710 ||| FW
amino  ||| S:6710 E:6716 ||| FW
acids ||| S:6716 E:6721 ||| FW
)  ||| S:6721 E:6723 ||| -RRB-
are  ||| S:6723 E:6727 ||| VBP
found  ||| S:6727 E:6733 ||| VBN
at  ||| S:6733 E:6736 ||| IN
both  ||| S:6736 E:6741 ||| PDT
the  ||| S:6741 E:6745 ||| DT
amino  ||| S:6745 E:6751 ||| NN
and  ||| S:6751 E:6755 ||| CC
carboxyl  ||| S:6755 E:6774 ||| JJ
termini  ||| S:6774 E:6782 ||| NN
of  ||| S:6782 E:6785 ||| IN
CD9  ||| S:6785 E:6789 ||| NNP
[  ||| S:6789 E:6791 ||| -LRB-
14  ||| S:6791 E:6794 ||| CD
]  ||| S:6794 E:6796 ||| -RRB-
.  ||| S:6796 E:6798 ||| .
As  ||| S:6798 E:6801 ||| RB
reported  ||| S:6801 E:6810 ||| VBD
previously ||| S:6810 E:6820 ||| RB
,  ||| S:6820 E:6822 ||| ,
we  ||| S:6822 E:6825 ||| PRP
used  ||| S:6825 E:6830 ||| VBD
a  ||| S:6830 E:6842 ||| DT
yeast  ||| S:6842 E:6848 ||| NN
two-hybrid  ||| S:6848 E:6859 ||| JJ
system  ||| S:6859 E:6866 ||| NN
and  ||| S:6866 E:6870 ||| CC
observed  ||| S:6870 E:6879 ||| VBD
interaction  ||| S:6879 E:6891 ||| VBN
between  ||| S:6891 E:6909 ||| IN
the  ||| S:6909 E:6913 ||| DT
second  ||| S:6913 E:6920 ||| JJ
extracellular  ||| S:6920 E:6934 ||| JJ
domain  ||| S:6934 E:6941 ||| NN
of  ||| S:6941 E:6944 ||| IN
MkCD9  ||| S:6944 E:6950 ||| NNP
and  ||| S:6950 E:6954 ||| CC
the  ||| S:6954 E:6968 ||| DT
extracellular  ||| S:6968 E:6982 ||| JJ
domain  ||| S:6982 E:6989 ||| NN
of  ||| S:6989 E:6992 ||| IN
proHB-EGF  ||| S:6992 E:7002 ||| NNP
[  ||| S:7002 E:7004 ||| -LRB-
9  ||| S:7004 E:7006 ||| CD
]  ||| S:7006 E:7008 ||| -RRB-
.  ||| S:7008 E:7010 ||| .
However ||| S:7010 E:7017 ||| RB
,  ||| S:7017 E:7029 ||| ,
despite  ||| S:7029 E:7037 ||| IN
repeated  ||| S:7037 E:7046 ||| JJ
attempts ||| S:7046 E:7054 ||| NNS
,  ||| S:7054 E:7056 ||| ,
using  ||| S:7056 E:7062 ||| VBG
the  ||| S:7062 E:7066 ||| DT
yeast  ||| S:7066 E:7072 ||| NN
two-hybrid  ||| S:7072 E:7093 ||| JJ
system ||| S:7093 E:7099 ||| NN
,  ||| S:7099 E:7101 ||| ,
we  ||| S:7101 E:7104 ||| PRP
were  ||| S:7104 E:7109 ||| VBD
unable  ||| S:7109 E:7116 ||| JJ
to  ||| S:7116 E:7119 ||| TO
show  ||| S:7119 E:7124 ||| VB
interaction  ||| S:7124 E:7136 ||| VBN
between  ||| S:7136 E:7144 ||| IN
the  ||| S:7144 E:7158 ||| DT
amino  ||| S:7158 E:7164 ||| JJ
terminal  ||| S:7164 E:7173 ||| NN
cytoplasmic  ||| S:7173 E:7185 ||| NN
domain  ||| S:7185 E:7192 ||| NN
of  ||| S:7192 E:7195 ||| IN
monkey  ||| S:7195 E:7202 ||| JJ
CD9  ||| S:7202 E:7206 ||| NN
and  ||| S:7206 E:7210 ||| CC
the  ||| S:7210 E:7224 ||| DT
cytoplasmic  ||| S:7224 E:7236 ||| JJ
domain  ||| S:7236 E:7243 ||| NN
of  ||| S:7243 E:7246 ||| IN
proHB-EGF ||| S:7246 E:7255 ||| JJ
;  ||| S:7255 E:7257 ||| :
these  ||| S:7257 E:7263 ||| DT
results  ||| S:7263 E:7271 ||| NNS
may  ||| S:7271 E:7285 ||| MD
reflect  ||| S:7285 E:7293 ||| VB
the  ||| S:7293 E:7297 ||| DT
limitation  ||| S:7297 E:7308 ||| NN
of  ||| S:7308 E:7311 ||| IN
the  ||| S:7311 E:7315 ||| DT
yeast  ||| S:7315 E:7321 ||| NN
two-hybrid  ||| S:7321 E:7332 ||| JJ
system  ||| S:7332 E:7339 ||| NN
as  ||| S:7339 E:7352 ||| IN
the  ||| S:7352 E:7356 ||| DT
insert  ||| S:7356 E:7363 ||| JJ
sizes  ||| S:7363 E:7369 ||| NNS
cloned  ||| S:7369 E:7376 ||| VBN
into  ||| S:7376 E:7381 ||| IN
the  ||| S:7381 E:7385 ||| DT
vectors  ||| S:7385 E:7393 ||| NN
may  ||| S:7393 E:7397 ||| MD
be  ||| S:7397 E:7400 ||| VB
too  ||| S:7400 E:7404 ||| RB
small  ||| S:7404 E:7420 ||| JJ
resulting  ||| S:7420 E:7430 ||| VBG
in  ||| S:7430 E:7433 ||| IN
Gal4  ||| S:7433 E:7438 ||| CD
fusion  ||| S:7438 E:7445 ||| NN
proteins  ||| S:7445 E:7454 ||| NNS
whose  ||| S:7454 E:7460 ||| WP$
"test  ||| S:7460 E:7466 ||| JJ
subunits ||| S:7466 E:7474 ||| NN
"  ||| S:7474 E:7486 ||| ``
are  ||| S:7486 E:7490 ||| VBP
masked  ||| S:7490 E:7497 ||| VBN
by  ||| S:7497 E:7500 ||| IN
the  ||| S:7500 E:7504 ||| DT
Gal4  ||| S:7504 E:7509 ||| JJ
subunit ||| S:7509 E:7516 ||| NN
.  ||| S:7516 E:7518 ||| .
This  ||| S:7518 E:7523 ||| DT
would  ||| S:7523 E:7529 ||| MD
result  ||| S:7529 E:7536 ||| VB
in  ||| S:7536 E:7539 ||| IN
the  ||| S:7539 E:7553 ||| DT
fusion  ||| S:7553 E:7560 ||| NN
proteins  ||| S:7560 E:7569 ||| NNS
being  ||| S:7569 E:7575 ||| VBG
unable  ||| S:7575 E:7582 ||| JJ
to  ||| S:7582 E:7585 ||| TO
recognize  ||| S:7585 E:7595 ||| VB
each  ||| S:7595 E:7600 ||| DT
other ||| S:7600 E:7605 ||| JJ
.  ||| S:7605 E:7617 ||| .
The  ||| S:7617 E:7621 ||| DT
results  ||| S:7621 E:7629 ||| NNS
of  ||| S:7629 E:7632 ||| IN
screening  ||| S:7632 E:7642 ||| VBG
the  ||| S:7642 E:7646 ||| DT
monkey  ||| S:7646 E:7653 ||| JJ
cv-1  ||| S:7653 E:7658 ||| CD
cDNA  ||| S:7658 E:7663 ||| JJ
library  ||| S:7663 E:7681 ||| NN
with  ||| S:7681 E:7686 ||| IN
the  ||| S:7686 E:7690 ||| DT
bait  ||| S:7690 E:7695 ||| FW
plasmid  ||| S:7695 E:7703 ||| FW
pGBT9 ||| S:7703 E:7708 ||| FW
/ ||| S:7708 E:7709 ||| FW
DTREx  ||| S:7709 E:7715 ||| NNP
were  ||| S:7715 E:7720 ||| VBD
somewhat  ||| S:7720 E:7739 ||| RB
surprising  ||| S:7739 E:7750 ||| JJ
in  ||| S:7750 E:7753 ||| IN
that  ||| S:7753 E:7758 ||| IN
no  ||| S:7758 E:7761 ||| DT
portions  ||| S:7761 E:7770 ||| NNS
of  ||| S:7770 E:7773 ||| IN
the  ||| S:7773 E:7777 ||| DT
CD9  ||| S:7777 E:7781 ||| JJ
protein  ||| S:7781 E:7789 ||| NN
were  ||| S:7789 E:7804 ||| VBD
represented  ||| S:7804 E:7816 ||| VBN
among  ||| S:7816 E:7822 ||| IN
the  ||| S:7822 E:7826 ||| DT
proteins  ||| S:7826 E:7835 ||| NNS
found  ||| S:7835 E:7841 ||| VBD
to  ||| S:7841 E:7844 ||| TO
interact  ||| S:7844 E:7853 ||| VB
with  ||| S:7853 E:7858 ||| IN
the  ||| S:7858 E:7872 ||| DT
extracellular  ||| S:7872 E:7886 ||| JJ
domain  ||| S:7886 E:7893 ||| NN
of  ||| S:7893 E:7896 ||| IN
proHB-EGF ||| S:7896 E:7905 ||| JJ
.  ||| S:7905 E:7907 ||| .
These  ||| S:7907 E:7913 ||| DT
results  ||| S:7913 E:7921 ||| NNS
may  ||| S:7921 E:7935 ||| MD
reflect  ||| S:7935 E:7943 ||| VB
improper  ||| S:7943 E:7952 ||| JJ
folding  ||| S:7952 E:7960 ||| NN
of  ||| S:7960 E:7963 ||| IN
CD9  ||| S:7963 E:7967 ||| CD
protein  ||| S:7967 E:7975 ||| NN
fragments  ||| S:7975 E:7985 ||| VBZ
encoded  ||| S:7985 E:8003 ||| VBN
by  ||| S:8003 E:8006 ||| IN
cDNA  ||| S:8006 E:8011 ||| JJ
inserts  ||| S:8011 E:8019 ||| NNS
or  ||| S:8019 E:8022 ||| CC
these  ||| S:8022 E:8028 ||| DT
results  ||| S:8028 E:8036 ||| NNS
may  ||| S:8036 E:8040 ||| MD
be  ||| S:8040 E:8043 ||| VB
due  ||| S:8043 E:8047 ||| JJ
to  ||| S:8047 E:8050 ||| TO
under  ||| S:8050 E:8066 ||| IN
representation  ||| S:8066 E:8081 ||| NN
of  ||| S:8081 E:8084 ||| IN
the  ||| S:8084 E:8088 ||| DT
CD9  ||| S:8088 E:8092 ||| JJ
cDNA  ||| S:8092 E:8097 ||| NN
in  ||| S:8097 E:8100 ||| IN
the  ||| S:8100 E:8104 ||| DT
monkey  ||| S:8104 E:8111 ||| JJ
cv-1  ||| S:8111 E:8116 ||| CD
cDNA  ||| S:8116 E:8131 ||| JJ
library ||| S:8131 E:8138 ||| NN
.  ||| S:8138 E:8140 ||| .
It  ||| S:8140 E:8143 ||| PRP
was  ||| S:8143 E:8147 ||| VBD
also  ||| S:8147 E:8152 ||| RB
surprising  ||| S:8152 E:8163 ||| JJ
that  ||| S:8163 E:8168 ||| IN
the  ||| S:8168 E:8172 ||| DT
extracellular  ||| S:8172 E:8196 ||| JJ
portion  ||| S:8196 E:8204 ||| NN
of  ||| S:8204 E:8207 ||| IN
any  ||| S:8207 E:8211 ||| DT
of  ||| S:8211 E:8214 ||| IN
the  ||| S:8214 E:8218 ||| DT
EGF  ||| S:8218 E:8222 ||| NNP
receptor  ||| S:8222 E:8231 ||| NN
proteins  ||| S:8231 E:8240 ||| NNS
was  ||| S:8240 E:8244 ||| VBD
also  ||| S:8244 E:8249 ||| RB
not  ||| S:8249 E:8263 ||| RB
represented  ||| S:8263 E:8275 ||| VBN
among  ||| S:8275 E:8281 ||| IN
the  ||| S:8281 E:8285 ||| DT
proteins  ||| S:8285 E:8294 ||| NNS
found  ||| S:8294 E:8300 ||| VBD
to  ||| S:8300 E:8303 ||| TO
interact  ||| S:8303 E:8312 ||| VB
with  ||| S:8312 E:8317 ||| IN
the  ||| S:8317 E:8331 ||| DT
extracellular  ||| S:8331 E:8345 ||| JJ
domain  ||| S:8345 E:8352 ||| NN
of  ||| S:8352 E:8355 ||| IN
proHB-EGF ||| S:8355 E:8364 ||| NNP
,  ||| S:8364 E:8366 ||| ,
since  ||| S:8366 E:8372 ||| IN
the  ||| S:8372 E:8376 ||| DT
mature  ||| S:8376 E:8393 ||| JJ
protein  ||| S:8393 E:8401 ||| NN
proteolytically  ||| S:8401 E:8417 ||| NN
cleaved  ||| S:8417 E:8425 ||| NN
from  ||| S:8425 E:8430 ||| IN
proHB-EGF  ||| S:8430 E:8440 ||| NNP
( ||| S:8440 E:8441 ||| -LRB-
mHB-EGF ||| S:8441 E:8448 ||| NNP
)  ||| S:8448 E:8460 ||| -RRB-
as  ||| S:8460 E:8463 ||| IN
well  ||| S:8463 E:8468 ||| RB
as  ||| S:8468 E:8471 ||| IN
the  ||| S:8471 E:8475 ||| DT
membrane  ||| S:8475 E:8484 ||| JJ
bound  ||| S:8484 E:8490 ||| JJ
form  ||| S:8490 E:8495 ||| NN
are  ||| S:8495 E:8499 ||| VBP
known  ||| S:8499 E:8505 ||| VBN
to  ||| S:8505 E:8508 ||| TO
interact  ||| S:8508 E:8527 ||| VB
with  ||| S:8527 E:8532 ||| IN
the  ||| S:8532 E:8536 ||| DT
EGF  ||| S:8536 E:8540 ||| NNP
receptor ||| S:8540 E:8548 ||| NN
.  ||| S:8548 E:8578 ||| .
The  ||| S:8578 E:8582 ||| DT
extracellular  ||| S:8582 E:8596 ||| JJ
domain  ||| S:8596 E:8603 ||| NN
of  ||| S:8603 E:8606 ||| IN
proHB-EGF  ||| S:8606 E:8616 ||| JJ
interacts  ||| S:8616 E:8636 ||| NN
with  ||| S:8636 E:8641 ||| IN
monkey  ||| S:8641 E:8648 ||| CD
LTBP-3  ||| S:8648 E:8665 ||| CD
The  ||| S:8665 E:8669 ||| DT
positive  ||| S:8669 E:8678 ||| JJ
interaction  ||| S:8678 E:8690 ||| NN
of  ||| S:8690 E:8693 ||| IN
the  ||| S:8693 E:8697 ||| DT
fragment  ||| S:8697 E:8706 ||| NN
of  ||| S:8706 E:8709 ||| IN
the  ||| S:8709 E:8713 ||| DT
latent  ||| S:8713 E:8730 ||| JJ
transforming  ||| S:8730 E:8743 ||| JJ
growth  ||| S:8743 E:8750 ||| NN
factor  ||| S:8750 E:8757 ||| NN
β-binding  ||| S:8757 E:8767 ||| NNP
protein-3  ||| S:8767 E:8777 ||| NNP
( ||| S:8777 E:8778 ||| -LRB-
LTBP-3 ||| S:8778 E:8784 ||| NNP
)  ||| S:8784 E:8796 ||| -RRB-
with  ||| S:8796 E:8801 ||| IN
the  ||| S:8801 E:8805 ||| DT
extracellular  ||| S:8805 E:8819 ||| JJ
domain  ||| S:8819 E:8826 ||| NN
of  ||| S:8826 E:8829 ||| IN
proHB-EGF  ||| S:8829 E:8839 ||| NNP
was  ||| S:8839 E:8843 ||| VBD
of  ||| S:8843 E:8846 ||| IN
great  ||| S:8846 E:8862 ||| JJ
interest  ||| S:8862 E:8871 ||| NN
( ||| S:8871 E:8872 ||| -LRB-
Additional  ||| S:8872 E:8883 ||| JJ
file  ||| S:8883 E:8888 ||| NN
1 ||| S:8888 E:8889 ||| CD
) ||| S:8889 E:8890 ||| -RRB-
.  ||| S:8890 E:8892 ||| .
Recently  ||| S:8892 E:8901 ||| RB
it  ||| S:8901 E:8904 ||| PRP
has  ||| S:8904 E:8908 ||| VBZ
been  ||| S:8908 E:8923 ||| VBN
reported  ||| S:8923 E:8932 ||| VBN
that  ||| S:8932 E:8937 ||| IN
treatment  ||| S:8937 E:8947 ||| NN
of  ||| S:8947 E:8950 ||| IN
EGF-responsive ||| S:8950 E:8964 ||| NNP
,  ||| S:8964 E:8966 ||| ,
nontransformed  ||| S:8966 E:8991 ||| FW
rat  ||| S:8991 E:8995 ||| FW
intestinal  ||| S:8995 E:9006 ||| FW
crypt  ||| S:9006 E:9012 ||| FW
cell  ||| S:9012 E:9017 ||| NN
line  ||| S:9017 E:9022 ||| NN
RIE-1  ||| S:9022 E:9028 ||| CD
cells  ||| S:9028 E:9034 ||| NNS
with  ||| S:9034 E:9039 ||| IN
TGF-β  ||| S:9039 E:9055 ||| NNP
resulted  ||| S:9055 E:9064 ||| VBD
in  ||| S:9064 E:9067 ||| IN
an  ||| S:9067 E:9070 ||| DT
increased  ||| S:9070 E:9080 ||| JJ
level  ||| S:9080 E:9086 ||| NN
of  ||| S:9086 E:9089 ||| IN
expression  ||| S:9089 E:9100 ||| NN
of  ||| S:9100 E:9103 ||| IN
HB-EGF  ||| S:9103 E:9110 ||| NNP
[  ||| S:9110 E:9122 ||| -LRB-
16  ||| S:9122 E:9125 ||| CD
]  ||| S:9125 E:9127 ||| -RRB-
.  ||| S:9127 E:9129 ||| .
LTBP-3  ||| S:9129 E:9136 ||| NNP
is  ||| S:9136 E:9139 ||| VBZ
a  ||| S:9139 E:9141 ||| DT
protein  ||| S:9141 E:9149 ||| NN
that  ||| S:9149 E:9154 ||| WDT
is  ||| S:9154 E:9157 ||| VBZ
ubiquitous  ||| S:9157 E:9168 ||| VBN
in  ||| S:9168 E:9171 ||| IN
tissues  ||| S:9171 E:9189 ||| NNS
and  ||| S:9189 E:9193 ||| CC
cells ||| S:9193 E:9198 ||| NNS
.  ||| S:9198 E:9200 ||| .
Human  ||| S:9200 E:9206 ||| NNP
LTBP-3  ||| S:9206 E:9213 ||| NNP
( ||| S:9213 E:9214 ||| -LRB-
Fig.  ||| S:9214 E:9219 ||| CD
1 ||| S:9219 E:9220 ||| CD
)  ||| S:9220 E:9222 ||| -RRB-
and  ||| S:9222 E:9226 ||| CC
mouse  ||| S:9226 E:9232 ||| CD
LTBP-3  ||| S:9232 E:9239 ||| CD
contain  ||| S:9239 E:9257 ||| CD
1242  ||| S:9257 E:9262 ||| CD
and  ||| S:9262 E:9266 ||| CC
1251  ||| S:9266 E:9271 ||| CD
amino  ||| S:9271 E:9277 ||| CD
acids ||| S:9277 E:9282 ||| NNS
,  ||| S:9282 E:9284 ||| ,
respectively ||| S:9284 E:9296 ||| RB
,  ||| S:9296 E:9298 ||| ,
and  ||| S:9298 E:9302 ||| CC
each  ||| S:9302 E:9307 ||| DT
protein  ||| S:9307 E:9325 ||| NN
has  ||| S:9325 E:9329 ||| VBZ
five  ||| S:9329 E:9334 ||| CD
structural  ||| S:9334 E:9345 ||| JJ
domains ||| S:9345 E:9352 ||| NN
.  ||| S:9352 E:9354 ||| .
Each  ||| S:9354 E:9359 ||| DT
has  ||| S:9359 E:9363 ||| VBZ
a  ||| S:9363 E:9365 ||| DT
signal  ||| S:9365 E:9372 ||| NN
sequence  ||| S:9372 E:9391 ||| NN
( ||| S:9391 E:9392 ||| -LRB-
55  ||| S:9392 E:9395 ||| CD
amino  ||| S:9395 E:9401 ||| CD
acids  ||| S:9401 E:9407 ||| NNS
and  ||| S:9407 E:9411 ||| CC
49 ||| S:9411 E:9413 ||| CD
,  ||| S:9413 E:9415 ||| ,
respectively ||| S:9415 E:9427 ||| RB
) ||| S:9427 E:9428 ||| -RRB-
,  ||| S:9428 E:9430 ||| ,
a  ||| S:9430 E:9432 ||| DT
second  ||| S:9432 E:9439 ||| JJ
domain  ||| S:9439 E:9456 ||| NN
containing  ||| S:9456 E:9467 ||| VBG
an  ||| S:9467 E:9470 ||| DT
EGF-like  ||| S:9470 E:9479 ||| JJ
repeat ||| S:9479 E:9485 ||| NN
,  ||| S:9485 E:9487 ||| ,
a  ||| S:9487 E:9489 ||| DT
proline ||| S:9489 E:9496 ||| JJ
/ ||| S:9496 E:9497 ||| CD
glycine  ||| S:9497 E:9505 ||| CD
rich  ||| S:9505 E:9520 ||| JJ
region ||| S:9520 E:9526 ||| NN
,  ||| S:9526 E:9528 ||| ,
a  ||| S:9528 E:9530 ||| DT
fibrillin  ||| S:9530 E:9540 ||| JJ
motif  ||| S:9540 E:9546 ||| NNS
[  ||| S:9546 E:9548 ||| -LRB-
17  ||| S:9548 E:9551 ||| CD
]  ||| S:9551 E:9553 ||| -RRB-
,  ||| S:9553 E:9555 ||| ,
an  ||| S:9555 E:9558 ||| DT
EGF  ||| S:9558 E:9562 ||| NNP
calcium-binding  ||| S:9562 E:9588 ||| JJ
repeat ||| S:9588 E:9594 ||| NN
,  ||| S:9594 E:9596 ||| ,
and  ||| S:9596 E:9600 ||| CC
a  ||| S:9600 E:9602 ||| DT
TGF-β  ||| S:9602 E:9608 ||| JJ
repeat  ||| S:9608 E:9615 ||| NN
( ||| S:9615 E:9616 ||| -LRB-
390  ||| S:9616 E:9620 ||| CD
and  ||| S:9620 E:9624 ||| CC
389  ||| S:9624 E:9628 ||| CD
amino  ||| S:9628 E:9634 ||| CD
acids ||| S:9634 E:9639 ||| NNS
,  ||| S:9639 E:9651 ||| ,
respectively ||| S:9651 E:9663 ||| RB
) ||| S:9663 E:9664 ||| -RRB-
,  ||| S:9664 E:9666 ||| ,
a  ||| S:9666 E:9668 ||| DT
third  ||| S:9668 E:9674 ||| JJ
domain  ||| S:9674 E:9681 ||| NN
containing  ||| S:9681 E:9692 ||| VBG
a  ||| S:9692 E:9704 ||| DT
proline ||| S:9704 E:9711 ||| JJ
/ ||| S:9711 E:9712 ||| CD
glycine  ||| S:9712 E:9720 ||| CD
rich  ||| S:9720 E:9725 ||| JJ
region  ||| S:9725 E:9732 ||| NN
( ||| S:9732 E:9733 ||| -LRB-
113  ||| S:9733 E:9737 ||| CD
and  ||| S:9737 E:9741 ||| CC
111  ||| S:9741 E:9745 ||| CD
amino  ||| S:9745 E:9751 ||| CD
acids ||| S:9751 E:9756 ||| NNS
,  ||| S:9756 E:9768 ||| ,
respectively ||| S:9768 E:9780 ||| RB
) ||| S:9780 E:9781 ||| -RRB-
,  ||| S:9781 E:9783 ||| ,
a  ||| S:9783 E:9785 ||| DT
fourth  ||| S:9785 E:9792 ||| JJ
domain  ||| S:9792 E:9799 ||| NN
containing  ||| S:9799 E:9810 ||| VBG
numerous  ||| S:9810 E:9829 ||| JJ
calcium-binding  ||| S:9829 E:9845 ||| JJ
type  ||| S:9845 E:9850 ||| NN
II  ||| S:9850 E:9853 ||| NNP
EGF-like  ||| S:9853 E:9862 ||| JJ
modules  ||| S:9862 E:9880 ||| NNS
( ||| S:9880 E:9881 ||| -LRB-
D ||| S:9881 E:9882 ||| NNP
/ ||| S:9882 E:9883 ||| NNP
N ||| S:9883 E:9884 ||| NNP
) ||| S:9884 E:9885 ||| -RRB-
( ||| S:9885 E:9886 ||| -LRB-
I ||| S:9886 E:9887 ||| NNP
/ ||| S:9887 E:9888 ||| NNP
V ||| S:9888 E:9889 ||| NNP
) ||| S:9889 E:9890 ||| -RRB-
( ||| S:9890 E:9891 ||| -LRB-
D ||| S:9891 E:9892 ||| NNP
/ ||| S:9892 E:9893 ||| NNP
N ||| S:9893 E:9894 ||| NNP
) ||| S:9894 E:9895 ||| -RRB-
( ||| S:9895 E:9896 ||| -LRB-
E ||| S:9896 E:9897 ||| NNP
/ ||| S:9897 E:9898 ||| NNP
D ||| S:9898 E:9899 ||| NNP
) ||| S:9899 E:9900 ||| -RRB-
C  ||| S:9900 E:9913 ||| NNP
1  ||| S:9913 E:9915 ||| CD
( ||| S:9915 E:9916 ||| -LRB-
678  ||| S:9916 E:9920 ||| CD
and  ||| S:9920 E:9924 ||| CC
677  ||| S:9924 E:9928 ||| CD
amino  ||| S:9928 E:9934 ||| CD
acids ||| S:9934 E:9939 ||| NNS
,  ||| S:9939 E:9951 ||| ,
respectively ||| S:9951 E:9963 ||| RB
)  ||| S:9963 E:9965 ||| -RRB-
and  ||| S:9965 E:9969 ||| CC
a  ||| S:9969 E:9971 ||| DT
fifth  ||| S:9971 E:9977 ||| JJ
carboxyl-terminal  ||| S:9977 E:9995 ||| JJ
domain  ||| S:9995 E:10002 ||| NN
( ||| S:10002 E:10003 ||| -LRB-
5  ||| S:10003 E:10005 ||| CD
and  ||| S:10005 E:10019 ||| CC
21  ||| S:10019 E:10022 ||| CD
amino  ||| S:10022 E:10028 ||| CD
acids ||| S:10028 E:10033 ||| NNS
,  ||| S:10033 E:10035 ||| ,
respectively ||| S:10035 E:10047 ||| RB
)  ||| S:10047 E:10049 ||| -RRB-
( ||| S:10049 E:10050 ||| -LRB-
human  ||| S:10050 E:10056 ||| JJ
LTBP-3  ||| S:10056 E:10063 ||| CD
information  ||| S:10063 E:10085 ||| NN
was  ||| S:10085 E:10089 ||| VBD
obtained  ||| S:10089 E:10098 ||| VBN
from  ||| S:10098 E:10103 ||| IN
the  ||| S:10103 E:10107 ||| DT
GenBank  ||| S:10107 E:10115 ||| JJ
database  ||| S:10115 E:10124 ||| NN
accession  ||| S:10124 E:10134 ||| VBZ
no ||| S:10134 E:10136 ||| RB
.  ||| S:10136 E:10148 ||| .
AF135960.2 ||| S:10148 E:10158 ||| NNP
;  ||| S:10158 E:10160 ||| :
[  ||| S:10160 E:10162 ||| -LRB-
18  ||| S:10162 E:10165 ||| CD
]  ||| S:10165 E:10167 ||| CD
) ||| S:10167 E:10168 ||| -RRB-
.  ||| S:10168 E:10170 ||| .
Colony  ||| S:10170 E:10177 ||| NN
hybridization  ||| S:10177 E:10191 ||| NN
experiments  ||| S:10191 E:10213 ||| NNS
using  ||| S:10213 E:10219 ||| VBG
the  ||| S:10219 E:10223 ||| DT
LTBP-3  ||| S:10223 E:10230 ||| JJ
probe  ||| S:10230 E:10236 ||| NN
( ||| S:10236 E:10237 ||| -LRB-
see  ||| S:10237 E:10241 ||| VB
materials  ||| S:10241 E:10251 ||| NNS
and  ||| S:10251 E:10255 ||| CC
methods ||| S:10255 E:10262 ||| NNS
)  ||| S:10262 E:10264 ||| -RRB-
and  ||| S:10264 E:10278 ||| CC
the  ||| S:10278 E:10282 ||| DT
monkey  ||| S:10282 E:10289 ||| JJ
cv-1  ||| S:10289 E:10294 ||| CD
cDNA  ||| S:10294 E:10299 ||| JJ
library  ||| S:10299 E:10307 ||| NN
yielded  ||| S:10307 E:10315 ||| VBD
a  ||| S:10315 E:10317 ||| DT
set  ||| S:10317 E:10321 ||| NN
of  ||| S:10321 E:10324 ||| IN
six  ||| S:10324 E:10328 ||| CD
( ||| S:10328 E:10329 ||| -LRB-
two  ||| S:10329 E:10343 ||| CD
identical ||| S:10343 E:10352 ||| CD
)  ||| S:10352 E:10354 ||| -RRB-
overlapping  ||| S:10354 E:10366 ||| JJ
clones  ||| S:10366 E:10373 ||| NNS
( ||| S:10373 E:10374 ||| -LRB-
Fig.  ||| S:10374 E:10379 ||| CD
2 ||| S:10379 E:10380 ||| CD
) ||| S:10380 E:10381 ||| -RRB-
.  ||| S:10381 E:10383 ||| .
The  ||| S:10383 E:10387 ||| DT
amino  ||| S:10387 E:10393 ||| JJ
acid  ||| S:10393 E:10408 ||| NN
sequence  ||| S:10408 E:10417 ||| VBZ
derived  ||| S:10417 E:10425 ||| VBN
from  ||| S:10425 E:10430 ||| IN
the  ||| S:10430 E:10434 ||| DT
nucleotide  ||| S:10434 E:10445 ||| JJ
sequence  ||| S:10445 E:10454 ||| NN
obtained  ||| S:10454 E:10473 ||| VBN
for  ||| S:10473 E:10477 ||| IN
the  ||| S:10477 E:10481 ||| DT
monkey  ||| S:10481 E:10488 ||| FW
LTBP-3  ||| S:10488 E:10495 ||| FW
sequence  ||| S:10495 E:10504 ||| FW
( ||| S:10504 E:10505 ||| -LRB-
GenBank  ||| S:10505 E:10513 ||| JJ
accession  ||| S:10513 E:10523 ||| JJ
number  ||| S:10523 E:10540 ||| NN
AF395658 ||| S:10540 E:10548 ||| CD
)  ||| S:10548 E:10550 ||| -RRB-
shows  ||| S:10550 E:10556 ||| VBZ
it  ||| S:10556 E:10559 ||| PRP
to  ||| S:10559 E:10562 ||| TO
share  ||| S:10562 E:10568 ||| VB
98.6  ||| S:10568 E:10573 ||| CD
%  ||| S:10573 E:10575 ||| NN
identity  ||| S:10575 E:10584 ||| NN
with  ||| S:10584 E:10589 ||| IN
the  ||| S:10589 E:10603 ||| DT
human  ||| S:10603 E:10609 ||| JJ
LTBP-3  ||| S:10609 E:10616 ||| FW
amino  ||| S:10616 E:10622 ||| FW
acid  ||| S:10622 E:10627 ||| FW
sequence  ||| S:10627 E:10636 ||| FW
( ||| S:10636 E:10637 ||| -LRB-
GenBank  ||| S:10637 E:10645 ||| JJ
accession  ||| S:10645 E:10665 ||| JJ
number  ||| S:10665 E:10672 ||| NN
NP_066548 ||| S:10672 E:10681 ||| CD
)  ||| S:10681 E:10683 ||| -RRB-
and  ||| S:10683 E:10687 ||| CC
86.7  ||| S:10687 E:10692 ||| CD
%  ||| S:10692 E:10694 ||| NN
identity  ||| S:10694 E:10703 ||| NN
with  ||| S:10703 E:10708 ||| IN
the  ||| S:10708 E:10712 ||| DT
mouse  ||| S:10712 E:10728 ||| FW
LTBP-3  ||| S:10728 E:10735 ||| FW
amino  ||| S:10735 E:10741 ||| FW
acid  ||| S:10741 E:10746 ||| FW
sequence  ||| S:10746 E:10755 ||| FW
( ||| S:10755 E:10756 ||| -LRB-
GenBank  ||| S:10756 E:10764 ||| JJ
accession  ||| S:10764 E:10774 ||| JJ
number  ||| S:10774 E:10791 ||| NN
NP_032546 ||| S:10791 E:10800 ||| CD
) ||| S:10800 E:10801 ||| -RRB-
.  ||| S:10801 E:10813 ||| .
The  ||| S:10813 E:10817 ||| DT
presence  ||| S:10817 E:10826 ||| NN
of  ||| S:10826 E:10829 ||| IN
the  ||| S:10829 E:10833 ||| DT
calcium-binding  ||| S:10833 E:10849 ||| JJ
EGF-like  ||| S:10849 E:10858 ||| JJ
modules  ||| S:10858 E:10876 ||| NN
in  ||| S:10876 E:10879 ||| IN
monkey  ||| S:10879 E:10886 ||| JJ
LTBP-3  ||| S:10886 E:10893 ||| NN
is  ||| S:10893 E:10896 ||| VBZ
noteworthy ||| S:10896 E:10906 ||| VBN
.  ||| S:10906 E:10908 ||| .
It  ||| S:10908 E:10911 ||| PRP
is  ||| S:10911 E:10914 ||| VBZ
well  ||| S:10914 E:10919 ||| RB
established  ||| S:10919 E:10941 ||| VBN
that  ||| S:10941 E:10946 ||| IN
EGF-like  ||| S:10946 E:10955 ||| JJ
modules  ||| S:10955 E:10963 ||| NNS
are  ||| S:10963 E:10967 ||| VBP
important  ||| S:10967 E:10977 ||| JJ
structural  ||| S:10977 E:10988 ||| JJ
features  ||| S:10988 E:11007 ||| NNS
found  ||| S:11007 E:11013 ||| VBD
in  ||| S:11013 E:11016 ||| IN
many  ||| S:11016 E:11021 ||| JJ
extracellular  ||| S:11021 E:11035 ||| JJ
proteins  ||| S:11035 E:11044 ||| NNS
and  ||| S:11044 E:11048 ||| CC
that  ||| S:11048 E:11053 ||| IN
these  ||| S:11053 E:11069 ||| DT
modules  ||| S:11069 E:11077 ||| NNS
enable  ||| S:11077 E:11084 ||| VBP
numerous  ||| S:11084 E:11093 ||| JJ
protein  ||| S:11093 E:11101 ||| NN
: ||| S:11101 E:11102 ||| :
protein  ||| S:11102 E:11110 ||| NN
interactions ||| S:11110 E:11122 ||| NNS
;  ||| S:11122 E:11134 ||| :
the  ||| S:11134 E:11138 ||| DT
binding  ||| S:11138 E:11146 ||| NN
of  ||| S:11146 E:11149 ||| IN
EGF-like  ||| S:11149 E:11158 ||| JJ
modules  ||| S:11158 E:11166 ||| NN
in  ||| S:11166 E:11169 ||| IN
laminin  ||| S:11169 E:11177 ||| VBG
to  ||| S:11177 E:11180 ||| TO
nidogen  ||| S:11180 E:11188 ||| VB
[  ||| S:11188 E:11200 ||| -LRB-
19  ||| S:11200 E:11203 ||| CD
]  ||| S:11203 E:11205 ||| -RRB-
and  ||| S:11205 E:11209 ||| CC
the  ||| S:11209 E:11213 ||| DT
interaction  ||| S:11213 E:11225 ||| NN
of  ||| S:11225 E:11228 ||| IN
EGF-like  ||| S:11228 E:11237 ||| JJ
modules  ||| S:11237 E:11245 ||| NN
within  ||| S:11245 E:11262 ||| IN
fibrillin  ||| S:11262 E:11272 ||| JJ
monomers  ||| S:11272 E:11281 ||| NNS
[  ||| S:11281 E:11283 ||| -LRB-
20  ||| S:11283 E:11286 ||| CD
21  ||| S:11286 E:11289 ||| CD
]  ||| S:11289 E:11291 ||| -RRB-
.  ||| S:11291 E:11293 ||| .
Calcium  ||| S:11293 E:11301 ||| NNP
may  ||| S:11301 E:11305 ||| MD
be  ||| S:11305 E:11308 ||| VB
required  ||| S:11308 E:11327 ||| VBN
for  ||| S:11327 E:11331 ||| IN
some  ||| S:11331 E:11336 ||| DT
of  ||| S:11336 E:11339 ||| IN
these  ||| S:11339 E:11345 ||| DT
protein  ||| S:11345 E:11353 ||| NN
interactions ||| S:11353 E:11365 ||| NNS
.  ||| S:11365 E:11377 ||| .
At  ||| S:11377 E:11380 ||| IN
the  ||| S:11380 E:11384 ||| DT
time  ||| S:11384 E:11389 ||| NN
of  ||| S:11389 E:11392 ||| IN
writing ||| S:11392 E:11399 ||| NN
,  ||| S:11399 E:11401 ||| ,
there  ||| S:11401 E:11407 ||| EX
have  ||| S:11407 E:11412 ||| VBP
not  ||| S:11412 E:11416 ||| RB
been  ||| S:11416 E:11421 ||| VBN
any  ||| S:11421 E:11435 ||| DT
reported  ||| S:11435 E:11444 ||| JJ
interactions  ||| S:11444 E:11457 ||| NNS
of  ||| S:11457 E:11460 ||| IN
these  ||| S:11460 E:11466 ||| DT
EGF-like  ||| S:11466 E:11475 ||| JJ
modules  ||| S:11475 E:11483 ||| NN
in  ||| S:11483 E:11486 ||| IN
LTBP-3  ||| S:11486 E:11503 ||| CD
proteins  ||| S:11503 E:11512 ||| NNS
with  ||| S:11512 E:11517 ||| IN
specific  ||| S:11517 E:11526 ||| JJ
proteins ||| S:11526 E:11534 ||| NNS
.  ||| S:11534 E:11536 ||| .
It  ||| S:11536 E:11539 ||| PRP
is  ||| S:11539 E:11542 ||| VBZ
interesting  ||| S:11542 E:11554 ||| JJ
that  ||| S:11554 E:11569 ||| IN
the  ||| S:11569 E:11573 ||| DT
combination  ||| S:11573 E:11585 ||| NN
of  ||| S:11585 E:11588 ||| IN
colony  ||| S:11588 E:11595 ||| NN
hybridization  ||| S:11595 E:11609 ||| NNS
and  ||| S:11609 E:11613 ||| CC
yeast  ||| S:11613 E:11629 ||| JJ
two-hybrid  ||| S:11629 E:11640 ||| JJ
screens  ||| S:11640 E:11648 ||| NNS
used  ||| S:11648 E:11653 ||| VBN
in  ||| S:11653 E:11656 ||| IN
this  ||| S:11656 E:11661 ||| DT
study  ||| S:11661 E:11667 ||| NN
to  ||| S:11667 E:11670 ||| TO
identify  ||| S:11670 E:11689 ||| VB
proteins  ||| S:11689 E:11698 ||| NNS
that  ||| S:11698 E:11703 ||| IN
interact  ||| S:11703 E:11712 ||| NN
with  ||| S:11712 E:11717 ||| IN
the  ||| S:11717 E:11721 ||| DT
extracellular  ||| S:11721 E:11735 ||| JJ
domain  ||| S:11735 E:11742 ||| NN
of  ||| S:11742 E:11755 ||| IN
proHB-EGF  ||| S:11755 E:11765 ||| NNP
yielded  ||| S:11765 E:11773 ||| VBD
independent  ||| S:11773 E:11785 ||| JJ
GAL4-LTBP-3  ||| S:11785 E:11797 ||| CD
fusion  ||| S:11797 E:11804 ||| NN
proteins  ||| S:11804 E:11823 ||| NNS
that  ||| S:11823 E:11828 ||| IN
all  ||| S:11828 E:11832 ||| DT
contained  ||| S:11832 E:11842 ||| VBN
these  ||| S:11842 E:11848 ||| DT
calcium-binding  ||| S:11848 E:11864 ||| JJ
type  ||| S:11864 E:11869 ||| NN
II  ||| S:11869 E:11872 ||| NNP
EGF-like  ||| S:11872 E:11891 ||| JJ
domains  ||| S:11891 E:11899 ||| NNS
( ||| S:11899 E:11900 ||| -LRB-
Fig.  ||| S:11900 E:11905 ||| CD
2 ||| S:11905 E:11906 ||| CD
) ||| S:11906 E:11907 ||| -RRB-
.  ||| S:11907 E:11909 ||| .
A  ||| S:11909 E:11911 ||| DT
constructed  ||| S:11911 E:11923 ||| JJ
clone ||| S:11923 E:11928 ||| NN
,  ||| S:11928 E:11930 ||| ,
pGAD424 ||| S:11930 E:11937 ||| FW
/ ||| S:11937 E:11938 ||| FW
LTBP-3  ||| S:11938 E:11955 ||| FW
EGF ||| S:11955 E:11958 ||| FW
# ||| S:11958 E:11959 ||| #
1-8 ||| S:11959 E:11962 ||| CD
,  ||| S:11962 E:11964 ||| ,
that  ||| S:11964 E:11969 ||| WDT
contained  ||| S:11969 E:11979 ||| VBD
calcium-binding  ||| S:11979 E:11995 ||| JJ
type  ||| S:11995 E:12000 ||| NN
EGF-like  ||| S:12000 E:12019 ||| JJ
modules  ||| S:12019 E:12027 ||| JJ
# ||| S:12027 E:12028 ||| #
1-8  ||| S:12028 E:12032 ||| CD
fused  ||| S:12032 E:12038 ||| NN
to  ||| S:12038 E:12041 ||| TO
the  ||| S:12041 E:12045 ||| DT
GAL4-activation  ||| S:12045 E:12061 ||| JJ
domain  ||| S:12061 E:12068 ||| NN
( ||| S:12068 E:12069 ||| -LRB-
see  ||| S:12069 E:12083 ||| VB
Fig.  ||| S:12083 E:12088 ||| CD
1and  ||| S:12088 E:12093 ||| CD
materials  ||| S:12093 E:12103 ||| NNS
and  ||| S:12103 E:12107 ||| CC
methods ||| S:12107 E:12114 ||| NNS
)  ||| S:12114 E:12116 ||| -RRB-
was  ||| S:12116 E:12120 ||| VBD
tested  ||| S:12120 E:12127 ||| VBN
using  ||| S:12127 E:12133 ||| VBG
the  ||| S:12133 E:12147 ||| DT
yeast  ||| S:12147 E:12153 ||| NN
two-hybrid  ||| S:12153 E:12164 ||| JJ
system  ||| S:12164 E:12171 ||| NN
and  ||| S:12171 E:12175 ||| CC
found  ||| S:12175 E:12181 ||| VBD
to  ||| S:12181 E:12184 ||| TO
interact  ||| S:12184 E:12193 ||| VB
with  ||| S:12193 E:12198 ||| IN
the  ||| S:12198 E:12212 ||| DT
extracellular  ||| S:12212 E:12226 ||| JJ
domain  ||| S:12226 E:12233 ||| NN
of  ||| S:12233 E:12236 ||| IN
proHB-EGF  ||| S:12236 E:12246 ||| NNP
( ||| S:12246 E:12247 ||| -LRB-
Additional  ||| S:12247 E:12258 ||| JJ
file  ||| S:12258 E:12263 ||| NN
1 ||| S:12263 E:12264 ||| CD
) ||| S:12264 E:12265 ||| -RRB-
.  ||| S:12265 E:12277 ||| .
These  ||| S:12277 E:12283 ||| DT
negatively-charged  ||| S:12283 E:12302 ||| JJ
EGF-like  ||| S:12302 E:12311 ||| JJ
modules  ||| S:12311 E:12319 ||| NN
of  ||| S:12319 E:12322 ||| IN
LTBP-3  ||| S:12322 E:12329 ||| NNP
may  ||| S:12329 E:12343 ||| MD
interact  ||| S:12343 E:12352 ||| VB
efficiently  ||| S:12352 E:12364 ||| RB
with  ||| S:12364 E:12369 ||| IN
the  ||| S:12369 E:12373 ||| DT
positively-charged  ||| S:12373 E:12402 ||| JJ
heparin-binding  ||| S:12402 E:12418 ||| JJ
domain  ||| S:12418 E:12425 ||| NN
of  ||| S:12425 E:12428 ||| IN
both  ||| S:12428 E:12433 ||| PDT
the  ||| S:12433 E:12437 ||| DT
membrane-bound  ||| S:12437 E:12452 ||| JJ
and  ||| S:12452 E:12466 ||| CC
soluble  ||| S:12466 E:12474 ||| JJ
forms  ||| S:12474 E:12480 ||| NNS
of  ||| S:12480 E:12483 ||| IN
HB-EGF ||| S:12483 E:12489 ||| JJ
.  ||| S:12489 E:12491 ||| .
The  ||| S:12491 E:12495 ||| DT
amino  ||| S:12495 E:12501 ||| JJ
acid  ||| S:12501 E:12506 ||| NN
sequence  ||| S:12506 E:12515 ||| NN
of  ||| S:12515 E:12518 ||| IN
the  ||| S:12518 E:12532 ||| DT
heparin-binding  ||| S:12532 E:12548 ||| JJ
region  ||| S:12548 E:12555 ||| NN
of  ||| S:12555 E:12558 ||| IN
HB-EGF  ||| S:12558 E:12565 ||| NNP
(  ||| S:12565 E:12577 ||| -LRB-
21KRKKKGKGLGKKRDPCLRKYK  ||| S:12577 E:12601 ||| CD
41 ||| S:12601 E:12603 ||| CD
)  ||| S:12603 E:12605 ||| -RRB-
[  ||| S:12605 E:12607 ||| -LRB-
2  ||| S:12607 E:12609 ||| LS
]  ||| S:12609 E:12611 ||| -RRB-
has  ||| S:12611 E:12615 ||| VBZ
been  ||| S:12615 E:12620 ||| VBN
shown  ||| S:12620 E:12626 ||| VBN
to  ||| S:12626 E:12629 ||| TO
have  ||| S:12629 E:12644 ||| VB
a  ||| S:12644 E:12646 ||| DT
strong  ||| S:12646 E:12653 ||| JJ
affinity  ||| S:12653 E:12662 ||| NN
for  ||| S:12662 E:12666 ||| IN
heparin  ||| S:12666 E:12674 ||| NN
and  ||| S:12674 E:12678 ||| CC
may  ||| S:12678 E:12682 ||| MD
influence  ||| S:12682 E:12692 ||| VB
the  ||| S:12692 E:12706 ||| DT
interaction  ||| S:12706 E:12718 ||| NN
of  ||| S:12718 E:12721 ||| IN
this  ||| S:12721 E:12726 ||| DT
growth  ||| S:12726 E:12733 ||| NN
factor  ||| S:12733 E:12740 ||| NN
with  ||| S:12740 E:12745 ||| IN
cell-surface  ||| S:12745 E:12768 ||| FW
negatively  ||| S:12768 E:12779 ||| FW
charged  ||| S:12779 E:12787 ||| FW
heparan  ||| S:12787 E:12795 ||| FW
sulfate  ||| S:12795 E:12803 ||| FW
proteoglycans  ||| S:12803 E:12817 ||| FW
[  ||| S:12817 E:12819 ||| -LRB-
22  ||| S:12819 E:12822 ||| CD
]  ||| S:12822 E:12824 ||| -RRB-
.  ||| S:12824 E:12836 ||| .
It  ||| S:12836 E:12839 ||| PRP
remains  ||| S:12839 E:12847 ||| VBZ
to  ||| S:12847 E:12850 ||| TO
be  ||| S:12850 E:12853 ||| VB
seen  ||| S:12853 E:12858 ||| VBN
whether  ||| S:12858 E:12866 ||| IN
specific ||| S:12866 E:12874 ||| JJ
/ ||| S:12874 E:12875 ||| NN
all  ||| S:12875 E:12879 ||| RB
of  ||| S:12879 E:12882 ||| IN
the  ||| S:12882 E:12896 ||| DT
EGF-like  ||| S:12896 E:12905 ||| JJ
modules  ||| S:12905 E:12913 ||| NNS
are  ||| S:12913 E:12917 ||| VBP
required  ||| S:12917 E:12926 ||| VBN
and  ||| S:12926 E:12930 ||| CC
whether  ||| S:12930 E:12938 ||| IN
calcium  ||| S:12938 E:12946 ||| NN
is  ||| S:12946 E:12959 ||| VBZ
needed  ||| S:12959 E:12966 ||| VBN
for  ||| S:12966 E:12970 ||| IN
the  ||| S:12970 E:12974 ||| DT
interaction  ||| S:12974 E:12986 ||| NN
of  ||| S:12986 E:12989 ||| IN
HB-EGF  ||| S:12989 E:12996 ||| JJ
with  ||| S:12996 E:13001 ||| IN
LTBP-3 ||| S:13001 E:13007 ||| CD
.  ||| S:13007 E:13019 ||| .
The  ||| S:13019 E:13023 ||| DT
LTBP-3  ||| S:13023 E:13030 ||| JJ
protein  ||| S:13030 E:13038 ||| NN
is  ||| S:13038 E:13041 ||| VBZ
secreted  ||| S:13041 E:13050 ||| VBN
as  ||| S:13050 E:13053 ||| IN
a  ||| S:13053 E:13055 ||| DT
soluble  ||| S:13055 E:13063 ||| JJ
protein  ||| S:13063 E:13081 ||| NN
from  ||| S:13081 E:13086 ||| IN
the  ||| S:13086 E:13090 ||| DT
cell  ||| S:13090 E:13095 ||| NN
surface  ||| S:13095 E:13103 ||| NN
into  ||| S:13103 E:13108 ||| IN
the  ||| S:13108 E:13112 ||| DT
extracellular  ||| S:13112 E:13126 ||| JJ
matrix ||| S:13126 E:13132 ||| NN
.  ||| S:13132 E:13134 ||| .
Two  ||| S:13134 E:13148 ||| CD
of  ||| S:13148 E:13151 ||| IN
the  ||| S:13151 E:13155 ||| DT
proposed  ||| S:13155 E:13164 ||| JJ
functions  ||| S:13164 E:13174 ||| NNS
of  ||| S:13174 E:13177 ||| IN
LTBP  ||| S:13177 E:13182 ||| NNP
proteins  ||| S:13182 E:13191 ||| NNS
include  ||| S:13191 E:13209 ||| VBP
protecting  ||| S:13209 E:13220 ||| VBG
TGF-β  ||| S:13220 E:13226 ||| JJ
from  ||| S:13226 E:13231 ||| IN
premature  ||| S:13231 E:13241 ||| JJ
proteolytic  ||| S:13241 E:13253 ||| JJ
cleavage  ||| S:13253 E:13262 ||| NN
and  ||| S:13262 E:13276 ||| CC
targeting  ||| S:13276 E:13286 ||| VBG
TGF-β  ||| S:13286 E:13292 ||| JJ
to  ||| S:13292 E:13295 ||| TO
its  ||| S:13295 E:13299 ||| PRP$
appropriate  ||| S:13299 E:13311 ||| JJ
cell-surface  ||| S:13311 E:13324 ||| JJ
receptor ||| S:13324 E:13332 ||| NN
.  ||| S:13332 E:13344 ||| .
During  ||| S:13344 E:13351 ||| IN
cellular  ||| S:13351 E:13360 ||| JJ
synthesis  ||| S:13360 E:13370 ||| NN
of  ||| S:13370 E:13373 ||| IN
TGF-β ||| S:13373 E:13378 ||| NNP
,  ||| S:13378 E:13380 ||| ,
a  ||| S:13380 E:13382 ||| DT
small  ||| S:13382 E:13388 ||| JJ
latent  ||| S:13388 E:13405 ||| JJ
complex  ||| S:13405 E:13413 ||| NN
containing  ||| S:13413 E:13424 ||| VBG
the  ||| S:13424 E:13428 ||| DT
latency-associated  ||| S:13428 E:13447 ||| JJ
peptide  ||| S:13447 E:13455 ||| NN
and  ||| S:13455 E:13459 ||| CC
the  ||| S:13459 E:13473 ||| DT
mature  ||| S:13473 E:13480 ||| JJ
TGF-β  ||| S:13480 E:13486 ||| NN
is  ||| S:13486 E:13489 ||| VBZ
synthesized ||| S:13489 E:13500 ||| VBN
.  ||| S:13500 E:13502 ||| .
This  ||| S:13502 E:13507 ||| DT
small  ||| S:13507 E:13513 ||| JJ
latent  ||| S:13513 E:13520 ||| JJ
complex  ||| S:13520 E:13538 ||| NN
may  ||| S:13538 E:13542 ||| MD
be  ||| S:13542 E:13545 ||| VB
secreted  ||| S:13545 E:13554 ||| JJ
inefficiently  ||| S:13554 E:13568 ||| NN
from  ||| S:13568 E:13573 ||| IN
the  ||| S:13573 E:13577 ||| DT
cell  ||| S:13577 E:13582 ||| NN
surface  ||| S:13582 E:13590 ||| NN
at  ||| S:13590 E:13603 ||| IN
relatively  ||| S:13603 E:13614 ||| RB
slow  ||| S:13614 E:13619 ||| JJ
rates  ||| S:13619 E:13625 ||| NNS
[  ||| S:13625 E:13627 ||| -LRB-
23  ||| S:13627 E:13630 ||| CD
]  ||| S:13630 E:13632 ||| -RRB-
.  ||| S:13632 E:13634 ||| .
However ||| S:13634 E:13641 ||| RB
,  ||| S:13641 E:13643 ||| ,
when  ||| S:13643 E:13648 ||| WRB
the  ||| S:13648 E:13652 ||| DT
small  ||| S:13652 E:13668 ||| JJ
latent  ||| S:13668 E:13675 ||| JJ
complex  ||| S:13675 E:13683 ||| NN
is  ||| S:13683 E:13686 ||| VBZ
bound  ||| S:13686 E:13692 ||| VBN
by  ||| S:13692 E:13695 ||| IN
the  ||| S:13695 E:13699 ||| DT
latent  ||| S:13699 E:13706 ||| JJ
transforming  ||| S:13706 E:13719 ||| JJ
growth  ||| S:13719 E:13736 ||| NN
factor  ||| S:13736 E:13743 ||| NN
β-binding  ||| S:13743 E:13753 ||| JJ
protein  ||| S:13753 E:13761 ||| NN
via  ||| S:13761 E:13765 ||| IN
a  ||| S:13765 E:13767 ||| DT
disulfide  ||| S:13767 E:13777 ||| JJ
bond  ||| S:13777 E:13782 ||| NN
to  ||| S:13782 E:13785 ||| TO
the  ||| S:13785 E:13799 ||| DT
latency-associated  ||| S:13799 E:13818 ||| JJ
peptide ||| S:13818 E:13825 ||| NN
,  ||| S:13825 E:13827 ||| ,
the  ||| S:13827 E:13831 ||| DT
result  ||| S:13831 E:13838 ||| NN
is  ||| S:13838 E:13841 ||| VBZ
the  ||| S:13841 E:13845 ||| DT
formation  ||| S:13845 E:13865 ||| NN
of  ||| S:13865 E:13868 ||| IN
a  ||| S:13868 E:13870 ||| DT
large  ||| S:13870 E:13876 ||| JJ
latent  ||| S:13876 E:13883 ||| JJ
complex  ||| S:13883 E:13891 ||| NN
which  ||| S:13891 E:13897 ||| WDT
may  ||| S:13897 E:13901 ||| MD
be  ||| S:13901 E:13904 ||| VB
secreted  ||| S:13904 E:13923 ||| JJ
efficiently  ||| S:13923 E:13935 ||| NN
and  ||| S:13935 E:13939 ||| CC
at  ||| S:13939 E:13942 ||| IN
a  ||| S:13942 E:13944 ||| DT
relatively  ||| S:13944 E:13955 ||| RB
high  ||| S:13955 E:13960 ||| JJ
rate  ||| S:13960 E:13965 ||| NN
compared  ||| S:13965 E:13974 ||| VBN
to  ||| S:13974 E:13977 ||| TO
the  ||| S:13977 E:13991 ||| DT
small  ||| S:13991 E:13997 ||| JJ
latent  ||| S:13997 E:14004 ||| JJ
complex  ||| S:14004 E:14012 ||| NN
[  ||| S:14012 E:14014 ||| -LRB-
23  ||| S:14014 E:14017 ||| CD
]  ||| S:14017 E:14019 ||| -RRB-
.  ||| S:14019 E:14021 ||| .
Latent  ||| S:14021 E:14028 ||| NNP
TGF-β  ||| S:14028 E:14034 ||| NNP
is  ||| S:14034 E:14037 ||| VBZ
then  ||| S:14037 E:14052 ||| RB
released  ||| S:14052 E:14061 ||| VBN
from  ||| S:14061 E:14066 ||| IN
the  ||| S:14066 E:14070 ||| DT
extracellular  ||| S:14070 E:14084 ||| JJ
matrix  ||| S:14084 E:14091 ||| NN
via  ||| S:14091 E:14095 ||| IN
proteolytic  ||| S:14095 E:14117 ||| JJ
cleavage  ||| S:14117 E:14126 ||| NN
from  ||| S:14126 E:14131 ||| IN
the  ||| S:14131 E:14135 ||| DT
large  ||| S:14135 E:14141 ||| JJ
latent  ||| S:14141 E:14148 ||| JJ
complex ||| S:14148 E:14155 ||| NN
,  ||| S:14155 E:14157 ||| ,
and  ||| S:14157 E:14161 ||| CC
the  ||| S:14161 E:14165 ||| DT
resulting  ||| S:14165 E:14185 ||| VBG
active  ||| S:14185 E:14192 ||| JJ
TGF-β  ||| S:14192 E:14198 ||| NN
is  ||| S:14198 E:14201 ||| VBZ
now  ||| S:14201 E:14205 ||| RB
able  ||| S:14205 E:14210 ||| JJ
to  ||| S:14210 E:14213 ||| TO
bind  ||| S:14213 E:14218 ||| VB
to  ||| S:14218 E:14221 ||| TO
the  ||| S:14221 E:14225 ||| DT
appropriate  ||| S:14225 E:14237 ||| JJ
TGF-β  ||| S:14237 E:14253 ||| JJ
cell-surface  ||| S:14253 E:14266 ||| JJ
receptors  ||| S:14266 E:14276 ||| NNS
[  ||| S:14276 E:14278 ||| -LRB-
24  ||| S:14278 E:14281 ||| CD
]  ||| S:14281 E:14283 ||| -RRB-
.  ||| S:14283 E:14295 ||| .
It  ||| S:14295 E:14298 ||| PRP
is  ||| S:14298 E:14301 ||| VBZ
well  ||| S:14301 E:14306 ||| RB
accepted  ||| S:14306 E:14315 ||| VBN
that  ||| S:14315 E:14320 ||| IN
TGF-β  ||| S:14320 E:14326 ||| NNP
is  ||| S:14326 E:14329 ||| VBZ
important  ||| S:14329 E:14339 ||| JJ
for  ||| S:14339 E:14343 ||| IN
the  ||| S:14343 E:14357 ||| DT
regulation  ||| S:14357 E:14368 ||| NN
of  ||| S:14368 E:14371 ||| IN
extracellular  ||| S:14371 E:14385 ||| JJ
matrix  ||| S:14385 E:14392 ||| JJ
synthesis  ||| S:14392 E:14402 ||| NN
and  ||| S:14402 E:14416 ||| CC
degradation ||| S:14416 E:14427 ||| NN
.  ||| S:14427 E:14429 ||| .
The  ||| S:14429 E:14433 ||| DT
presence  ||| S:14433 E:14442 ||| NN
of  ||| S:14442 E:14445 ||| IN
TGF-β  ||| S:14445 E:14451 ||| JJ
increases  ||| S:14451 E:14461 ||| NNS
the  ||| S:14461 E:14475 ||| DT
expression  ||| S:14475 E:14486 ||| NN
of  ||| S:14486 E:14489 ||| IN
such  ||| S:14489 E:14494 ||| JJ
extracellular  ||| S:14494 E:14508 ||| JJ
matrix  ||| S:14508 E:14515 ||| JJ
proteins  ||| S:14515 E:14524 ||| NNS
as  ||| S:14524 E:14537 ||| IN
fibronectin ||| S:14537 E:14548 ||| NN
,  ||| S:14548 E:14550 ||| ,
the  ||| S:14550 E:14554 ||| DT
fibronectin  ||| S:14554 E:14566 ||| JJ
receptor ||| S:14566 E:14574 ||| NN
,  ||| S:14574 E:14576 ||| ,
vitronectin ||| S:14576 E:14587 ||| NN
,  ||| S:14587 E:14599 ||| ,
tenascin ||| S:14599 E:14607 ||| NN
,  ||| S:14607 E:14609 ||| ,
elastin ||| S:14609 E:14616 ||| NN
,  ||| S:14616 E:14618 ||| ,
thrombospondin ||| S:14618 E:14632 ||| NN
,  ||| S:14632 E:14634 ||| ,
collagen ||| S:14634 E:14642 ||| NN
,  ||| S:14642 E:14644 ||| ,
and  ||| S:14644 E:14648 ||| CC
biglycan  ||| S:14648 E:14667 ||| NNS
[  ||| S:14667 E:14669 ||| -LRB-
25  ||| S:14669 E:14672 ||| CD
26  ||| S:14672 E:14675 ||| CD
27  ||| S:14675 E:14678 ||| CD
28  ||| S:14678 E:14681 ||| CD
29  ||| S:14681 E:14684 ||| CD
30  ||| S:14684 E:14687 ||| CD
31  ||| S:14687 E:14690 ||| CD
32  ||| S:14690 E:14693 ||| CD
]  ||| S:14693 E:14695 ||| -RRB-
and  ||| S:14695 E:14699 ||| CC
also  ||| S:14699 E:14704 ||| RB
inhibits  ||| S:14704 E:14713 ||| JJ
expression  ||| S:14713 E:14734 ||| NN
of  ||| S:14734 E:14737 ||| IN
proteases  ||| S:14737 E:14747 ||| NNS
that  ||| S:14747 E:14752 ||| WDT
degrade  ||| S:14752 E:14760 ||| VBZ
the  ||| S:14760 E:14764 ||| DT
extracellular  ||| S:14764 E:14778 ||| JJ
matrix  ||| S:14778 E:14785 ||| NN
while  ||| S:14785 E:14801 ||| IN
stimulating  ||| S:14801 E:14813 ||| VBG
the  ||| S:14813 E:14817 ||| DT
expression  ||| S:14817 E:14828 ||| NN
of  ||| S:14828 E:14831 ||| IN
protease  ||| S:14831 E:14840 ||| JJ
inhibitors  ||| S:14840 E:14851 ||| NNS
[  ||| S:14851 E:14853 ||| -LRB-
33  ||| S:14853 E:14856 ||| CD
34  ||| S:14856 E:14869 ||| CD
35  ||| S:14869 E:14872 ||| CD
36  ||| S:14872 E:14875 ||| CD
]  ||| S:14875 E:14877 ||| -RRB-
.  ||| S:14877 E:14889 ||| .
It  ||| S:14889 E:14892 ||| PRP
is  ||| S:14892 E:14895 ||| VBZ
interesting  ||| S:14895 E:14907 ||| JJ
to  ||| S:14907 E:14910 ||| TO
note  ||| S:14910 E:14915 ||| VB
that  ||| S:14915 E:14920 ||| IN
although  ||| S:14920 E:14929 ||| IN
Bulus  ||| S:14929 E:14935 ||| NNP
and  ||| S:14935 E:14949 ||| CC
Barnard  ||| S:14949 E:14957 ||| NNP
[  ||| S:14957 E:14959 ||| -LRB-
16  ||| S:14959 E:14962 ||| CD
]  ||| S:14962 E:14964 ||| -RRB-
showed  ||| S:14964 E:14971 ||| VBD
that  ||| S:14971 E:14976 ||| DT
TGF-β  ||| S:14976 E:14982 ||| JJ
treatment  ||| S:14982 E:14992 ||| NN
of  ||| S:14992 E:14995 ||| IN
R1E  ||| S:14995 E:14999 ||| CD
cells  ||| S:14999 E:15015 ||| NNS
resulted  ||| S:15015 E:15024 ||| VBD
in  ||| S:15024 E:15027 ||| IN
increased  ||| S:15027 E:15037 ||| JJ
level  ||| S:15037 E:15043 ||| NN
of  ||| S:15043 E:15046 ||| IN
HB-EGF  ||| S:15046 E:15053 ||| JJ
expression ||| S:15053 E:15063 ||| NN
,  ||| S:15063 E:15065 ||| ,
they  ||| S:15065 E:15080 ||| PRP
did  ||| S:15080 E:15084 ||| VBD
not  ||| S:15084 E:15088 ||| RB
report  ||| S:15088 E:15095 ||| VB
any  ||| S:15095 E:15099 ||| DT
direct  ||| S:15099 E:15106 ||| JJ
physical  ||| S:15106 E:15115 ||| JJ
interactions  ||| S:15115 E:15128 ||| NNS
between  ||| S:15128 E:15146 ||| IN
the  ||| S:15146 E:15150 ||| DT
growth  ||| S:15150 E:15157 ||| NN
factors  ||| S:15157 E:15165 ||| NNS
TGF-β  ||| S:15165 E:15171 ||| JJ
and  ||| S:15171 E:15175 ||| CC
HB-EGF ||| S:15175 E:15181 ||| JJ
.  ||| S:15181 E:15183 ||| .
It  ||| S:15183 E:15186 ||| PRP
may  ||| S:15186 E:15190 ||| MD
be  ||| S:15190 E:15193 ||| VB
that  ||| S:15193 E:15208 ||| IN
LTBP-3  ||| S:15208 E:15215 ||| NNP
provides  ||| S:15215 E:15224 ||| VBZ
a  ||| S:15224 E:15226 ||| DT
physical  ||| S:15226 E:15235 ||| JJ
link  ||| S:15235 E:15240 ||| NN
between  ||| S:15240 E:15248 ||| IN
soluble  ||| S:15248 E:15256 ||| JJ
mHB-EGF  ||| S:15256 E:15274 ||| JJ
and  ||| S:15274 E:15278 ||| CC
TGF-β ||| S:15278 E:15283 ||| JJ
.  ||| S:15283 E:15285 ||| .
Possible  ||| S:15285 E:15294 ||| JJ
functions  ||| S:15294 E:15304 ||| NNS
for  ||| S:15304 E:15308 ||| IN
the  ||| S:15308 E:15312 ||| DT
apparent  ||| S:15312 E:15331 ||| JJ
interaction  ||| S:15331 E:15343 ||| NN
of  ||| S:15343 E:15346 ||| IN
mHB-EGF  ||| S:15346 E:15354 ||| JJ
with  ||| S:15354 E:15359 ||| IN
LTBP-3  ||| S:15359 E:15366 ||| NNP
include  ||| S:15366 E:15374 ||| VBP
the  ||| S:15374 E:15378 ||| DT
targeting  ||| S:15378 E:15398 ||| VBG
of  ||| S:15398 E:15401 ||| IN
the  ||| S:15401 E:15405 ||| DT
TGF-β  ||| S:15405 E:15411 ||| JJ
within  ||| S:15411 E:15418 ||| IN
its  ||| S:15418 E:15422 ||| PRP$
protective  ||| S:15422 E:15433 ||| JJ
large  ||| S:15433 E:15439 ||| JJ
latent  ||| S:15439 E:15446 ||| JJ
complex  ||| S:15446 E:15464 ||| NN
to  ||| S:15464 E:15467 ||| TO
its  ||| S:15467 E:15471 ||| PRP$
appropriate  ||| S:15471 E:15483 ||| JJ
TGF-β  ||| S:15483 E:15489 ||| JJ
cell-surface  ||| S:15489 E:15502 ||| JJ
receptor ||| S:15502 E:15510 ||| NN
,  ||| S:15510 E:15512 ||| ,
or  ||| S:15512 E:15515 ||| CC
the  ||| S:15515 E:15529 ||| DT
targeting  ||| S:15529 E:15539 ||| VBG
of  ||| S:15539 E:15542 ||| IN
the  ||| S:15542 E:15546 ||| DT
TGF-β  ||| S:15546 E:15552 ||| JJ
large  ||| S:15552 E:15558 ||| JJ
latent  ||| S:15558 E:15565 ||| JJ
complex  ||| S:15565 E:15573 ||| NN
to  ||| S:15573 E:15576 ||| TO
the  ||| S:15576 E:15580 ||| DT
EGF  ||| S:15580 E:15594 ||| NNP
receptor  ||| S:15594 E:15603 ||| NN
via  ||| S:15603 E:15607 ||| IN
binding  ||| S:15607 E:15615 ||| VBG
of  ||| S:15615 E:15618 ||| IN
mHB-EGF  ||| S:15618 E:15626 ||| JJ
to  ||| S:15626 E:15629 ||| TO
the  ||| S:15629 E:15633 ||| DT
appropriate  ||| S:15633 E:15645 ||| JJ
EGF  ||| S:15645 E:15659 ||| NNP
receptor ||| S:15659 E:15667 ||| NN
.  ||| S:15667 E:15669 ||| .
These  ||| S:15669 E:15675 ||| DT
are  ||| S:15675 E:15679 ||| VBP
reasonable  ||| S:15679 E:15690 ||| JJ
functions  ||| S:15690 E:15700 ||| NNS
for  ||| S:15700 E:15704 ||| IN
the  ||| S:15704 E:15708 ||| DT
role  ||| S:15708 E:15713 ||| NN
of  ||| S:15713 E:15726 ||| IN
the  ||| S:15726 E:15730 ||| DT
proposed  ||| S:15730 E:15739 ||| JJ
mHB-EGF  ||| S:15739 E:15747 ||| NN
: ||| S:15747 E:15748 ||| :
LTBP-3  ||| S:15748 E:15755 ||| CD
protein ||| S:15755 E:15762 ||| NN
: ||| S:15762 E:15763 ||| :
protein  ||| S:15763 E:15771 ||| NN
interactions  ||| S:15771 E:15794 ||| NNS
as  ||| S:15794 E:15797 ||| IN
the  ||| S:15797 E:15801 ||| DT
expression  ||| S:15801 E:15812 ||| NN
of  ||| S:15812 E:15815 ||| IN
both  ||| S:15815 E:15820 ||| DT
mHB-EGF  ||| S:15820 E:15828 ||| JJ
and  ||| S:15828 E:15832 ||| CC
TGF-β  ||| S:15832 E:15838 ||| NNP
is  ||| S:15838 E:15841 ||| VBZ
important  ||| S:15841 E:15861 ||| JJ
during  ||| S:15861 E:15868 ||| IN
extracellular  ||| S:15868 E:15882 ||| JJ
matrix  ||| S:15882 E:15889 ||| JJ
formation  ||| S:15889 E:15899 ||| NN
in  ||| S:15899 E:15902 ||| IN
wound  ||| S:15902 E:15908 ||| JJ
healing  ||| S:15908 E:15916 ||| NN
[  ||| S:15916 E:15928 ||| -LRB-
1  ||| S:15928 E:15930 ||| CD
25  ||| S:15930 E:15933 ||| CD
]  ||| S:15933 E:15935 ||| -RRB-
;  ||| S:15935 E:15937 ||| :
it  ||| S:15937 E:15940 ||| PRP
has  ||| S:15940 E:15944 ||| VBZ
been  ||| S:15944 E:15949 ||| VBN
suggested  ||| S:15949 E:15959 ||| VBN
that  ||| S:15959 E:15964 ||| IN
the  ||| S:15964 E:15968 ||| DT
coordinated  ||| S:15968 E:15990 ||| JJ
activities  ||| S:15990 E:16001 ||| NNS
of  ||| S:16001 E:16004 ||| IN
HB-EGF  ||| S:16004 E:16011 ||| JJ
and  ||| S:16011 E:16015 ||| CC
TGF-β  ||| S:16015 E:16021 ||| JJ
regulate  ||| S:16021 E:16030 ||| NNS
the  ||| S:16030 E:16034 ||| DT
wound  ||| S:16034 E:16040 ||| JJ
healing  ||| S:16040 E:16058 ||| NN
process  ||| S:16058 E:16066 ||| NN
[  ||| S:16066 E:16068 ||| -LRB-
16  ||| S:16068 E:16071 ||| CD
]  ||| S:16071 E:16073 ||| -RRB-
.  ||| S:16073 E:16103 ||| .
The  ||| S:16103 E:16107 ||| DT
extracellular  ||| S:16107 E:16121 ||| JJ
domain  ||| S:16121 E:16128 ||| NN
of  ||| S:16128 E:16131 ||| IN
proHB-EGF  ||| S:16131 E:16141 ||| JJ
interacts  ||| S:16141 E:16161 ||| NN
with  ||| S:16161 E:16166 ||| IN
monkey  ||| S:16166 E:16173 ||| JJ
fibulin  ||| S:16173 E:16181 ||| NNS
1C  ||| S:16181 E:16194 ||| VBP
The  ||| S:16194 E:16198 ||| DT
extracellular  ||| S:16198 E:16212 ||| JJ
domain  ||| S:16212 E:16219 ||| NN
of  ||| S:16219 E:16222 ||| IN
proHB-EGF  ||| S:16222 E:16232 ||| JJ
interacts  ||| S:16232 E:16242 ||| NN
with  ||| S:16242 E:16257 ||| IN
monkey  ||| S:16257 E:16264 ||| CD
fibulin-1C  ||| S:16264 E:16275 ||| CD
( ||| S:16275 E:16276 ||| -LRB-
Additional  ||| S:16276 E:16287 ||| JJ
file  ||| S:16287 E:16292 ||| NN
1 ||| S:16292 E:16293 ||| CD
) ||| S:16293 E:16294 ||| -RRB-
.  ||| S:16294 E:16296 ||| .
Fibulin-1  ||| S:16296 E:16306 ||| NNP
is  ||| S:16306 E:16309 ||| VBZ
a  ||| S:16309 E:16321 ||| DT
calcium-binding  ||| S:16321 E:16337 ||| JJ
extracellular  ||| S:16337 E:16351 ||| JJ
matrix  ||| S:16351 E:16358 ||| JJ
glycoprotein  ||| S:16358 E:16371 ||| NN
that  ||| S:16371 E:16376 ||| WDT
is  ||| S:16376 E:16389 ||| VBZ
associated  ||| S:16389 E:16400 ||| VBN
with  ||| S:16400 E:16405 ||| IN
various  ||| S:16405 E:16413 ||| JJ
connective  ||| S:16413 E:16424 ||| JJ
tissues ||| S:16424 E:16431 ||| NNS
,  ||| S:16431 E:16433 ||| ,
basement  ||| S:16433 E:16452 ||| JJ
membranes  ||| S:16452 E:16462 ||| NN
and  ||| S:16462 E:16466 ||| CC
blood  ||| S:16466 E:16472 ||| NN
[  ||| S:16472 E:16474 ||| -LRB-
37  ||| S:16474 E:16477 ||| CD
38  ||| S:16477 E:16480 ||| CD
39  ||| S:16480 E:16483 ||| CD
]  ||| S:16483 E:16485 ||| -RRB-
.  ||| S:16485 E:16487 ||| .
Splicing  ||| S:16487 E:16496 ||| NNP
of  ||| S:16496 E:16499 ||| IN
the  ||| S:16499 E:16503 ||| DT
C  ||| S:16503 E:16515 ||| NNP
terminal  ||| S:16515 E:16524 ||| NN
domain  ||| S:16524 E:16531 ||| NN
of  ||| S:16531 E:16534 ||| IN
fibulin-1  ||| S:16534 E:16544 ||| NNP
can  ||| S:16544 E:16548 ||| MD
lead  ||| S:16548 E:16553 ||| VB
to  ||| S:16553 E:16556 ||| TO
the  ||| S:16556 E:16560 ||| DT
expression  ||| S:16560 E:16581 ||| NN
of  ||| S:16581 E:16584 ||| IN
different  ||| S:16584 E:16594 ||| JJ
variants  ||| S:16594 E:16603 ||| NN
of  ||| S:16603 E:16606 ||| IN
fibulin-1  ||| S:16606 E:16616 ||| NNP
( ||| S:16616 E:16617 ||| -LRB-
A-D ||| S:16617 E:16620 ||| NNP
)  ||| S:16620 E:16622 ||| -RRB-
[  ||| S:16622 E:16624 ||| -LRB-
37  ||| S:16624 E:16627 ||| CD
]  ||| S:16627 E:16629 ||| -RRB-
.  ||| S:16629 E:16631 ||| .
The  ||| S:16631 E:16645 ||| DT
amino  ||| S:16645 E:16651 ||| JJ
acid  ||| S:16651 E:16656 ||| NN
sequence  ||| S:16656 E:16665 ||| NN
of  ||| S:16665 E:16668 ||| IN
the  ||| S:16668 E:16672 ||| DT
human  ||| S:16672 E:16678 ||| JJ
fibulin-1C  ||| S:16678 E:16689 ||| CD
protein  ||| S:16689 E:16707 ||| NN
encodes  ||| S:16707 E:16715 ||| VBD
five  ||| S:16715 E:16720 ||| CD
domains ||| S:16720 E:16727 ||| NNS
:  ||| S:16727 E:16729 ||| :
a  ||| S:16729 E:16731 ||| DT
signal  ||| S:16731 E:16738 ||| NN
sequence  ||| S:16738 E:16747 ||| NN
( ||| S:16747 E:16748 ||| -LRB-
35  ||| S:16748 E:16751 ||| CD
amino  ||| S:16751 E:16757 ||| JJ
acid  ||| S:16757 E:16772 ||| NN
residues ||| S:16772 E:16780 ||| NNS
) ||| S:16780 E:16781 ||| -RRB-
,  ||| S:16781 E:16783 ||| ,
three  ||| S:16783 E:16789 ||| CD
anaphylatoxin  ||| S:16789 E:16803 ||| JJ
type  ||| S:16803 E:16808 ||| NN
I  ||| S:16808 E:16810 ||| PRP
repeats  ||| S:16810 E:16818 ||| VBZ
( ||| S:16818 E:16819 ||| -LRB-
108  ||| S:16819 E:16833 ||| CD
residues ||| S:16833 E:16841 ||| CD
) ||| S:16841 E:16842 ||| -RRB-
,  ||| S:16842 E:16844 ||| ,
an  ||| S:16844 E:16847 ||| DT
adjoining  ||| S:16847 E:16857 ||| JJ
sequence  ||| S:16857 E:16866 ||| NN
( ||| S:16866 E:16867 ||| -LRB-
33  ||| S:16867 E:16870 ||| CD
amino  ||| S:16870 E:16876 ||| JJ
acid  ||| S:16876 E:16891 ||| NN
residues ||| S:16891 E:16899 ||| NNS
) ||| S:16899 E:16900 ||| -RRB-
,  ||| S:16900 E:16902 ||| ,
nine  ||| S:16902 E:16907 ||| CD
calcium-binding  ||| S:16907 E:16923 ||| JJ
type  ||| S:16923 E:16928 ||| NN
II  ||| S:16928 E:16931 ||| NNP
EGF-like  ||| S:16931 E:16940 ||| JJ
modules  ||| S:16940 E:16958 ||| NNS
( ||| S:16958 E:16959 ||| -LRB-
387  ||| S:16959 E:16963 ||| CD
amino  ||| S:16963 E:16969 ||| JJ
acid  ||| S:16969 E:16974 ||| NN
residues ||| S:16974 E:16982 ||| NNS
) ||| S:16982 E:16983 ||| -RRB-
,  ||| S:16983 E:16985 ||| ,
and  ||| S:16985 E:16989 ||| CC
a  ||| S:16989 E:16991 ||| DT
carboxyl  ||| S:16991 E:17000 ||| JJ
domain  ||| S:17000 E:17007 ||| NN
( ||| S:17007 E:17008 ||| -LRB-
116  ||| S:17008 E:17022 ||| CD
amino  ||| S:17022 E:17028 ||| JJ
acid  ||| S:17028 E:17033 ||| NN
residues ||| S:17033 E:17041 ||| NNS
)  ||| S:17041 E:17043 ||| -RRB-
[  ||| S:17043 E:17045 ||| -LRB-
37  ||| S:17045 E:17048 ||| CD
]  ||| S:17048 E:17050 ||| -RRB-
.  ||| S:17050 E:17052 ||| .
The  ||| S:17052 E:17056 ||| DT
amino  ||| S:17056 E:17062 ||| JJ
acid  ||| S:17062 E:17067 ||| NN
sequence  ||| S:17067 E:17086 ||| VBZ
derived  ||| S:17086 E:17094 ||| VBN
from  ||| S:17094 E:17099 ||| IN
the  ||| S:17099 E:17103 ||| DT
nucleotide  ||| S:17103 E:17114 ||| JJ
sequence  ||| S:17114 E:17123 ||| NN
obtained  ||| S:17123 E:17132 ||| VBN
for  ||| S:17132 E:17136 ||| IN
monkey  ||| S:17136 E:17153 ||| CD
fibulin-1C  ||| S:17153 E:17164 ||| CD
( ||| S:17164 E:17165 ||| -LRB-
GenBank  ||| S:17165 E:17173 ||| JJ
accession  ||| S:17173 E:17183 ||| JJ
number  ||| S:17183 E:17190 ||| NN
AF395659 ||| S:17190 E:17198 ||| CD
)  ||| S:17198 E:17200 ||| -RRB-
shows  ||| S:17200 E:17206 ||| VBZ
it  ||| S:17206 E:17219 ||| PRP
to  ||| S:17219 E:17222 ||| TO
share  ||| S:17222 E:17228 ||| VB
97.2  ||| S:17228 E:17233 ||| CD
%  ||| S:17233 E:17235 ||| NN
identity  ||| S:17235 E:17244 ||| NN
with  ||| S:17244 E:17249 ||| IN
the  ||| S:17249 E:17253 ||| DT
amino  ||| S:17253 E:17259 ||| JJ
acid  ||| S:17259 E:17264 ||| NN
sequence  ||| S:17264 E:17273 ||| NN
for  ||| S:17273 E:17287 ||| IN
human  ||| S:17287 E:17293 ||| JJ
fibulin-1C  ||| S:17293 E:17304 ||| NNP
( ||| S:17304 E:17305 ||| -LRB-
GenBank  ||| S:17305 E:17313 ||| JJ
accession  ||| S:17313 E:17323 ||| JJ
number  ||| S:17323 E:17340 ||| NN
NP_001987 ||| S:17340 E:17349 ||| CD
) ||| S:17349 E:17350 ||| -RRB-
.  ||| S:17350 E:17362 ||| .
The  ||| S:17362 E:17366 ||| DT
EGF-like  ||| S:17366 E:17375 ||| JJ
modules  ||| S:17375 E:17383 ||| NN
found  ||| S:17383 E:17389 ||| VBD
in  ||| S:17389 E:17392 ||| IN
fibulin-1  ||| S:17392 E:17402 ||| NNP
are  ||| S:17402 E:17416 ||| VBP
instrumental  ||| S:17416 E:17429 ||| VBN
in  ||| S:17429 E:17432 ||| IN
a  ||| S:17432 E:17434 ||| DT
variety  ||| S:17434 E:17442 ||| NN
of  ||| S:17442 E:17445 ||| IN
extracellular  ||| S:17445 E:17469 ||| JJ
protein ||| S:17469 E:17476 ||| NN
: ||| S:17476 E:17477 ||| :
protein  ||| S:17477 E:17485 ||| NN
interactions ||| S:17485 E:17497 ||| NNS
.  ||| S:17497 E:17499 ||| .
Fibulin-1  ||| S:17499 E:17509 ||| NNP
has  ||| S:17509 E:17513 ||| VBZ
been  ||| S:17513 E:17518 ||| VBN
reported  ||| S:17518 E:17537 ||| VBN
to  ||| S:17537 E:17540 ||| TO
interact  ||| S:17540 E:17549 ||| VB
with  ||| S:17549 E:17554 ||| IN
such  ||| S:17554 E:17559 ||| JJ
extracellular  ||| S:17559 E:17573 ||| JJ
matrix  ||| S:17573 E:17580 ||| JJ
proteins  ||| S:17580 E:17589 ||| NNS
as  ||| S:17589 E:17602 ||| IN
fibronectin ||| S:17602 E:17613 ||| NN
,  ||| S:17613 E:17615 ||| ,
laminin ||| S:17615 E:17622 ||| NN
,  ||| S:17622 E:17624 ||| ,
nidogen ||| S:17624 E:17631 ||| NN
,  ||| S:17631 E:17633 ||| ,
aggrecan  ||| S:17633 E:17642 ||| NN
and  ||| S:17642 E:17646 ||| CC
versican  ||| S:17646 E:17655 ||| NNS
[  ||| S:17655 E:17657 ||| -LRB-
39  ||| S:17657 E:17670 ||| CD
40  ||| S:17670 E:17673 ||| CD
41  ||| S:17673 E:17676 ||| CD
42  ||| S:17676 E:17679 ||| CD
]  ||| S:17679 E:17681 ||| -RRB-
.  ||| S:17681 E:17683 ||| .
Fibronectin  ||| S:17683 E:17695 ||| NNP
is  ||| S:17695 E:17698 ||| VBZ
a  ||| S:17698 E:17700 ||| DT
glycoprotein  ||| S:17700 E:17713 ||| NN
found  ||| S:17713 E:17719 ||| VBD
as  ||| S:17719 E:17732 ||| IN
multimers  ||| S:17732 E:17742 ||| NN
in  ||| S:17742 E:17745 ||| IN
insoluble  ||| S:17745 E:17755 ||| JJ
form  ||| S:17755 E:17760 ||| NN
in  ||| S:17760 E:17763 ||| IN
the  ||| S:17763 E:17767 ||| DT
extracellular  ||| S:17767 E:17781 ||| JJ
matrix ||| S:17781 E:17787 ||| NN
.  ||| S:17787 E:17799 ||| .
Fibronectin  ||| S:17799 E:17811 ||| NNP
contains  ||| S:17811 E:17820 ||| VBZ
three  ||| S:17820 E:17826 ||| CD
types  ||| S:17826 E:17832 ||| NNS
of  ||| S:17832 E:17835 ||| IN
homology  ||| S:17835 E:17844 ||| JJ
sequences ||| S:17844 E:17853 ||| NN
,  ||| S:17853 E:17865 ||| ,
I-III ||| S:17865 E:17870 ||| JJ
;  ||| S:17870 E:17872 ||| :
type  ||| S:17872 E:17877 ||| NN
I  ||| S:17877 E:17879 ||| PRP
sequences  ||| S:17879 E:17889 ||| VBP
bind  ||| S:17889 E:17894 ||| JJ
heparin ||| S:17894 E:17901 ||| NN
,  ||| S:17901 E:17914 ||| ,
Staphylococcus  ||| S:17914 E:17929 ||| NNP
aureus ||| S:17929 E:17935 ||| NN
,  ||| S:17935 E:17937 ||| ,
fibrin ||| S:17937 E:17943 ||| NN
,  ||| S:17943 E:17945 ||| ,
and  ||| S:17945 E:17959 ||| CC
cell  ||| S:17959 E:17964 ||| NN
surfaces ||| S:17964 E:17972 ||| NN
,  ||| S:17972 E:17974 ||| ,
type  ||| S:17974 E:17979 ||| NN
II  ||| S:17979 E:17982 ||| NNP
sequences  ||| S:17982 E:17992 ||| JJ
bind  ||| S:17992 E:17997 ||| NN
collagen  ||| S:17997 E:18006 ||| NN
and  ||| S:18006 E:18020 ||| CC
gelatin ||| S:18020 E:18027 ||| NN
,  ||| S:18027 E:18029 ||| ,
and  ||| S:18029 E:18033 ||| CC
type  ||| S:18033 E:18038 ||| NN
III  ||| S:18038 E:18042 ||| NNP
sequences  ||| S:18042 E:18052 ||| FW
bind  ||| S:18052 E:18057 ||| FW
DNA ||| S:18057 E:18060 ||| NNP
,  ||| S:18060 E:18062 ||| ,
cell  ||| S:18062 E:18067 ||| NN
surfaces ||| S:18067 E:18075 ||| NN
,  ||| S:18075 E:18087 ||| ,
heparin ||| S:18087 E:18094 ||| NN
,  ||| S:18094 E:18096 ||| ,
and  ||| S:18096 E:18100 ||| CC
fibulin-1  ||| S:18100 E:18110 ||| NNP
[  ||| S:18110 E:18112 ||| -LRB-
40  ||| S:18112 E:18115 ||| CD
43  ||| S:18115 E:18118 ||| CD
]  ||| S:18118 E:18120 ||| -RRB-
.  ||| S:18120 E:18122 ||| .
Fibulin-1  ||| S:18122 E:18132 ||| NNP
interacts  ||| S:18132 E:18152 ||| NN
with  ||| S:18152 E:18157 ||| IN
fibronectin  ||| S:18157 E:18169 ||| NN
through  ||| S:18169 E:18177 ||| IN
a  ||| S:18177 E:18179 ||| DT
heparin-binding  ||| S:18179 E:18195 ||| JJ
region  ||| S:18195 E:18202 ||| NN
in  ||| S:18202 E:18205 ||| IN
type  ||| S:18205 E:18220 ||| NN
III  ||| S:18220 E:18235 ||| NNP
13  ||| S:18235 E:18238 ||| CD
repeat ||| S:18238 E:18244 ||| NN
;  ||| S:18244 E:18246 ||| :
the  ||| S:18246 E:18250 ||| DT
binding  ||| S:18250 E:18258 ||| NN
of  ||| S:18258 E:18261 ||| IN
fibulin-1  ||| S:18261 E:18271 ||| CD
to  ||| S:18271 E:18284 ||| TO
this  ||| S:18284 E:18289 ||| DT
site  ||| S:18289 E:18294 ||| NN
is  ||| S:18294 E:18297 ||| VBZ
independent  ||| S:18297 E:18309 ||| JJ
of  ||| S:18309 E:18312 ||| IN
the  ||| S:18312 E:18316 ||| DT
binding  ||| S:18316 E:18324 ||| NN
of  ||| S:18324 E:18327 ||| IN
heparin  ||| S:18327 E:18335 ||| NN
as  ||| S:18335 E:18348 ||| IN
addition  ||| S:18348 E:18357 ||| NN
of  ||| S:18357 E:18360 ||| IN
exogenous  ||| S:18360 E:18370 ||| JJ
heparin  ||| S:18370 E:18378 ||| NN
does  ||| S:18378 E:18383 ||| VBZ
not  ||| S:18383 E:18387 ||| RB
inhibit  ||| S:18387 E:18395 ||| VB
fibulin-1  ||| S:18395 E:18415 ||| CD
binding  ||| S:18415 E:18423 ||| NN
to  ||| S:18423 E:18426 ||| TO
fibronectin  ||| S:18426 E:18438 ||| VB
[  ||| S:18438 E:18440 ||| -LRB-
40  ||| S:18440 E:18443 ||| CD
]  ||| S:18443 E:18445 ||| -RRB-
.  ||| S:18445 E:18447 ||| .
The  ||| S:18447 E:18451 ||| DT
fibronectin-binding  ||| S:18451 E:18481 ||| JJ
site  ||| S:18481 E:18486 ||| NN
in  ||| S:18486 E:18489 ||| IN
fibulin-1  ||| S:18489 E:18499 ||| NNP
is  ||| S:18499 E:18502 ||| VBZ
located  ||| S:18502 E:18510 ||| VBN
in  ||| S:18510 E:18513 ||| IN
EGF-like  ||| S:18513 E:18522 ||| JJ
modules  ||| S:18522 E:18530 ||| NN
5  ||| S:18530 E:18532 ||| CD
and  ||| S:18532 E:18536 ||| CC
6  ||| S:18536 E:18548 ||| CD
[  ||| S:18548 E:18550 ||| -LRB-
44  ||| S:18550 E:18553 ||| CD
]  ||| S:18553 E:18555 ||| -RRB-
;  ||| S:18555 E:18557 ||| :
the  ||| S:18557 E:18561 ||| DT
binding  ||| S:18561 E:18569 ||| NN
of  ||| S:18569 E:18572 ||| IN
fibulin-1  ||| S:18572 E:18582 ||| CD
to  ||| S:18582 E:18585 ||| TO
fibronectin  ||| S:18585 E:18597 ||| NN
is  ||| S:18597 E:18600 ||| VBZ
a  ||| S:18600 E:18612 ||| DT
heterotypic  ||| S:18612 E:18624 ||| JJ
interaction  ||| S:18624 E:18636 ||| NN
in  ||| S:18636 E:18639 ||| IN
which  ||| S:18639 E:18645 ||| WDT
an  ||| S:18645 E:18648 ||| DT
EGF-like  ||| S:18648 E:18657 ||| JJ
module  ||| S:18657 E:18664 ||| JJ
binds  ||| S:18664 E:18680 ||| NN
to  ||| S:18680 E:18683 ||| TO
a  ||| S:18683 E:18685 ||| DT
non  ||| S:18685 E:18689 ||| JJ
EGF-like  ||| S:18689 E:18698 ||| JJ
domain  ||| S:18698 E:18705 ||| NN
( ||| S:18705 E:18706 ||| -LRB-
the  ||| S:18706 E:18710 ||| DT
type  ||| S:18710 E:18715 ||| NN
III  ||| S:18715 E:18730 ||| NNP
13  ||| S:18730 E:18733 ||| CD
fibronectin  ||| S:18733 E:18745 ||| JJ
repeat ||| S:18745 E:18751 ||| NN
)  ||| S:18751 E:18753 ||| -RRB-
[  ||| S:18753 E:18755 ||| -LRB-
40  ||| S:18755 E:18758 ||| CD
]  ||| S:18758 E:18760 ||| -RRB-
.  ||| S:18760 E:18772 ||| .
Laminin  ||| S:18772 E:18780 ||| NNP
is  ||| S:18780 E:18783 ||| VBZ
a  ||| S:18783 E:18785 ||| DT
glycoprotein  ||| S:18785 E:18798 ||| NN
composed  ||| S:18798 E:18807 ||| VBN
of  ||| S:18807 E:18810 ||| IN
three  ||| S:18810 E:18816 ||| CD
chains ||| S:18816 E:18822 ||| NNS
,  ||| S:18822 E:18824 ||| ,
A ||| S:18824 E:18825 ||| NNP
,  ||| S:18825 E:18837 ||| ,
B1 ||| S:18837 E:18839 ||| NNP
,  ||| S:18839 E:18841 ||| ,
and  ||| S:18841 E:18845 ||| CC
B2  ||| S:18845 E:18848 ||| NN
in  ||| S:18848 E:18851 ||| IN
a  ||| S:18851 E:18853 ||| DT
cross-shaped  ||| S:18853 E:18866 ||| JJ
molecule ||| S:18866 E:18874 ||| NN
;  ||| S:18874 E:18876 ||| :
this  ||| S:18876 E:18881 ||| DT
protein  ||| S:18881 E:18889 ||| NN
is  ||| S:18889 E:18902 ||| VBZ
found  ||| S:18902 E:18908 ||| VBN
in  ||| S:18908 E:18911 ||| IN
basement  ||| S:18911 E:18920 ||| JJ
membranes  ||| S:18920 E:18930 ||| NN
where  ||| S:18930 E:18936 ||| WRB
it  ||| S:18936 E:18939 ||| PRP
interacts  ||| S:18939 E:18949 ||| VBD
with  ||| S:18949 E:18954 ||| IN
other  ||| S:18954 E:18970 ||| JJ
such  ||| S:18970 E:18975 ||| JJ
components  ||| S:18975 E:18986 ||| NNS
as  ||| S:18986 E:18989 ||| IN
collagen  ||| S:18989 E:18998 ||| JJ
IV ||| S:18998 E:19000 ||| NNP
,  ||| S:19000 E:19002 ||| ,
heparan-sulfate  ||| S:19002 E:19028 ||| JJ
proteoglycan ||| S:19028 E:19040 ||| NN
,  ||| S:19040 E:19042 ||| ,
and  ||| S:19042 E:19046 ||| CC
nidogen  ||| S:19046 E:19054 ||| NNS
[  ||| S:19054 E:19056 ||| -LRB-
45  ||| S:19056 E:19059 ||| CD
]  ||| S:19059 E:19061 ||| -RRB-
.  ||| S:19061 E:19063 ||| .
Laminin  ||| S:19063 E:19071 ||| NNP
contains  ||| S:19071 E:19090 ||| VBZ
EGF-like  ||| S:19090 E:19099 ||| JJ
modules  ||| S:19099 E:19107 ||| NN
in  ||| S:19107 E:19110 ||| IN
the  ||| S:19110 E:19114 ||| DT
amino-terminal  ||| S:19114 E:19129 ||| JJ
region  ||| S:19129 E:19136 ||| NN
of  ||| S:19136 E:19139 ||| IN
the  ||| S:19139 E:19143 ||| DT
A ||| S:19143 E:19144 ||| NNP
,  ||| S:19144 E:19156 ||| ,
B1 ||| S:19156 E:19158 ||| NNP
,  ||| S:19158 E:19160 ||| ,
and  ||| S:19160 E:19164 ||| CC
B2  ||| S:19164 E:19167 ||| JJ
chains  ||| S:19167 E:19174 ||| NNS
[  ||| S:19174 E:19176 ||| -LRB-
45  ||| S:19176 E:19179 ||| CD
]  ||| S:19179 E:19181 ||| -RRB-
.  ||| S:19181 E:19183 ||| .
Surprisingly ||| S:19183 E:19195 ||| RB
,  ||| S:19195 E:19197 ||| ,
these  ||| S:19197 E:19203 ||| DT
modules  ||| S:19203 E:19211 ||| NNS
do  ||| S:19211 E:19224 ||| VBP
not  ||| S:19224 E:19228 ||| RB
appear  ||| S:19228 E:19235 ||| VB
to  ||| S:19235 E:19238 ||| TO
be  ||| S:19238 E:19241 ||| VB
involved  ||| S:19241 E:19250 ||| VBN
in  ||| S:19250 E:19253 ||| IN
the  ||| S:19253 E:19257 ||| DT
binding  ||| S:19257 E:19265 ||| NN
of  ||| S:19265 E:19268 ||| IN
fibulin-1 ||| S:19268 E:19277 ||| CD
.  ||| S:19277 E:19289 ||| .
The  ||| S:19289 E:19293 ||| DT
site  ||| S:19293 E:19298 ||| NN
of  ||| S:19298 E:19301 ||| IN
fibulin-1  ||| S:19301 E:19311 ||| CD
binding  ||| S:19311 E:19319 ||| NN
to  ||| S:19319 E:19322 ||| TO
laminin  ||| S:19322 E:19330 ||| VB
maps  ||| S:19330 E:19335 ||| NNS
to  ||| S:19335 E:19338 ||| TO
the  ||| S:19338 E:19352 ||| DT
carboxyl-terminal  ||| S:19352 E:19370 ||| JJ
segment  ||| S:19370 E:19378 ||| NN
of  ||| S:19378 E:19381 ||| IN
the  ||| S:19381 E:19385 ||| DT
laminin  ||| S:19385 E:19393 ||| NN
A  ||| S:19393 E:19395 ||| DT
chain  ||| S:19395 E:19401 ||| NN
which  ||| S:19401 E:19417 ||| WDT
consists  ||| S:19417 E:19426 ||| VBZ
of  ||| S:19426 E:19429 ||| IN
five  ||| S:19429 E:19434 ||| CD
basic  ||| S:19434 E:19440 ||| JJ
tandem  ||| S:19440 E:19447 ||| NN
repeats  ||| S:19447 E:19455 ||| VBZ
containing  ||| S:19455 E:19476 ||| VBG
conserved  ||| S:19476 E:19486 ||| JJ
glycine  ||| S:19486 E:19494 ||| NN
and  ||| S:19494 E:19498 ||| CC
cysteine  ||| S:19498 E:19507 ||| JJ
residues  ||| S:19507 E:19516 ||| NNS
[  ||| S:19516 E:19518 ||| -LRB-
39  ||| S:19518 E:19521 ||| CD
46  ||| S:19521 E:19524 ||| CD
]  ||| S:19524 E:19526 ||| -RRB-
.  ||| S:19526 E:19528 ||| .
The  ||| S:19528 E:19542 ||| DT
binding  ||| S:19542 E:19550 ||| JJ
site  ||| S:19550 E:19555 ||| NN
of  ||| S:19555 E:19558 ||| IN
laminin  ||| S:19558 E:19566 ||| VBG
to  ||| S:19566 E:19569 ||| TO
fibulin-1  ||| S:19569 E:19579 ||| CD
maps  ||| S:19579 E:19584 ||| NNS
to  ||| S:19584 E:19587 ||| TO
the  ||| S:19587 E:19601 ||| DT
calcium-binding  ||| S:19601 E:19617 ||| JJ
type  ||| S:19617 E:19622 ||| NN
II  ||| S:19622 E:19625 ||| NNP
EGF-like  ||| S:19625 E:19634 ||| JJ
modules  ||| S:19634 E:19642 ||| NN
of  ||| S:19642 E:19645 ||| IN
fibulin-1  ||| S:19645 E:19655 ||| NNP
[  ||| S:19655 E:19667 ||| -LRB-
39  ||| S:19667 E:19670 ||| CD
]  ||| S:19670 E:19672 ||| -RRB-
.  ||| S:19672 E:19684 ||| .
Nidogen  ||| S:19684 E:19692 ||| NNP
is  ||| S:19692 E:19695 ||| VBZ
a  ||| S:19695 E:19697 ||| DT
basement  ||| S:19697 E:19706 ||| NN
membrane  ||| S:19706 E:19715 ||| NN
protein  ||| S:19715 E:19723 ||| NN
composed  ||| S:19723 E:19732 ||| VBN
of  ||| S:19732 E:19745 ||| IN
three  ||| S:19745 E:19751 ||| CD
globular  ||| S:19751 E:19760 ||| CD
domains  ||| S:19760 E:19768 ||| CD
G1-G3  ||| S:19768 E:19774 ||| CD
and  ||| S:19774 E:19778 ||| CC
two  ||| S:19778 E:19782 ||| CD
linking  ||| S:19782 E:19790 ||| CD
sequences ||| S:19790 E:19799 ||| NNS
;  ||| S:19799 E:19811 ||| :
domain  ||| S:19811 E:19818 ||| JJ
G1  ||| S:19818 E:19821 ||| NN
is  ||| S:19821 E:19824 ||| VBZ
joined  ||| S:19824 E:19831 ||| VBN
to  ||| S:19831 E:19834 ||| TO
domain  ||| S:19834 E:19841 ||| CD
G2  ||| S:19841 E:19844 ||| CD
through  ||| S:19844 E:19852 ||| IN
a  ||| S:19852 E:19854 ||| DT
flexible  ||| S:19854 E:19863 ||| JJ
link  ||| S:19863 E:19878 ||| NN
and  ||| S:19878 E:19882 ||| CC
domain  ||| S:19882 E:19889 ||| JJ
G2  ||| S:19889 E:19892 ||| NN
is  ||| S:19892 E:19895 ||| VBZ
connected  ||| S:19895 E:19905 ||| VBN
to  ||| S:19905 E:19908 ||| TO
domain  ||| S:19908 E:19915 ||| CD
G3  ||| S:19915 E:19918 ||| CD
by  ||| S:19918 E:19921 ||| IN
a  ||| S:19921 E:19923 ||| DT
rod-like  ||| S:19923 E:19942 ||| JJ
element  ||| S:19942 E:19950 ||| NN
consisting  ||| S:19950 E:19961 ||| VBG
of  ||| S:19961 E:19964 ||| IN
EGF-like  ||| S:19964 E:19973 ||| JJ
modules  ||| S:19973 E:19981 ||| NNS
[  ||| S:19981 E:19983 ||| -LRB-
47  ||| S:19983 E:19986 ||| CD
]  ||| S:19986 E:19988 ||| -RRB-
.  ||| S:19988 E:19990 ||| .
Nidogen1  ||| S:19990 E:20009 ||| NNP
is  ||| S:20009 E:20012 ||| VBZ
an  ||| S:20012 E:20015 ||| DT
important  ||| S:20015 E:20025 ||| JJ
structural  ||| S:20025 E:20036 ||| JJ
component  ||| S:20036 E:20046 ||| NN
of  ||| S:20046 E:20049 ||| IN
tertiary  ||| S:20049 E:20068 ||| JJ
complexes  ||| S:20068 E:20078 ||| NNS
with  ||| S:20078 E:20083 ||| IN
other  ||| S:20083 E:20089 ||| JJ
such  ||| S:20089 E:20094 ||| JJ
extracellular  ||| S:20094 E:20108 ||| JJ
components  ||| S:20108 E:20119 ||| NNS
as  ||| S:20119 E:20132 ||| IN
laminins ||| S:20132 E:20140 ||| NN
,  ||| S:20140 E:20142 ||| ,
collagen  ||| S:20142 E:20151 ||| VBG
IV ||| S:20151 E:20153 ||| NNP
,  ||| S:20153 E:20155 ||| ,
perlecan ||| S:20155 E:20163 ||| NN
,  ||| S:20163 E:20165 ||| ,
and  ||| S:20165 E:20169 ||| CC
fibulins  ||| S:20169 E:20178 ||| NNS
[  ||| S:20178 E:20180 ||| -LRB-
48  ||| S:20180 E:20183 ||| CD
]  ||| S:20183 E:20185 ||| -RRB-
.  ||| S:20185 E:20197 ||| .
Fibulin-1C  ||| S:20197 E:20208 ||| NNP
binds  ||| S:20208 E:20214 ||| VBD
to  ||| S:20214 E:20217 ||| TO
nidogen1  ||| S:20217 E:20226 ||| CD
through  ||| S:20226 E:20234 ||| IN
domain  ||| S:20234 E:20241 ||| JJ
G2  ||| S:20241 E:20244 ||| NN
of  ||| S:20244 E:20247 ||| IN
nidogen  ||| S:20247 E:20265 ||| NNS
[  ||| S:20265 E:20267 ||| -LRB-
48  ||| S:20267 E:20270 ||| CD
]  ||| S:20270 E:20272 ||| -RRB-
.  ||| S:20272 E:20274 ||| .
The  ||| S:20274 E:20278 ||| DT
nidogen  ||| S:20278 E:20286 ||| JJ
binding  ||| S:20286 E:20294 ||| JJ
site  ||| S:20294 E:20299 ||| NN
of  ||| S:20299 E:20302 ||| IN
fibulin-1C  ||| S:20302 E:20313 ||| NNP
includes  ||| S:20313 E:20332 ||| VBZ
the  ||| S:20332 E:20336 ||| DT
type  ||| S:20336 E:20341 ||| NN
II  ||| S:20341 E:20344 ||| NNP
EGF-like  ||| S:20344 E:20353 ||| NNP
modules  ||| S:20353 E:20361 ||| VBD
6-9  ||| S:20361 E:20365 ||| CD
and  ||| S:20365 E:20369 ||| CC
the  ||| S:20369 E:20383 ||| DT
carboxyl-terminal  ||| S:20383 E:20401 ||| JJ
domain  ||| S:20401 E:20408 ||| NN
[  ||| S:20408 E:20410 ||| -LRB-
42  ||| S:20410 E:20413 ||| CD
]  ||| S:20413 E:20415 ||| -RRB-
.  ||| S:20415 E:20427 ||| .
Aggrecan  ||| S:20427 E:20436 ||| NNP
and  ||| S:20436 E:20440 ||| CC
versican  ||| S:20440 E:20449 ||| NNS
are  ||| S:20449 E:20453 ||| VBP
aggregating  ||| S:20453 E:20465 ||| JJ
proteoglycans  ||| S:20465 E:20489 ||| NN
that  ||| S:20489 E:20494 ||| WDT
are  ||| S:20494 E:20498 ||| VBP
key  ||| S:20498 E:20502 ||| JJ
constituents  ||| S:20502 E:20515 ||| NNS
found  ||| S:20515 E:20521 ||| VBD
in  ||| S:20521 E:20524 ||| IN
the  ||| S:20524 E:20528 ||| DT
extracellular  ||| S:20528 E:20552 ||| JJ
matrix  ||| S:20552 E:20559 ||| NNS
[  ||| S:20559 E:20561 ||| -LRB-
41  ||| S:20561 E:20564 ||| CD
]  ||| S:20564 E:20566 ||| -RRB-
.  ||| S:20566 E:20568 ||| .
Both  ||| S:20568 E:20573 ||| DT
proteoglycans  ||| S:20573 E:20587 ||| NNS
contain  ||| S:20587 E:20595 ||| VBP
amino-terminal  ||| S:20595 E:20620 ||| JJ
hyaluronic  ||| S:20620 E:20631 ||| JJ
acid-binding  ||| S:20631 E:20644 ||| JJ
regions ||| S:20644 E:20651 ||| NNS
,  ||| S:20651 E:20653 ||| ,
central  ||| S:20653 E:20661 ||| JJ
core  ||| S:20661 E:20676 ||| NN
glycosaminoglycan  ||| S:20676 E:20694 ||| FW
attachment  ||| S:20694 E:20705 ||| FW
domains ||| S:20705 E:20712 ||| FW
,  ||| S:20712 E:20714 ||| ,
and  ||| S:20714 E:20728 ||| CC
carboxyl-terminal  ||| S:20728 E:20746 ||| JJ
domains  ||| S:20746 E:20754 ||| NNS
containing  ||| S:20754 E:20765 ||| VBG
EGF-like  ||| S:20765 E:20774 ||| JJ
modules  ||| S:20774 E:20792 ||| NNS
( ||| S:20792 E:20793 ||| -LRB-
one  ||| S:20793 E:20797 ||| CD
in  ||| S:20797 E:20800 ||| IN
aggrecan  ||| S:20800 E:20809 ||| NN
and  ||| S:20809 E:20813 ||| CC
two  ||| S:20813 E:20817 ||| CD
in  ||| S:20817 E:20820 ||| IN
versican ||| S:20820 E:20828 ||| CD
) ||| S:20828 E:20829 ||| -RRB-
,  ||| S:20829 E:20831 ||| ,
C-type  ||| S:20831 E:20838 ||| JJ
lectin  ||| S:20838 E:20845 ||| NN
like  ||| S:20845 E:20860 ||| IN
modules  ||| S:20860 E:20868 ||| NN
and  ||| S:20868 E:20872 ||| CC
complement  ||| S:20872 E:20883 ||| VB
regulatory  ||| S:20883 E:20894 ||| JJ
protein-like  ||| S:20894 E:20907 ||| JJ
modules  ||| S:20907 E:20915 ||| NNS
[  ||| S:20915 E:20927 ||| -LRB-
49  ||| S:20927 E:20930 ||| CD
50  ||| S:20930 E:20933 ||| CD
]  ||| S:20933 E:20935 ||| -RRB-
.  ||| S:20935 E:20937 ||| .
Fibulin-1  ||| S:20937 E:20947 ||| NNP
exhibits  ||| S:20947 E:20956 ||| VBZ
calcium-dependent  ||| S:20956 E:20974 ||| JJ
binding  ||| S:20974 E:20982 ||| NN
to  ||| S:20982 E:20995 ||| TO
the  ||| S:20995 E:20999 ||| DT
carboxyl-terminal  ||| S:20999 E:21017 ||| JJ
domain  ||| S:21017 E:21024 ||| NN
of  ||| S:21024 E:21027 ||| IN
aggrecan  ||| S:21027 E:21036 ||| NN
and  ||| S:21036 E:21040 ||| CC
versican  ||| S:21040 E:21049 ||| NNS
[  ||| S:21049 E:21061 ||| -LRB-
41  ||| S:21061 E:21064 ||| CD
]  ||| S:21064 E:21066 ||| -RRB-
.  ||| S:21066 E:21068 ||| .
The  ||| S:21068 E:21072 ||| DT
binding  ||| S:21072 E:21080 ||| JJ
site  ||| S:21080 E:21085 ||| NN
of  ||| S:21085 E:21088 ||| IN
aggrecan  ||| S:21088 E:21097 ||| VBG
to  ||| S:21097 E:21100 ||| TO
fibulin-1  ||| S:21100 E:21110 ||| CD
maps  ||| S:21110 E:21115 ||| NNS
to  ||| S:21115 E:21128 ||| TO
the  ||| S:21128 E:21132 ||| DT
type  ||| S:21132 E:21137 ||| NN
II  ||| S:21137 E:21140 ||| NNP
EGF-like  ||| S:21140 E:21149 ||| NNP
modules  ||| S:21149 E:21157 ||| VBD
8-9  ||| S:21157 E:21161 ||| CD
and  ||| S:21161 E:21165 ||| CC
the  ||| S:21165 E:21179 ||| DT
carboxyl-terminal  ||| S:21179 E:21197 ||| JJ
domain  ||| S:21197 E:21204 ||| NN
of  ||| S:21204 E:21207 ||| IN
fibulin-1  ||| S:21207 E:21217 ||| NNP
[  ||| S:21217 E:21219 ||| -LRB-
41  ||| S:21219 E:21222 ||| CD
]  ||| S:21222 E:21224 ||| -RRB-
.  ||| S:21224 E:21226 ||| .
The  ||| S:21226 E:21240 ||| DT
binding  ||| S:21240 E:21248 ||| JJ
site  ||| S:21248 E:21253 ||| NN
of  ||| S:21253 E:21256 ||| IN
versican  ||| S:21256 E:21265 ||| VBG
to  ||| S:21265 E:21268 ||| TO
fibulin-1  ||| S:21268 E:21278 ||| CD
maps  ||| S:21278 E:21283 ||| NNS
to  ||| S:21283 E:21286 ||| TO
the  ||| S:21286 E:21290 ||| DT
type  ||| S:21290 E:21295 ||| NN
II  ||| S:21295 E:21308 ||| NNP
EGF-like  ||| S:21308 E:21317 ||| NNP
modules  ||| S:21317 E:21325 ||| VBD
2-8  ||| S:21325 E:21329 ||| CD
of  ||| S:21329 E:21332 ||| IN
fibulin-1  ||| S:21332 E:21342 ||| NNP
[  ||| S:21342 E:21344 ||| -LRB-
41  ||| S:21344 E:21347 ||| CD
]  ||| S:21347 E:21349 ||| -RRB-
.  ||| S:21349 E:21361 ||| .
Fibulin-1  ||| S:21361 E:21371 ||| NNP
has  ||| S:21371 E:21375 ||| VBZ
been  ||| S:21375 E:21380 ||| VBN
reported  ||| S:21380 E:21389 ||| VBN
two  ||| S:21389 E:21393 ||| CD
exhibit  ||| S:21393 E:21411 ||| NN
calcium-dependent  ||| S:21411 E:21429 ||| JJ
self-association  ||| S:21429 E:21446 ||| NN
[  ||| S:21446 E:21448 ||| -LRB-
40  ||| S:21448 E:21451 ||| CD
44  ||| S:21451 E:21454 ||| CD
]  ||| S:21454 E:21456 ||| -RRB-
.  ||| S:21456 E:21458 ||| .
The  ||| S:21458 E:21462 ||| DT
two  ||| S:21462 E:21476 ||| CD
self-association  ||| S:21476 E:21493 ||| JJ
sites  ||| S:21493 E:21499 ||| NNS
map  ||| S:21499 E:21503 ||| VBP
to  ||| S:21503 E:21506 ||| TO
type  ||| S:21506 E:21511 ||| NN
II  ||| S:21511 E:21514 ||| NNP
EGF-like  ||| S:21514 E:21523 ||| NNP
modules  ||| S:21523 E:21531 ||| VBD
5  ||| S:21531 E:21543 ||| CD
and  ||| S:21543 E:21547 ||| CC
6  ||| S:21547 E:21549 ||| CD
and  ||| S:21549 E:21553 ||| CC
to  ||| S:21553 E:21556 ||| TO
a  ||| S:21556 E:21558 ||| DT
cryptic  ||| S:21558 E:21566 ||| JJ
site  ||| S:21566 E:21571 ||| NN
in  ||| S:21571 E:21574 ||| IN
the  ||| S:21574 E:21578 ||| DT
amino-terminal  ||| S:21578 E:21593 ||| JJ
region  ||| S:21593 E:21610 ||| NN
of  ||| S:21610 E:21613 ||| IN
fibulin-1  ||| S:21613 E:21623 ||| NNP
[  ||| S:21623 E:21625 ||| -LRB-
40  ||| S:21625 E:21628 ||| CD
44  ||| S:21628 E:21631 ||| CD
]  ||| S:21631 E:21633 ||| -RRB-
.  ||| S:21633 E:21645 ||| .
As  ||| S:21645 E:21648 ||| RB
described  ||| S:21648 E:21658 ||| VBN
above ||| S:21658 E:21663 ||| IN
,  ||| S:21663 E:21665 ||| ,
the  ||| S:21665 E:21669 ||| DT
calcium-binding  ||| S:21669 E:21685 ||| JJ
type  ||| S:21685 E:21690 ||| NN
II  ||| S:21690 E:21703 ||| NNP
EGF-like  ||| S:21703 E:21712 ||| JJ
modules  ||| S:21712 E:21720 ||| NN
of  ||| S:21720 E:21723 ||| IN
fibulin-1  ||| S:21723 E:21733 ||| NNP
are  ||| S:21733 E:21737 ||| VBP
used  ||| S:21737 E:21742 ||| VBN
in  ||| S:21742 E:21745 ||| IN
various  ||| S:21745 E:21763 ||| JJ
extracellular  ||| S:21763 E:21777 ||| JJ
matrix  ||| S:21777 E:21784 ||| JJ
interactions ||| S:21784 E:21796 ||| NNS
.  ||| S:21796 E:21798 ||| .
It  ||| S:21798 E:21801 ||| PRP
is  ||| S:21801 E:21804 ||| VBZ
noteworthy  ||| S:21804 E:21815 ||| VBN
that  ||| S:21815 E:21830 ||| IN
these  ||| S:21830 E:21836 ||| DT
modules  ||| S:21836 E:21844 ||| NN
may  ||| S:21844 E:21848 ||| MD
interact  ||| S:21848 E:21857 ||| VB
with  ||| S:21857 E:21862 ||| IN
other  ||| S:21862 E:21868 ||| JJ
EGF-like  ||| S:21868 E:21877 ||| JJ
modules  ||| S:21877 E:21885 ||| NN
or  ||| S:21885 E:21898 ||| CC
with  ||| S:21898 E:21903 ||| IN
non  ||| S:21903 E:21907 ||| JJ
EGF-like  ||| S:21907 E:21916 ||| JJ
modules ||| S:21916 E:21923 ||| NN
.  ||| S:21923 E:21935 ||| .
The  ||| S:21935 E:21939 ||| DT
yeast  ||| S:21939 E:21945 ||| NN
two-hybrid  ||| S:21945 E:21956 ||| JJ
system  ||| S:21956 E:21963 ||| NN
and  ||| S:21963 E:21967 ||| CC
colony  ||| S:21967 E:21974 ||| NN
hybridization  ||| S:21974 E:21998 ||| NN
screens  ||| S:21998 E:22006 ||| VBZ
used  ||| S:22006 E:22011 ||| VBN
in  ||| S:22011 E:22014 ||| IN
this  ||| S:22014 E:22019 ||| DT
study  ||| S:22019 E:22025 ||| NN
indicated  ||| S:22025 E:22035 ||| VBD
that  ||| S:22035 E:22040 ||| IN
a  ||| S:22040 E:22042 ||| DT
monkey  ||| S:22042 E:22049 ||| JJ
cDNA  ||| S:22049 E:22064 ||| JJ
clone  ||| S:22064 E:22070 ||| NNS
( ||| S:22070 E:22071 ||| -LRB-
Fig.  ||| S:22071 E:22076 ||| CD
3 ||| S:22076 E:22077 ||| CD
) ||| S:22077 E:22078 ||| -RRB-
,  ||| S:22078 E:22080 ||| ,
containing  ||| S:22080 E:22091 ||| VBG
half  ||| S:22091 E:22096 ||| NN
of  ||| S:22096 E:22099 ||| IN
the  ||| S:22099 E:22103 ||| DT
anaphylatoxin  ||| S:22103 E:22117 ||| JJ
type  ||| S:22117 E:22132 ||| NN
I  ||| S:22132 E:22134 ||| PRP
repeats ||| S:22134 E:22141 ||| VBZ
,  ||| S:22141 E:22143 ||| ,
an  ||| S:22143 E:22146 ||| DT
EGF-adjoining  ||| S:22146 E:22160 ||| JJ
sequence ||| S:22160 E:22168 ||| NN
,  ||| S:22168 E:22170 ||| ,
calcium-binding  ||| S:22170 E:22196 ||| JJ
EGF-like  ||| S:22196 E:22205 ||| JJ
modules  ||| S:22205 E:22213 ||| NN
and  ||| S:22213 E:22217 ||| CC
a  ||| S:22217 E:22219 ||| DT
carboxyl-terminal  ||| S:22219 E:22237 ||| JJ
fibulin-type  ||| S:22237 E:22260 ||| JJ
module ||| S:22260 E:22266 ||| NN
,  ||| S:22266 E:22268 ||| ,
demonstrated  ||| S:22268 E:22281 ||| VBD
interaction  ||| S:22281 E:22293 ||| VBN
with  ||| S:22293 E:22298 ||| IN
the  ||| S:22298 E:22302 ||| DT
extracellular  ||| S:22302 E:22326 ||| JJ
domain  ||| S:22326 E:22333 ||| NN
of  ||| S:22333 E:22336 ||| IN
proHB-EGF  ||| S:22336 E:22346 ||| NNP
( ||| S:22346 E:22347 ||| -LRB-
Additional  ||| S:22347 E:22358 ||| JJ
file  ||| S:22358 E:22363 ||| NN
1 ||| S:22363 E:22364 ||| CD
) ||| S:22364 E:22365 ||| -RRB-
.  ||| S:22365 E:22367 ||| .
To  ||| S:22367 E:22370 ||| TO
see  ||| S:22370 E:22374 ||| VB
if  ||| S:22374 E:22377 ||| IN
the  ||| S:22377 E:22391 ||| DT
any ||| S:22391 E:22394 ||| DT
/ ||| S:22394 E:22395 ||| NN
all  ||| S:22395 E:22399 ||| RB
of  ||| S:22399 E:22402 ||| IN
the  ||| S:22402 E:22406 ||| DT
calcium-binding  ||| S:22406 E:22422 ||| JJ
EGF-like  ||| S:22422 E:22431 ||| JJ
modules  ||| S:22431 E:22439 ||| NN
were  ||| S:22439 E:22454 ||| VBD
necessary  ||| S:22454 E:22464 ||| JJ
for  ||| S:22464 E:22468 ||| IN
this  ||| S:22468 E:22473 ||| DT
interaction ||| S:22473 E:22484 ||| NN
,  ||| S:22484 E:22486 ||| ,
two  ||| S:22486 E:22490 ||| CD
clones  ||| S:22490 E:22497 ||| NNS
were  ||| S:22497 E:22512 ||| VBD
constructed ||| S:22512 E:22523 ||| VBN
.  ||| S:22523 E:22525 ||| .
A  ||| S:22525 E:22527 ||| DT
clone ||| S:22527 E:22532 ||| NN
,  ||| S:22532 E:22534 ||| ,
pGAD424 ||| S:22534 E:22541 ||| FW
/ ||| S:22541 E:22542 ||| FW
Fib-1C  ||| S:22542 E:22549 ||| FW
EGF  ||| S:22549 E:22553 ||| FW
# ||| S:22553 E:22554 ||| #
5-COOH ||| S:22554 E:22560 ||| CD
,  ||| S:22560 E:22562 ||| ,
that  ||| S:22562 E:22577 ||| WDT
contained  ||| S:22577 E:22587 ||| VBD
calcium-binding  ||| S:22587 E:22603 ||| JJ
type  ||| S:22603 E:22608 ||| NN
EGF-like  ||| S:22608 E:22617 ||| JJ
modules  ||| S:22617 E:22625 ||| JJ
# ||| S:22625 E:22626 ||| #
5-9  ||| S:22626 E:22630 ||| CD
and  ||| S:22630 E:22644 ||| CC
the  ||| S:22644 E:22648 ||| DT
carboxyl-terminus  ||| S:22648 E:22666 ||| JJ
of  ||| S:22666 E:22669 ||| IN
fibulin-1C  ||| S:22669 E:22680 ||| CD
fused  ||| S:22680 E:22686 ||| NN
to  ||| S:22686 E:22689 ||| TO
the  ||| S:22689 E:22703 ||| DT
GAL4-activation  ||| S:22703 E:22719 ||| JJ
domain  ||| S:22719 E:22726 ||| NN
( ||| S:22726 E:22727 ||| -LRB-
see  ||| S:22727 E:22731 ||| VB
Fig.  ||| S:22731 E:22736 ||| CD
3and  ||| S:22736 E:22741 ||| CD
materials  ||| S:22741 E:22751 ||| NNS
and  ||| S:22751 E:22765 ||| CC
methods ||| S:22765 E:22772 ||| NNS
)  ||| S:22772 E:22774 ||| -RRB-
was  ||| S:22774 E:22778 ||| VBD
tested  ||| S:22778 E:22785 ||| VBN
using  ||| S:22785 E:22791 ||| VBG
the  ||| S:22791 E:22795 ||| DT
yeast  ||| S:22795 E:22801 ||| NN
two-hybrid  ||| S:22801 E:22812 ||| JJ
system  ||| S:22812 E:22819 ||| NN
and  ||| S:22819 E:22833 ||| CC
found  ||| S:22833 E:22839 ||| VBD
to  ||| S:22839 E:22842 ||| TO
interact  ||| S:22842 E:22851 ||| VB
with  ||| S:22851 E:22856 ||| IN
the  ||| S:22856 E:22860 ||| DT
extracellular  ||| S:22860 E:22874 ||| JJ
domain  ||| S:22874 E:22881 ||| NN
of  ||| S:22881 E:22894 ||| IN
proHB-EGF  ||| S:22894 E:22904 ||| NNP
( ||| S:22904 E:22905 ||| -LRB-
Table  ||| S:22905 E:22911 ||| NNP
1 ||| S:22911 E:22912 ||| CD
) ||| S:22912 E:22913 ||| -RRB-
.  ||| S:22913 E:22915 ||| .
In  ||| S:22915 E:22918 ||| IN
constrast ||| S:22918 E:22927 ||| NN
,  ||| S:22927 E:22929 ||| ,
the  ||| S:22929 E:22933 ||| DT
construct ||| S:22933 E:22942 ||| NN
,  ||| S:22942 E:22954 ||| ,
pGAD424 ||| S:22954 E:22961 ||| FW
/ ||| S:22961 E:22962 ||| FW
Fib-1C  ||| S:22962 E:22969 ||| FW
EGF ||| S:22969 E:22972 ||| FW
# ||| S:22972 E:22973 ||| #
1-5 ||| S:22973 E:22976 ||| CD
,  ||| S:22976 E:22978 ||| ,
that  ||| S:22978 E:22983 ||| WDT
contained  ||| S:22983 E:22993 ||| VBD
calcium-binding  ||| S:22993 E:23019 ||| JJ
type  ||| S:23019 E:23024 ||| NN
II  ||| S:23024 E:23027 ||| NNP
EGF-like  ||| S:23027 E:23036 ||| NNP
modules  ||| S:23036 E:23044 ||| VBD
# ||| S:23044 E:23045 ||| #
1-5  ||| S:23045 E:23049 ||| CD
fused  ||| S:23049 E:23055 ||| NN
to  ||| S:23055 E:23058 ||| TO
the  ||| S:23058 E:23062 ||| DT
GAL4  ||| S:23062 E:23077 ||| FW
activation  ||| S:23077 E:23088 ||| FW
domain  ||| S:23088 E:23095 ||| FW
( ||| S:23095 E:23096 ||| -LRB-
see  ||| S:23096 E:23100 ||| VB
Fig.  ||| S:23100 E:23105 ||| CD
3and  ||| S:23105 E:23110 ||| CD
materials  ||| S:23110 E:23120 ||| NNS
and  ||| S:23120 E:23124 ||| CC
methods ||| S:23124 E:23131 ||| NNS
)  ||| S:23131 E:23143 ||| -RRB-
did  ||| S:23143 E:23147 ||| VBD
not  ||| S:23147 E:23151 ||| RB
interact  ||| S:23151 E:23160 ||| VBN
with  ||| S:23160 E:23165 ||| IN
proHB-EGF  ||| S:23165 E:23175 ||| NNP
( ||| S:23175 E:23176 ||| -LRB-
Additional  ||| S:23176 E:23187 ||| JJ
file  ||| S:23187 E:23192 ||| NN
1 ||| S:23192 E:23193 ||| CD
) ||| S:23193 E:23194 ||| -RRB-
.  ||| S:23194 E:23196 ||| .
It  ||| S:23196 E:23209 ||| PRP
remains  ||| S:23209 E:23217 ||| VBZ
to  ||| S:23217 E:23220 ||| TO
be  ||| S:23220 E:23223 ||| VB
determined  ||| S:23223 E:23234 ||| VBN
which  ||| S:23234 E:23240 ||| WDT
of  ||| S:23240 E:23243 ||| IN
the  ||| S:23243 E:23247 ||| DT
regions  ||| S:23247 E:23255 ||| NNS
within  ||| S:23255 E:23262 ||| IN
the  ||| S:23262 E:23276 ||| DT
EGF-like  ||| S:23276 E:23285 ||| JJ
modules  ||| S:23285 E:23293 ||| JJ
# ||| S:23293 E:23294 ||| #
5-9  ||| S:23294 E:23298 ||| CD
( ||| S:23298 E:23299 ||| -LRB-
e.g.  ||| S:23299 E:23304 ||| CD
hydroxylation  ||| S:23304 E:23318 ||| NNS
and  ||| S:23318 E:23332 ||| CC
glycosylation  ||| S:23332 E:23346 ||| JJ
sites ||| S:23346 E:23351 ||| NNS
)  ||| S:23351 E:23353 ||| -RRB-
and  ||| S:23353 E:23357 ||| CC
the  ||| S:23357 E:23361 ||| DT
carboxyl-terminus  ||| S:23361 E:23379 ||| JJ
of  ||| S:23379 E:23392 ||| IN
fibulin-1C  ||| S:23392 E:23403 ||| NNP
are  ||| S:23403 E:23407 ||| VBP
necessary  ||| S:23407 E:23417 ||| JJ
for  ||| S:23417 E:23421 ||| IN
the  ||| S:23421 E:23425 ||| DT
interaction  ||| S:23425 E:23437 ||| NN
with  ||| S:23437 E:23452 ||| IN
proHB-EGF ||| S:23452 E:23461 ||| JJ
.  ||| S:23461 E:23463 ||| .
The  ||| S:23463 E:23467 ||| DT
interaction  ||| S:23467 E:23479 ||| NN
of  ||| S:23479 E:23482 ||| IN
fibulin-1C  ||| S:23482 E:23493 ||| NNP
may  ||| S:23493 E:23497 ||| MD
map  ||| S:23497 E:23501 ||| VB
to  ||| S:23501 E:23504 ||| TO
the  ||| S:23504 E:23518 ||| DT
heparin-binding  ||| S:23518 E:23534 ||| JJ
region  ||| S:23534 E:23541 ||| NN
of  ||| S:23541 E:23544 ||| IN
the  ||| S:23544 E:23548 ||| DT
extracellular  ||| S:23548 E:23562 ||| JJ
domain  ||| S:23562 E:23569 ||| NN
of  ||| S:23569 E:23582 ||| IN
proHB-EGF  ||| S:23582 E:23592 ||| JJ
or  ||| S:23592 E:23595 ||| CC
it  ||| S:23595 E:23598 ||| PRP
may  ||| S:23598 E:23602 ||| MD
map  ||| S:23602 E:23606 ||| VB
to  ||| S:23606 E:23609 ||| TO
the  ||| S:23609 E:23613 ||| DT
EGF-like  ||| S:23613 E:23622 ||| JJ
module  ||| S:23622 E:23629 ||| NN
of  ||| S:23629 E:23642 ||| IN
proHB-EGF  ||| S:23642 E:23652 ||| JJ
or  ||| S:23652 E:23655 ||| CC
it  ||| S:23655 E:23658 ||| PRP
may  ||| S:23658 E:23662 ||| MD
map  ||| S:23662 E:23666 ||| VB
to  ||| S:23666 E:23669 ||| TO
both  ||| S:23669 E:23674 ||| DT
of  ||| S:23674 E:23677 ||| IN
these  ||| S:23677 E:23683 ||| DT
regions  ||| S:23683 E:23691 ||| NNS
within  ||| S:23691 E:23708 ||| IN
proHB-EGF ||| S:23708 E:23717 ||| JJ
.  ||| S:23717 E:23719 ||| .
To  ||| S:23719 E:23722 ||| TO
test  ||| S:23722 E:23727 ||| VB
whether  ||| S:23727 E:23735 ||| IN
the  ||| S:23735 E:23739 ||| DT
fibulin-1C  ||| S:23739 E:23750 ||| JJ
interaction  ||| S:23750 E:23772 ||| NN
with  ||| S:23772 E:23777 ||| IN
proHB-EGF  ||| S:23777 E:23787 ||| JJ
maps  ||| S:23787 E:23792 ||| NNS
to  ||| S:23792 E:23795 ||| TO
the  ||| S:23795 E:23799 ||| DT
heparin-binding  ||| S:23799 E:23815 ||| JJ
region ||| S:23815 E:23821 ||| NN
,  ||| S:23821 E:23823 ||| ,
a  ||| S:23823 E:23835 ||| DT
construct ||| S:23835 E:23844 ||| NN
,  ||| S:23844 E:23846 ||| ,
pGBT9 ||| S:23846 E:23851 ||| NNP
/ ||| S:23851 E:23852 ||| NNP
prodelHB-EGF ||| S:23852 E:23864 ||| NNP
,  ||| S:23864 E:23866 ||| ,
containing  ||| S:23866 E:23877 ||| VBG
amino  ||| S:23877 E:23883 ||| JJ
acid  ||| S:23883 E:23898 ||| NN
residues  ||| S:23898 E:23907 ||| VBD
Asp  ||| S:23907 E:23911 ||| NNP
106-His  ||| S:23911 E:23919 ||| CD
159 ||| S:23919 E:23922 ||| CD
( ||| S:23922 E:23923 ||| -LRB-
the  ||| S:23923 E:23927 ||| DT
entire  ||| S:23927 E:23934 ||| JJ
EGF  ||| S:23934 E:23938 ||| NN
like  ||| S:23938 E:23943 ||| IN
region  ||| S:23943 E:23950 ||| NN
of  ||| S:23950 E:23963 ||| IN
proHB-EGF  ||| S:23963 E:23973 ||| JJ
and  ||| S:23973 E:23977 ||| CC
18  ||| S:23977 E:23980 ||| CD
out  ||| S:23980 E:23984 ||| IN
of  ||| S:23984 E:23987 ||| IN
32  ||| S:23987 E:23990 ||| CD
residues  ||| S:23990 E:23999 ||| NNS
of  ||| S:23999 E:24002 ||| IN
the  ||| S:24002 E:24016 ||| DT
heparin-binding  ||| S:24016 E:24032 ||| JJ
region ||| S:24032 E:24038 ||| NN
)  ||| S:24038 E:24040 ||| -RRB-
[  ||| S:24040 E:24042 ||| -LRB-
2  ||| S:24042 E:24044 ||| LS
]  ||| S:24044 E:24046 ||| -RRB-
was  ||| S:24046 E:24050 ||| VBD
used  ||| S:24050 E:24055 ||| VBN
in  ||| S:24055 E:24058 ||| IN
the  ||| S:24058 E:24062 ||| DT
yeast  ||| S:24062 E:24078 ||| NN
two-hybrid  ||| S:24078 E:24089 ||| JJ
system  ||| S:24089 E:24096 ||| NN
( ||| S:24096 E:24097 ||| -LRB-
see  ||| S:24097 E:24101 ||| VB
materials  ||| S:24101 E:24111 ||| NNS
and  ||| S:24111 E:24115 ||| CC
methods ||| S:24115 E:24122 ||| NNS
) ||| S:24122 E:24123 ||| -RRB-
.  ||| S:24123 E:24125 ||| .
Construct  ||| S:24125 E:24145 ||| NNP
pGBT9 ||| S:24145 E:24150 ||| NNP
/ ||| S:24150 E:24151 ||| NNP
prodelHB-EGF  ||| S:24151 E:24164 ||| NNP
was  ||| S:24164 E:24168 ||| VBD
unable  ||| S:24168 E:24175 ||| JJ
to  ||| S:24175 E:24178 ||| TO
interact  ||| S:24178 E:24187 ||| VB
with  ||| S:24187 E:24202 ||| IN
pGAD424 ||| S:24202 E:24209 ||| CD
/ ||| S:24209 E:24210 ||| CD
Fib-1C  ||| S:24210 E:24217 ||| CD
EGF ||| S:24217 E:24220 ||| JJ
# ||| S:24220 E:24221 ||| #
5-COOH  ||| S:24221 E:24228 ||| CD
( ||| S:24228 E:24229 ||| -LRB-
data  ||| S:24229 E:24234 ||| NNS
not  ||| S:24234 E:24238 ||| RB
shown ||| S:24238 E:24243 ||| VBN
) ||| S:24243 E:24244 ||| -RRB-
.  ||| S:24244 E:24246 ||| .
Caution  ||| S:24246 E:24254 ||| NN
must  ||| S:24254 E:24269 ||| MD
be  ||| S:24269 E:24272 ||| VB
used  ||| S:24272 E:24277 ||| VBN
with  ||| S:24277 E:24282 ||| IN
this  ||| S:24282 E:24287 ||| DT
result  ||| S:24287 E:24294 ||| NN
however ||| S:24294 E:24301 ||| RB
,  ||| S:24301 E:24303 ||| ,
as  ||| S:24303 E:24306 ||| IN
the  ||| S:24306 E:24310 ||| DT
size  ||| S:24310 E:24315 ||| NN
of  ||| S:24315 E:24318 ||| IN
the  ||| S:24318 E:24332 ||| DT
cloned  ||| S:24332 E:24339 ||| JJ
prodelHB-EGF  ||| S:24339 E:24352 ||| JJ
region  ||| S:24352 E:24359 ||| NN
is  ||| S:24359 E:24362 ||| VBZ
small ||| S:24362 E:24367 ||| JJ
,  ||| S:24367 E:24369 ||| ,
encoding  ||| S:24369 E:24378 ||| VBD
just  ||| S:24378 E:24383 ||| RB
54  ||| S:24383 E:24396 ||| CD
amino  ||| S:24396 E:24402 ||| CD
acids ||| S:24402 E:24407 ||| NNS
;  ||| S:24407 E:24409 ||| :
this  ||| S:24409 E:24414 ||| DT
may  ||| S:24414 E:24418 ||| MD
have  ||| S:24418 E:24423 ||| VB
resulted  ||| S:24423 E:24432 ||| VBN
in  ||| S:24432 E:24435 ||| IN
a  ||| S:24435 E:24437 ||| DT
Gal4  ||| S:24437 E:24442 ||| JJ
fusion  ||| S:24442 E:24459 ||| NN
protein  ||| S:24459 E:24467 ||| NN
in  ||| S:24467 E:24470 ||| IN
which  ||| S:24470 E:24476 ||| WDT
the  ||| S:24476 E:24480 ||| DT
EGF  ||| S:24480 E:24484 ||| NNP
epitopes  ||| S:24484 E:24493 ||| NN
in  ||| S:24493 E:24496 ||| IN
prodelHB-EGF  ||| S:24496 E:24509 ||| NNS
are  ||| S:24509 E:24523 ||| VBP
hidden  ||| S:24523 E:24530 ||| VBN
by  ||| S:24530 E:24533 ||| IN
the  ||| S:24533 E:24537 ||| DT
Gal4  ||| S:24537 E:24542 ||| CD
subunit  ||| S:24542 E:24550 ||| NNS
and  ||| S:24550 E:24554 ||| CC
thus  ||| S:24554 E:24559 ||| RB
not  ||| S:24559 E:24563 ||| RB
recognized  ||| S:24563 E:24574 ||| VBN
by  ||| S:24574 E:24577 ||| IN
the  ||| S:24577 E:24591 ||| DT
GAL4  ||| S:24591 E:24596 ||| JJ
fusion  ||| S:24596 E:24603 ||| NN
partner  ||| S:24603 E:24611 ||| NN
protein  ||| S:24611 E:24619 ||| NN
( ||| S:24619 E:24620 ||| -LRB-
GAL4 ||| S:24620 E:24624 ||| FW
/ ||| S:24624 E:24625 ||| FW
Fib-lC  ||| S:24625 E:24632 ||| FW
EGF  ||| S:24632 E:24646 ||| FW
# ||| S:24646 E:24647 ||| #
5-COOH ||| S:24647 E:24653 ||| CD
) ||| S:24653 E:24654 ||| -RRB-
.  ||| S:24654 E:24666 ||| .
Additional  ||| S:24666 E:24677 ||| JJ
file  ||| S:24677 E:24682 ||| NN
1  ||| S:24682 E:24694 ||| CD
β-galatosidase  ||| S:24694 E:24709 ||| JJ
activity  ||| S:24709 E:24718 ||| NN
of  ||| S:24718 E:24721 ||| IN
years  ||| S:24721 E:24727 ||| NNS
two-hybrid  ||| S:24727 E:24738 ||| JJ
fusion  ||| S:24738 E:24755 ||| NN
proteins  ||| S:24755 E:24764 ||| NNS
with  ||| S:24764 E:24769 ||| IN
the  ||| S:24769 E:24773 ||| DT
extracellular  ||| S:24773 E:24787 ||| JJ
domain  ||| S:24787 E:24794 ||| NN
of  ||| S:24794 E:24797 ||| IN
proHB-EGF ||| S:24797 E:24806 ||| JJ
.  ||| S:24806 E:24818 ||| .
Click  ||| S:24818 E:24824 ||| NNP
here  ||| S:24824 E:24829 ||| RB
for  ||| S:24829 E:24833 ||| IN
file  ||| S:24833 E:24848 ||| NN
Fibulin-1  ||| S:24848 E:24858 ||| NN
is  ||| S:24858 E:24861 ||| VBZ
incorporated  ||| S:24861 E:24874 ||| VBN
into  ||| S:24874 E:24879 ||| IN
fibronectin-containing  ||| S:24879 E:24912 ||| JJ
matrix  ||| S:24912 E:24919 ||| JJ
fibers  ||| S:24919 E:24926 ||| NNS
[  ||| S:24926 E:24928 ||| -LRB-
44  ||| S:24928 E:24931 ||| CD
51  ||| S:24931 E:24934 ||| CD
]  ||| S:24934 E:24936 ||| -RRB-
.  ||| S:24936 E:24938 ||| .
Although  ||| S:24938 E:24947 ||| IN
a  ||| S:24947 E:24949 ||| DT
distinct  ||| S:24949 E:24958 ||| JJ
function  ||| S:24958 E:24977 ||| NN
for  ||| S:24977 E:24981 ||| IN
fibulin-1  ||| S:24981 E:24991 ||| NNP
has  ||| S:24991 E:24995 ||| VBZ
not  ||| S:24995 E:24999 ||| RB
yet  ||| S:24999 E:25003 ||| RB
been  ||| S:25003 E:25008 ||| VBN
described ||| S:25008 E:25017 ||| VBN
,  ||| S:25017 E:25019 ||| ,
it  ||| S:25019 E:25022 ||| PRP
is  ||| S:25022 E:25035 ||| VBZ
conceivable  ||| S:25035 E:25047 ||| VBN
that  ||| S:25047 E:25052 ||| IN
fibulin-1  ||| S:25052 E:25062 ||| NNP
is  ||| S:25062 E:25065 ||| VBZ
important  ||| S:25065 E:25075 ||| JJ
for  ||| S:25075 E:25079 ||| IN
cell  ||| S:25079 E:25084 ||| NN
adhesion  ||| S:25084 E:25103 ||| NNS
and  ||| S:25103 E:25107 ||| CC
migration  ||| S:25107 E:25117 ||| NN
along  ||| S:25117 E:25123 ||| IN
protein  ||| S:25123 E:25131 ||| NN
fibers  ||| S:25131 E:25138 ||| NNS
within  ||| S:25138 E:25145 ||| IN
the  ||| S:25145 E:25159 ||| DT
extracellular  ||| S:25159 E:25173 ||| JJ
matrix ||| S:25173 E:25179 ||| NN
.  ||| S:25179 E:25181 ||| .
Fibulin-1  ||| S:25181 E:25191 ||| NNP
may  ||| S:25191 E:25195 ||| MD
serve  ||| S:25195 E:25201 ||| VB
to  ||| S:25201 E:25204 ||| TO
anchor  ||| S:25204 E:25211 ||| VB
the  ||| S:25211 E:25225 ||| DT
mHB-EGF  ||| S:25225 E:25233 ||| JJ
to  ||| S:25233 E:25236 ||| TO
its  ||| S:25236 E:25240 ||| PRP$
fibers  ||| S:25240 E:25247 ||| NNS
as  ||| S:25247 E:25250 ||| IN
it  ||| S:25250 E:25253 ||| PRP
migrates  ||| S:25253 E:25262 ||| VBD
through  ||| S:25262 E:25270 ||| IN
the  ||| S:25270 E:25284 ||| DT
extracellular  ||| S:25284 E:25298 ||| JJ
matrix ||| S:25298 E:25304 ||| NN
.  ||| S:25304 E:25306 ||| .
As  ||| S:25306 E:25309 ||| RB
explained  ||| S:25309 E:25319 ||| VBD
above ||| S:25319 E:25324 ||| RB
,  ||| S:25324 E:25326 ||| ,
mHB-EGF  ||| S:25326 E:25334 ||| NNP
has  ||| S:25334 E:25348 ||| VBZ
been  ||| S:25348 E:25353 ||| VBN
reported  ||| S:25353 E:25362 ||| VBN
to  ||| S:25362 E:25365 ||| TO
be  ||| S:25365 E:25368 ||| VB
involved  ||| S:25368 E:25377 ||| VBN
as  ||| S:25377 E:25380 ||| IN
a  ||| S:25380 E:25382 ||| DT
structural  ||| S:25382 E:25393 ||| JJ
protein  ||| S:25393 E:25401 ||| NN
in  ||| S:25401 E:25414 ||| IN
such  ||| S:25414 E:25419 ||| JJ
tissue  ||| S:25419 E:25426 ||| NN
developmental  ||| S:25426 E:25440 ||| NN
processes  ||| S:25440 E:25450 ||| NNS
as  ||| S:25450 E:25453 ||| IN
wound  ||| S:25453 E:25459 ||| JJ
healing  ||| S:25459 E:25467 ||| NN
and  ||| S:25467 E:25481 ||| CC
it  ||| S:25481 E:25484 ||| PRP
is  ||| S:25484 E:25487 ||| VBZ
feasible  ||| S:25487 E:25496 ||| VBN
that  ||| S:25496 E:25501 ||| IN
the  ||| S:25501 E:25505 ||| DT
direct  ||| S:25505 E:25512 ||| JJ
physical  ||| S:25512 E:25521 ||| JJ
association  ||| S:25521 E:25533 ||| NN
of  ||| S:25533 E:25546 ||| IN
mHB-EGF  ||| S:25546 E:25554 ||| JJ
with  ||| S:25554 E:25559 ||| IN
fibulin-1  ||| S:25559 E:25569 ||| NNP
may  ||| S:25569 E:25573 ||| MD
be  ||| S:25573 E:25576 ||| VB
useful  ||| S:25576 E:25583 ||| JJ
in  ||| S:25583 E:25586 ||| IN
the  ||| S:25586 E:25590 ||| DT
tissue  ||| S:25590 E:25607 ||| NN
remodeling  ||| S:25607 E:25618 ||| NN
of  ||| S:25618 E:25621 ||| IN
a  ||| S:25621 E:25623 ||| DT
wound  ||| S:25623 E:25629 ||| JJ
site  ||| S:25629 E:25634 ||| NN
and  ||| S:25634 E:25638 ||| CC
in  ||| S:25638 E:25641 ||| IN
scar  ||| S:25641 E:25646 ||| JJ
formation ||| S:25646 E:25655 ||| NN
.  ||| S:25655 E:25667 ||| .
The  ||| S:25667 E:25671 ||| DT
results  ||| S:25671 E:25679 ||| NNS
presented  ||| S:25679 E:25689 ||| VBN
in  ||| S:25689 E:25692 ||| IN
this  ||| S:25692 E:25697 ||| DT
paper  ||| S:25697 E:25703 ||| NN
now  ||| S:25703 E:25707 ||| RB
suggest  ||| S:25707 E:25715 ||| VB
that  ||| S:25715 E:25730 ||| IN
there  ||| S:25730 E:25736 ||| EX
is  ||| S:25736 E:25739 ||| VBZ
potential  ||| S:25739 E:25749 ||| JJ
in  ||| S:25749 E:25752 ||| IN
carrying  ||| S:25752 E:25761 ||| VBG
out  ||| S:25761 E:25765 ||| RP
experiments  ||| S:25765 E:25777 ||| NNS
to  ||| S:25777 E:25780 ||| TO
further  ||| S:25780 E:25798 ||| VB
delineate  ||| S:25798 E:25808 ||| VBN
the  ||| S:25808 E:25812 ||| DT
molecular  ||| S:25812 E:25822 ||| JJ
interactions  ||| S:25822 E:25835 ||| NNS
between  ||| S:25835 E:25843 ||| IN
proHB-EGF  ||| S:25843 E:25863 ||| JJ
and  ||| S:25863 E:25867 ||| CC
LTBP-3  ||| S:25867 E:25874 ||| NNP
and  ||| S:25874 E:25878 ||| CC
between  ||| S:25878 E:25886 ||| IN
proHB-EGF  ||| S:25886 E:25896 ||| JJ
and  ||| S:25896 E:25900 ||| CC
fibulin-1C ||| S:25900 E:25910 ||| NNP
.  ||| S:25910 E:25912 ||| .
A  ||| S:25912 E:25924 ||| DT
transitional  ||| S:25924 E:25937 ||| JJ
step  ||| S:25937 E:25942 ||| NN
in  ||| S:25942 E:25945 ||| IN
this  ||| S:25945 E:25950 ||| DT
process  ||| S:25950 E:25958 ||| NN
will  ||| S:25958 E:25963 ||| MD
be  ||| S:25963 E:25966 ||| VB
the  ||| S:25966 E:25970 ||| DT
expression  ||| S:25970 E:25991 ||| NN
and  ||| S:25991 E:25995 ||| CC
purification  ||| S:25995 E:26008 ||| NN
of  ||| S:26008 E:26011 ||| IN
these  ||| S:26011 E:26017 ||| DT
proteins ||| S:26017 E:26025 ||| NNS
.  ||| S:26025 E:26027 ||| .
In  ||| S:26027 E:26030 ||| IN
order  ||| S:26030 E:26036 ||| NN
to  ||| S:26036 E:26039 ||| TO
rule  ||| S:26039 E:26044 ||| VB
out  ||| S:26044 E:26058 ||| RP
false  ||| S:26058 E:26064 ||| JJ
positives  ||| S:26064 E:26074 ||| NN
that  ||| S:26074 E:26079 ||| WDT
may  ||| S:26079 E:26083 ||| MD
have  ||| S:26083 E:26088 ||| VB
resulted  ||| S:26088 E:26097 ||| VBN
from  ||| S:26097 E:26102 ||| IN
the  ||| S:26102 E:26106 ||| DT
yeast  ||| S:26106 E:26122 ||| NN
two-hybrid  ||| S:26122 E:26133 ||| JJ
system ||| S:26133 E:26139 ||| NN
,  ||| S:26139 E:26141 ||| ,
experiments  ||| S:26141 E:26153 ||| NNS
that  ||| S:26153 E:26158 ||| WDT
provide  ||| S:26158 E:26176 ||| VBP
co-immunoprecipitation  ||| S:26176 E:26199 ||| JJ
data  ||| S:26199 E:26204 ||| NNS
or  ||| S:26204 E:26207 ||| CC
solid  ||| S:26207 E:26213 ||| JJ
phase  ||| S:26213 E:26219 ||| NN
binding  ||| S:26219 E:26237 ||| JJ
results  ||| S:26237 E:26245 ||| NNS
of  ||| S:26245 E:26248 ||| IN
the  ||| S:26248 E:26252 ||| DT
interaction  ||| S:26252 E:26264 ||| NN
of  ||| S:26264 E:26267 ||| IN
these  ||| S:26267 E:26273 ||| DT
proteins  ||| S:26273 E:26282 ||| NNS
will  ||| S:26282 E:26287 ||| MD
be  ||| S:26287 E:26300 ||| VB
useful ||| S:26300 E:26306 ||| JJ
.  ||| S:26306 E:26318 ||| .
The  ||| S:26318 E:26322 ||| DT
interaction  ||| S:26322 E:26334 ||| NN
of  ||| S:26334 E:26337 ||| IN
EGF-modules  ||| S:26337 E:26349 ||| JJ
with  ||| S:26349 E:26354 ||| IN
either  ||| S:26354 E:26361 ||| DT
non  ||| S:26361 E:26375 ||| JJ
EGF-like  ||| S:26375 E:26384 ||| JJ
modules  ||| S:26384 E:26392 ||| NNS
( ||| S:26392 E:26393 ||| -LRB-
e.g.  ||| S:26393 E:26398 ||| CD
the  ||| S:26398 E:26402 ||| DT
EGF-like  ||| S:26402 E:26411 ||| JJ
modules  ||| S:26411 E:26419 ||| NN
of  ||| S:26419 E:26422 ||| IN
fibulin-1C  ||| S:26422 E:26443 ||| CD
interacting  ||| S:26443 E:26455 ||| NN
with  ||| S:26455 E:26460 ||| IN
the  ||| S:26460 E:26464 ||| DT
heparin-binding  ||| S:26464 E:26480 ||| JJ
region  ||| S:26480 E:26487 ||| NN
of  ||| S:26487 E:26500 ||| IN
fibronectin ||| S:26500 E:26511 ||| CD
)  ||| S:26511 E:26513 ||| -RRB-
or  ||| S:26513 E:26516 ||| CC
with  ||| S:26516 E:26521 ||| IN
EGF-like  ||| S:26521 E:26530 ||| JJ
modules  ||| S:26530 E:26538 ||| NNS
( ||| S:26538 E:26539 ||| -LRB-
e.g.  ||| S:26539 E:26544 ||| CD
the  ||| S:26544 E:26558 ||| DT
interaction  ||| S:26558 E:26570 ||| NN
of  ||| S:26570 E:26573 ||| IN
fibulin-1C  ||| S:26573 E:26584 ||| CD
with  ||| S:26584 E:26589 ||| IN
aggrecan  ||| S:26589 E:26598 ||| NN
and  ||| S:26598 E:26602 ||| CC
versican ||| S:26602 E:26610 ||| CD
)  ||| S:26610 E:26622 ||| -RRB-
between  ||| S:26622 E:26630 ||| IN
extracellular  ||| S:26630 E:26644 ||| JJ
matrix  ||| S:26644 E:26651 ||| JJ
proteins  ||| S:26651 E:26660 ||| NNS
argues  ||| S:26660 E:26667 ||| VBZ
for  ||| S:26667 E:26671 ||| IN
the  ||| S:26671 E:26685 ||| DT
interaction  ||| S:26685 E:26697 ||| NN
of  ||| S:26697 E:26700 ||| IN
the  ||| S:26700 E:26704 ||| DT
EGF-modules  ||| S:26704 E:26716 ||| JJ
containing  ||| S:26716 E:26727 ||| NN
within  ||| S:26727 E:26744 ||| IN
fibulin-1C  ||| S:26744 E:26755 ||| NNP
and  ||| S:26755 E:26759 ||| CC
LTBP-3  ||| S:26759 E:26766 ||| CD
with  ||| S:26766 E:26771 ||| IN
either  ||| S:26771 E:26778 ||| RB
the  ||| S:26778 E:26782 ||| DT
heparin-binding  ||| S:26782 E:26808 ||| JJ
region  ||| S:26808 E:26815 ||| NN
or  ||| S:26815 E:26818 ||| CC
with  ||| S:26818 E:26823 ||| IN
the  ||| S:26823 E:26827 ||| DT
EGF-like  ||| S:26827 E:26836 ||| JJ
domain  ||| S:26836 E:26843 ||| NN
of  ||| S:26843 E:26846 ||| IN
HB-EGF ||| S:26846 E:26852 ||| JJ
.  ||| S:26852 E:26885 ||| .
Conclusions  ||| S:26885 E:26905 ||| NNS
In  ||| S:26905 E:26908 ||| IN
summary ||| S:26908 E:26915 ||| NN
,  ||| S:26915 E:26917 ||| ,
we  ||| S:26917 E:26920 ||| PRP
have  ||| S:26920 E:26925 ||| VBP
shown  ||| S:26925 E:26931 ||| VBN
the  ||| S:26931 E:26935 ||| DT
interaction  ||| S:26935 E:26947 ||| NN
of  ||| S:26947 E:26950 ||| IN
two  ||| S:26950 E:26954 ||| CD
novel  ||| S:26954 E:26968 ||| NN
proteins  ||| S:26968 E:26977 ||| NNS
with  ||| S:26977 E:26982 ||| IN
the  ||| S:26982 E:26986 ||| DT
extracellular  ||| S:26986 E:27000 ||| JJ
domain  ||| S:27000 E:27007 ||| NN
of  ||| S:27007 E:27010 ||| IN
proHB-EGF  ||| S:27010 E:27020 ||| JJ
using  ||| S:27020 E:27026 ||| VBG
a  ||| S:27026 E:27036 ||| DT
yeast  ||| S:27036 E:27042 ||| NN
two-hybrid  ||| S:27042 E:27053 ||| JJ
system ||| S:27053 E:27059 ||| NN
.  ||| S:27059 E:27061 ||| .
The  ||| S:27061 E:27065 ||| DT
interactions  ||| S:27065 E:27078 ||| NN
of  ||| S:27078 E:27081 ||| IN
LTBP-3  ||| S:27081 E:27088 ||| NNP
and  ||| S:27088 E:27100 ||| CC
fibulin-1C  ||| S:27100 E:27111 ||| CD
with  ||| S:27111 E:27116 ||| IN
the  ||| S:27116 E:27120 ||| DT
extracellular  ||| S:27120 E:27134 ||| JJ
domain  ||| S:27134 E:27141 ||| NN
of  ||| S:27141 E:27144 ||| IN
proHB-EGF  ||| S:27144 E:27154 ||| NNP
may  ||| S:27154 E:27166 ||| MD
provide  ||| S:27166 E:27174 ||| VB
further  ||| S:27174 E:27182 ||| JJ
insights  ||| S:27182 E:27191 ||| NNS
into  ||| S:27191 E:27196 ||| IN
the  ||| S:27196 E:27200 ||| DT
roles  ||| S:27200 E:27206 ||| NNS
that  ||| S:27206 E:27211 ||| IN
these  ||| S:27211 E:27217 ||| DT
proteins  ||| S:27217 E:27234 ||| NNS
play  ||| S:27234 E:27239 ||| VBP
in  ||| S:27239 E:27242 ||| IN
cellular  ||| S:27242 E:27251 ||| JJ
and  ||| S:27251 E:27255 ||| CC
tissue  ||| S:27255 E:27262 ||| NN
development  ||| S:27262 E:27274 ||| NN
processes ||| S:27274 E:27283 ||| NNS
.  ||| S:27283 E:27285 ||| .
The  ||| S:27285 E:27297 ||| DT
trafficking  ||| S:27297 E:27309 ||| NN
of  ||| S:27309 E:27312 ||| IN
such  ||| S:27312 E:27317 ||| JJ
growth  ||| S:27317 E:27324 ||| NN
factors  ||| S:27324 E:27332 ||| NNS
as  ||| S:27332 E:27335 ||| IN
HB-EGF  ||| S:27335 E:27342 ||| JJ
and  ||| S:27342 E:27346 ||| CC
TGF-β  ||| S:27346 E:27352 ||| JJ
and  ||| S:27352 E:27364 ||| CC
structural  ||| S:27364 E:27375 ||| JJ
proteins  ||| S:27375 E:27384 ||| NNS
within  ||| S:27384 E:27391 ||| IN
the  ||| S:27391 E:27395 ||| DT
extracellular  ||| S:27395 E:27409 ||| JJ
matrix  ||| S:27409 E:27416 ||| NN
is  ||| S:27416 E:27427 ||| VBZ
important  ||| S:27427 E:27437 ||| JJ
in  ||| S:27437 E:27440 ||| IN
wound  ||| S:27440 E:27446 ||| JJ
healing  ||| S:27446 E:27454 ||| NN
processes ||| S:27454 E:27463 ||| NNS
.  ||| S:27463 E:27465 ||| .
Therefore ||| S:27465 E:27474 ||| RB
,  ||| S:27474 E:27476 ||| ,
the  ||| S:27476 E:27488 ||| DT
interactions  ||| S:27488 E:27501 ||| NN
of  ||| S:27501 E:27504 ||| IN
HB-EGF  ||| S:27504 E:27511 ||| JJ
with  ||| S:27511 E:27516 ||| IN
LTBP-3  ||| S:27516 E:27523 ||| NNP
and  ||| S:27523 E:27527 ||| CC
fibulin-1C  ||| S:27527 E:27538 ||| NNP
described  ||| S:27538 E:27556 ||| VBD
in  ||| S:27556 E:27559 ||| IN
this  ||| S:27559 E:27564 ||| DT
study  ||| S:27564 E:27570 ||| NN
suggest  ||| S:27570 E:27578 ||| VBP
novel  ||| S:27578 E:27584 ||| JJ
functions  ||| S:27584 E:27594 ||| NNS
for  ||| S:27594 E:27598 ||| IN
HB-EGF  ||| S:27598 E:27605 ||| JJ
between  ||| S:27605 E:27621 ||| IN
cell-surfaces  ||| S:27621 E:27635 ||| JJ
and  ||| S:27635 E:27639 ||| CC
tissue  ||| S:27639 E:27646 ||| NN
surfaces ||| S:27646 E:27654 ||| NN
.  ||| S:27654 E:27678 ||| .
Materials  ||| S:27678 E:27688 ||| NNS
and  ||| S:27688 E:27692 ||| CC
methods  ||| S:27692 E:27708 ||| NNS
The  ||| S:27708 E:27712 ||| DT
plasmid  ||| S:27712 E:27720 ||| JJ
vectors ||| S:27720 E:27727 ||| NN
,  ||| S:27727 E:27729 ||| ,
pGBT9 ||| S:27729 E:27734 ||| NNP
,  ||| S:27734 E:27736 ||| ,
pGAD424 ||| S:27736 E:27743 ||| NNP
,  ||| S:27743 E:27745 ||| ,
pTD1 ||| S:27745 E:27749 ||| NNP
,  ||| S:27749 E:27751 ||| ,
pVA3 ||| S:27751 E:27755 ||| NNP
,  ||| S:27755 E:27757 ||| ,
the  ||| S:27757 E:27769 ||| DT
monkey  ||| S:27769 E:27776 ||| JJ
cv-1  ||| S:27776 E:27781 ||| CD
cDNA  ||| S:27781 E:27786 ||| JJ
library  ||| S:27786 E:27794 ||| NN
in  ||| S:27794 E:27797 ||| IN
pGAD10 ||| S:27797 E:27803 ||| NNP
,  ||| S:27803 E:27805 ||| ,
and  ||| S:27805 E:27809 ||| CC
the  ||| S:27809 E:27822 ||| DT
S.  ||| S:27822 E:27825 ||| NNP
cerevisiae  ||| S:27825 E:27836 ||| FW
strains  ||| S:27836 E:27844 ||| FW
Y187  ||| S:27844 E:27849 ||| FW
and  ||| S:27849 E:27853 ||| CC
Y190  ||| S:27853 E:27866 ||| NNP
were  ||| S:27866 E:27871 ||| VBD
obtained  ||| S:27871 E:27880 ||| VBN
from  ||| S:27880 E:27885 ||| IN
Clontech ||| S:27885 E:27893 ||| NNP
.  ||| S:27893 E:27895 ||| .
The  ||| S:27895 E:27899 ||| DT
cv-1  ||| S:27899 E:27904 ||| JJ
cDNA  ||| S:27904 E:27909 ||| JJ
library  ||| S:27909 E:27917 ||| NN
was  ||| S:27917 E:27929 ||| VBD
amplified  ||| S:27929 E:27939 ||| VBN
and  ||| S:27939 E:27943 ||| CC
stored  ||| S:27943 E:27950 ||| VBD
as  ||| S:27950 E:27953 ||| RB
per  ||| S:27953 E:27957 ||| IN
the  ||| S:27957 E:27961 ||| DT
manufacturer ||| S:27961 E:27973 ||| NN
's  ||| S:27973 E:27984 ||| POS
instructions ||| S:27984 E:27996 ||| NNS
.  ||| S:27996 E:27998 ||| .
Unless  ||| S:27998 E:28005 ||| IN
otherwise  ||| S:28005 E:28015 ||| RB
noted ||| S:28015 E:28020 ||| VBD
,  ||| S:28020 E:28022 ||| ,
all  ||| S:28022 E:28026 ||| DT
chemicals  ||| S:28026 E:28036 ||| NNS
and  ||| S:28036 E:28048 ||| CC
reagents  ||| S:28048 E:28057 ||| NNS
were  ||| S:28057 E:28062 ||| VBD
obtained  ||| S:28062 E:28071 ||| VBN
from  ||| S:28071 E:28076 ||| IN
Sigma ||| S:28076 E:28081 ||| NNP
.  ||| S:28081 E:28100 ||| .
E.  ||| S:28100 E:28103 ||| NNP
coli  ||| S:28103 E:28108 ||| NNS
strain  ||| S:28108 E:28115 ||| VBP
DH5α  ||| S:28115 E:28120 ||| RB
was  ||| S:28120 E:28124 ||| VBD
used  ||| S:28124 E:28129 ||| VBN
as  ||| S:28129 E:28132 ||| IN
the  ||| S:28132 E:28144 ||| DT
host  ||| S:28144 E:28149 ||| NN
strain  ||| S:28149 E:28156 ||| NN
for  ||| S:28156 E:28160 ||| IN
cloning ||| S:28160 E:28167 ||| NN
.  ||| S:28167 E:28169 ||| .
The  ||| S:28169 E:28173 ||| DT
extracellular  ||| S:28173 E:28187 ||| JJ
domain  ||| S:28187 E:28194 ||| NN
( ||| S:28194 E:28195 ||| -LRB-
amino  ||| S:28195 E:28209 ||| FW
acid  ||| S:28209 E:28214 ||| FW
residues  ||| S:28214 E:28223 ||| FW
Glu  ||| S:28223 E:28227 ||| NNP
24-His  ||| S:28227 E:28234 ||| CD
159 ||| S:28234 E:28237 ||| CD
)  ||| S:28237 E:28239 ||| -RRB-
of  ||| S:28239 E:28242 ||| IN
monkey  ||| S:28242 E:28249 ||| JJ
proHB-EGF  ||| S:28249 E:28259 ||| NN
( ||| S:28259 E:28260 ||| -LRB-
GenBank  ||| S:28260 E:28276 ||| JJ
accession  ||| S:28276 E:28286 ||| JJ
number  ||| S:28286 E:28293 ||| NN
Q09118 ||| S:28293 E:28299 ||| CD
)  ||| S:28299 E:28301 ||| -RRB-
[  ||| S:28301 E:28303 ||| -LRB-
2  ||| S:28303 E:28305 ||| LS
]  ||| S:28305 E:28307 ||| -RRB-
was  ||| S:28307 E:28311 ||| VBD
amplified  ||| S:28311 E:28321 ||| VBN
by  ||| S:28321 E:28324 ||| IN
PCR  ||| S:28324 E:28328 ||| NNP
using  ||| S:28328 E:28342 ||| FW
primers  ||| S:28342 E:28350 ||| FW
MkHB-EGF  ||| S:28350 E:28368 ||| FW
ex  ||| S:28368 E:28371 ||| FW
( ||| S:28371 E:28372 ||| -LRB-
5 ||| S:28372 E:28373 ||| CD
' ||| S:28373 E:28374 ||| POS
)  ||| S:28374 E:28376 ||| -RRB-
TCGGCACTGGTGGAATTCGAGAGCCTGGAG  ||| S:28376 E:28415 ||| NNP
and  ||| S:28415 E:28419 ||| CC
MKHB-EGF  ||| S:28419 E:28437 ||| JJ
ex  ||| S:28437 E:28440 ||| FW
( ||| S:28440 E:28441 ||| -LRB-
3 ||| S:28441 E:28442 ||| NNP
' ||| S:28442 E:28443 ||| POS
)  ||| S:28443 E:28445 ||| -RRB-
CACAGCCAGGATGGATCCATGGTCATAGGT ||| S:28445 E:28475 ||| NNP
.  ||| S:28475 E:28485 ||| .
The  ||| S:28485 E:28489 ||| DT
PCR  ||| S:28489 E:28493 ||| NNP
product  ||| S:28493 E:28501 ||| NN
was  ||| S:28501 E:28505 ||| VBD
digested  ||| S:28505 E:28514 ||| VBN
with  ||| S:28514 E:28528 ||| IN
Eco  ||| S:28528 E:28532 ||| NNP
RI  ||| S:28532 E:28535 ||| NNP
and  ||| S:28535 E:28548 ||| CC
Bam  ||| S:28548 E:28552 ||| NNP
HI  ||| S:28552 E:28555 ||| NNP
and  ||| S:28555 E:28559 ||| CC
ligated  ||| S:28559 E:28567 ||| NN
into  ||| S:28567 E:28572 ||| IN
the  ||| S:28572 E:28585 ||| DT
Eco  ||| S:28585 E:28589 ||| NNP
RI  ||| S:28589 E:28592 ||| NNP
and  ||| S:28592 E:28605 ||| CC
Bam  ||| S:28605 E:28609 ||| NNP
HI  ||| S:28609 E:28612 ||| NNP
restriction  ||| S:28612 E:28624 ||| NN
sites  ||| S:28624 E:28630 ||| NNS
of  ||| S:28630 E:28633 ||| IN
pGBT9  ||| S:28633 E:28639 ||| NNP
and  ||| S:28639 E:28651 ||| CC
pGAD424  ||| S:28651 E:28659 ||| CD
to  ||| S:28659 E:28662 ||| TO
produce  ||| S:28662 E:28670 ||| VB
constructs  ||| S:28670 E:28681 ||| JJ
pGBT9 ||| S:28681 E:28686 ||| NNP
/ ||| S:28686 E:28687 ||| NNP
proHB-EGFEx  ||| S:28687 E:28699 ||| NNP
and  ||| S:28699 E:28711 ||| CC
pGAD424 ||| S:28711 E:28718 ||| NNP
/ ||| S:28718 E:28719 ||| NNP
proHB-EGFEx ||| S:28719 E:28730 ||| NNP
,  ||| S:28730 E:28732 ||| ,
respectively ||| S:28732 E:28744 ||| RB
.  ||| S:28744 E:28746 ||| .
The  ||| S:28746 E:28750 ||| DT
pGBT9 ||| S:28750 E:28755 ||| CD
/ ||| S:28755 E:28756 ||| CD
proHB-EGFEx  ||| S:28756 E:28776 ||| JJ
construct  ||| S:28776 E:28786 ||| NN
was  ||| S:28786 E:28790 ||| VBD
used  ||| S:28790 E:28795 ||| VBN
as  ||| S:28795 E:28798 ||| IN
the  ||| S:28798 E:28802 ||| DT
bait  ||| S:28802 E:28807 ||| JJ
construct  ||| S:28807 E:28817 ||| NN
in  ||| S:28817 E:28820 ||| IN
the  ||| S:28820 E:28824 ||| DT
yeast  ||| S:28824 E:28838 ||| NN
two-hybrid  ||| S:28838 E:28849 ||| JJ
screen  ||| S:28849 E:28856 ||| NN
to  ||| S:28856 E:28859 ||| TO
identify  ||| S:28859 E:28868 ||| VB
extracellular  ||| S:28868 E:28882 ||| JJ
proteins  ||| S:28882 E:28891 ||| NNS
that  ||| S:28891 E:28904 ||| IN
interact  ||| S:28904 E:28913 ||| NN
with  ||| S:28913 E:28918 ||| IN
the  ||| S:28918 E:28922 ||| DT
extracellular  ||| S:28922 E:28936 ||| JJ
domain  ||| S:28936 E:28943 ||| NN
of  ||| S:28943 E:28946 ||| IN
proHB-EGF ||| S:28946 E:28955 ||| JJ
.  ||| S:28955 E:28957 ||| .
The  ||| S:28957 E:28969 ||| DT
EGF-like  ||| S:28969 E:28978 ||| JJ
region  ||| S:28978 E:28985 ||| NN
( ||| S:28985 E:28986 ||| -LRB-
amino  ||| S:28986 E:28992 ||| FW
acid  ||| S:28992 E:28997 ||| FW
residues  ||| S:28997 E:29006 ||| FW
Asp  ||| S:29006 E:29010 ||| NNP
106-His  ||| S:29010 E:29018 ||| CD
159 ||| S:29018 E:29021 ||| CD
)  ||| S:29021 E:29023 ||| -RRB-
of  ||| S:29023 E:29034 ||| IN
monkey  ||| S:29034 E:29041 ||| JJ
proHB-EGF  ||| S:29041 E:29051 ||| NN
[  ||| S:29051 E:29053 ||| -LRB-
2  ||| S:29053 E:29055 ||| LS
]  ||| S:29055 E:29057 ||| -RRB-
was  ||| S:29057 E:29061 ||| VBD
amplified  ||| S:29061 E:29071 ||| VBN
by  ||| S:29071 E:29074 ||| IN
PCR  ||| S:29074 E:29078 ||| NNP
using  ||| S:29078 E:29084 ||| VBG
primers  ||| S:29084 E:29100 ||| JJ
MkHB-EGF  ||| S:29100 E:29109 ||| JJ
5 ||| S:29109 E:29110 ||| CD
' ||| S:29110 E:29111 ||| POS
CTAGGGAAGGAATTCGACCCATGTCTTCGG  ||| S:29111 E:29142 ||| NNP
and  ||| S:29142 E:29146 ||| CC
MkHB-EGF  ||| S:29146 E:29163 ||| JJ
3 ||| S:29163 E:29164 ||| CD
' ||| S:29164 E:29165 ||| POS
CACAGCCAGGATGGATCCTCAATGGTCATAGG ||| S:29165 E:29197 ||| NNP
.  ||| S:29197 E:29199 ||| .
The  ||| S:29199 E:29203 ||| DT
PCR  ||| S:29203 E:29207 ||| NNP
product  ||| S:29207 E:29215 ||| NN
was  ||| S:29215 E:29227 ||| VBD
digested  ||| S:29227 E:29236 ||| VBN
with  ||| S:29236 E:29250 ||| IN
Eco  ||| S:29250 E:29254 ||| NNP
RI  ||| S:29254 E:29257 ||| NNP
and  ||| S:29257 E:29270 ||| CC
Bam  ||| S:29270 E:29274 ||| NNP
HI  ||| S:29274 E:29277 ||| NNP
and  ||| S:29277 E:29281 ||| CC
ligated  ||| S:29281 E:29289 ||| NN
into  ||| S:29289 E:29294 ||| IN
the  ||| S:29294 E:29307 ||| DT
Eco  ||| S:29307 E:29311 ||| NNP
RI  ||| S:29311 E:29314 ||| NNP
and  ||| S:29314 E:29327 ||| CC
Bam  ||| S:29327 E:29331 ||| NNP
HI  ||| S:29331 E:29334 ||| NNP
restriction  ||| S:29334 E:29346 ||| NN
sites  ||| S:29346 E:29352 ||| NNS
of  ||| S:29352 E:29355 ||| IN
pGBT9  ||| S:29355 E:29361 ||| CD
to  ||| S:29361 E:29372 ||| TO
produce  ||| S:29372 E:29380 ||| VB
construct  ||| S:29380 E:29390 ||| VB
pGBT9 ||| S:29390 E:29395 ||| CD
/ ||| S:29395 E:29396 ||| CD
prodelHB-EGF ||| S:29396 E:29408 ||| NN
.  ||| S:29408 E:29418 ||| .
All  ||| S:29418 E:29422 ||| DT
plasmid  ||| S:29422 E:29430 ||| JJ
constructs  ||| S:29430 E:29441 ||| NN
were  ||| S:29441 E:29446 ||| VBD
transformed  ||| S:29446 E:29458 ||| VBN
into  ||| S:29458 E:29463 ||| IN
the  ||| S:29463 E:29476 ||| DT
S.  ||| S:29476 E:29479 ||| NNP
cerevisiae  ||| S:29479 E:29490 ||| NN
strains ||| S:29490 E:29497 ||| NNS
,  ||| S:29497 E:29499 ||| ,
Y187  ||| S:29499 E:29504 ||| NNP
and  ||| S:29504 E:29508 ||| CC
Y190 ||| S:29508 E:29512 ||| NNP
,  ||| S:29512 E:29522 ||| ,
using  ||| S:29522 E:29528 ||| VBG
the  ||| S:29528 E:29532 ||| DT
lithium  ||| S:29532 E:29540 ||| JJ
acetate  ||| S:29540 E:29548 ||| JJ
protocol  ||| S:29548 E:29557 ||| NN
as  ||| S:29557 E:29560 ||| IN
per  ||| S:29560 E:29564 ||| IN
the  ||| S:29564 E:29576 ||| DT
manufacturer ||| S:29576 E:29588 ||| NN
's  ||| S:29588 E:29591 ||| POS
instructions ||| S:29591 E:29603 ||| NNS
.  ||| S:29603 E:29605 ||| .
Y190  ||| S:29605 E:29610 ||| FW
transformants  ||| S:29610 E:29624 ||| FW
containing  ||| S:29624 E:29643 ||| FW
pGBT9 ||| S:29643 E:29648 ||| FW
/ ||| S:29648 E:29649 ||| FW
proHB-EGFEx  ||| S:29649 E:29661 ||| FW
and  ||| S:29661 E:29665 ||| CC
pGAD10 ||| S:29665 E:29671 ||| CD
/ ||| S:29671 E:29672 ||| CD
cv-1  ||| S:29672 E:29677 ||| CD
library  ||| S:29677 E:29685 ||| NN
were  ||| S:29685 E:29690 ||| VBD
plated  ||| S:29690 E:29697 ||| VBN
onto  ||| S:29697 E:29710 ||| IN
Trp  ||| S:29710 E:29714 ||| NNP
-Leu  ||| S:29714 E:29719 ||| JJ
-His  ||| S:29719 E:29724 ||| JJ
-agar  ||| S:29724 E:29730 ||| JJ
plates ||| S:29730 E:29736 ||| NN
.  ||| S:29736 E:29738 ||| .
The  ||| S:29738 E:29742 ||| DT
triple  ||| S:29742 E:29749 ||| JJ
auxotrophic  ||| S:29749 E:29769 ||| JJ
transformants  ||| S:29769 E:29783 ||| NN
were  ||| S:29783 E:29788 ||| VBD
tested  ||| S:29788 E:29795 ||| VBN
for  ||| S:29795 E:29799 ||| IN
β-galactosidase  ||| S:29799 E:29815 ||| JJ
activity  ||| S:29815 E:29832 ||| NN
using  ||| S:29832 E:29838 ||| VBG
the  ||| S:29838 E:29842 ||| DT
filter  ||| S:29842 E:29849 ||| JJ
paper  ||| S:29849 E:29855 ||| NN
assay  ||| S:29855 E:29861 ||| VBZ
described  ||| S:29861 E:29871 ||| VBN
in  ||| S:29871 E:29874 ||| IN
the  ||| S:29874 E:29878 ||| DT
manual  ||| S:29878 E:29893 ||| NN
provided  ||| S:29893 E:29902 ||| VBN
by  ||| S:29902 E:29905 ||| IN
Clontech ||| S:29905 E:29913 ||| NNP
.  ||| S:29913 E:29915 ||| .
A  ||| S:29915 E:29917 ||| DT
positive  ||| S:29917 E:29926 ||| JJ
control  ||| S:29926 E:29934 ||| NN
of  ||| S:29934 E:29937 ||| IN
Y187  ||| S:29937 E:29942 ||| NNP
or  ||| S:29942 E:29945 ||| CC
Y190  ||| S:29945 E:29958 ||| RB
containing  ||| S:29958 E:29969 ||| VBG
both  ||| S:29969 E:29974 ||| DT
plasmids  ||| S:29974 E:29983 ||| JJ
pTD1  ||| S:29983 E:29988 ||| NN
and  ||| S:29988 E:29992 ||| CC
pVA3  ||| S:29992 E:29997 ||| NNP
together  ||| S:29997 E:30006 ||| RB
was  ||| S:30006 E:30018 ||| VBD
included  ||| S:30018 E:30027 ||| VBN
in  ||| S:30027 E:30030 ||| IN
every  ||| S:30030 E:30036 ||| DT
β-galactosidase  ||| S:30036 E:30052 ||| JJ
assay ||| S:30052 E:30057 ||| NN
.  ||| S:30057 E:30059 ||| .
A  ||| S:30059 E:30061 ||| DT
negative  ||| S:30061 E:30070 ||| JJ
control  ||| S:30070 E:30086 ||| NN
of  ||| S:30086 E:30089 ||| IN
Y187  ||| S:30089 E:30094 ||| NNP
or  ||| S:30094 E:30097 ||| CC
Y190  ||| S:30097 E:30102 ||| RB
containing  ||| S:30102 E:30113 ||| VBG
both  ||| S:30113 E:30118 ||| DT
plasmid  ||| S:30118 E:30126 ||| JJ
vectors ||| S:30126 E:30133 ||| NN
,  ||| S:30133 E:30135 ||| ,
pGBT9  ||| S:30135 E:30141 ||| NNP
and  ||| S:30141 E:30153 ||| CC
pGAD424 ||| S:30153 E:30160 ||| NNP
,  ||| S:30160 E:30162 ||| ,
was  ||| S:30162 E:30166 ||| VBD
included  ||| S:30166 E:30175 ||| VBN
in  ||| S:30175 E:30178 ||| IN
all  ||| S:30178 E:30182 ||| DT
β-galactosidase  ||| S:30182 E:30198 ||| JJ
assays ||| S:30198 E:30204 ||| NN
.  ||| S:30204 E:30214 ||| .
Each  ||| S:30214 E:30219 ||| DT
construct  ||| S:30219 E:30229 ||| NN
from  ||| S:30229 E:30234 ||| IN
the  ||| S:30234 E:30238 ||| DT
cDNA  ||| S:30238 E:30243 ||| JJ
library  ||| S:30243 E:30251 ||| NN
that  ||| S:30251 E:30256 ||| WDT
tested  ||| S:30256 E:30271 ||| VBD
positive  ||| S:30271 E:30280 ||| JJ
for  ||| S:30280 E:30284 ||| IN
both  ||| S:30284 E:30298 ||| DT
lacZ  ||| S:30298 E:30303 ||| JJ
and  ||| S:30303 E:30316 ||| CC
his  ||| S:30316 E:30320 ||| PRP$
reporter  ||| S:30320 E:30329 ||| NN
gene  ||| S:30329 E:30334 ||| NN
expression  ||| S:30334 E:30345 ||| NN
was  ||| S:30345 E:30349 ||| VBD
also  ||| S:30349 E:30362 ||| RB
tested  ||| S:30362 E:30369 ||| VBN
for  ||| S:30369 E:30373 ||| IN
the  ||| S:30373 E:30377 ||| DT
ability  ||| S:30377 E:30385 ||| NN
to  ||| S:30385 E:30388 ||| TO
activate  ||| S:30388 E:30397 ||| VB
directly  ||| S:30397 E:30414 ||| RB
β-galactosidase ||| S:30414 E:30429 ||| JJ
/  ||| S:30429 E:30440 ||| NN
his  ||| S:30440 E:30444 ||| PRP$
reporter  ||| S:30444 E:30453 ||| NN
gene  ||| S:30453 E:30458 ||| NN
transcription  ||| S:30458 E:30480 ||| NN
without  ||| S:30480 E:30488 ||| IN
the  ||| S:30488 E:30492 ||| DT
presence  ||| S:30492 E:30501 ||| NN
of  ||| S:30501 E:30504 ||| IN
the  ||| S:30504 E:30508 ||| DT
bait  ||| S:30508 E:30513 ||| JJ
construct ||| S:30513 E:30522 ||| NN
,  ||| S:30522 E:30532 ||| ,
pGBT9 ||| S:30532 E:30537 ||| NNP
/ ||| S:30537 E:30538 ||| NNP
proHB-EGFEx ||| S:30538 E:30549 ||| NNP
.  ||| S:30549 E:30551 ||| .
False  ||| S:30551 E:30557 ||| JJ
positives  ||| S:30557 E:30567 ||| NN
were  ||| S:30567 E:30572 ||| VBD
eliminated  ||| S:30572 E:30583 ||| VBN
using  ||| S:30583 E:30597 ||| VBG
this  ||| S:30597 E:30602 ||| DT
screening  ||| S:30602 E:30612 ||| NN
assay ||| S:30612 E:30617 ||| NN
.  ||| S:30617 E:30619 ||| .
Potential  ||| S:30619 E:30629 ||| JJ
true  ||| S:30629 E:30634 ||| JJ
positive  ||| S:30634 E:30643 ||| JJ
clones  ||| S:30643 E:30650 ||| NNS
were  ||| S:30650 E:30663 ||| VBD
sequenced  ||| S:30663 E:30673 ||| VBN
using  ||| S:30673 E:30679 ||| VBG
primers  ||| S:30679 E:30687 ||| CD
GAD10SEQ  ||| S:30687 E:30696 ||| CD
5 ||| S:30696 E:30697 ||| CD
' ||| S:30697 E:30698 ||| POS
TACCACTACAATGGATG  ||| S:30698 E:30716 ||| NNP
and  ||| S:30716 E:30728 ||| CC
GAD10cSEQ  ||| S:30728 E:30738 ||| CD
5 ||| S:30738 E:30739 ||| CD
' ||| S:30739 E:30740 ||| POS
GTTGAAGTGAACTTGCGGGG  ||| S:30740 E:30761 ||| NNP
with  ||| S:30761 E:30766 ||| IN
the  ||| S:30766 E:30770 ||| DT
automated  ||| S:30770 E:30780 ||| JJ
DNA  ||| S:30780 E:30792 ||| NN
sequencing  ||| S:30792 E:30803 ||| NN
facilities  ||| S:30803 E:30814 ||| NNS
available  ||| S:30814 E:30824 ||| JJ
at  ||| S:30824 E:30827 ||| IN
our  ||| S:30827 E:30831 ||| PRP$
Institution ||| S:30831 E:30842 ||| NNP
.  ||| S:30842 E:30852 ||| .
Comparisons  ||| S:30852 E:30864 ||| NNS
of  ||| S:30864 E:30867 ||| IN
the  ||| S:30867 E:30871 ||| DT
obtained  ||| S:30871 E:30880 ||| JJ
sequences  ||| S:30880 E:30890 ||| NN
were  ||| S:30890 E:30895 ||| VBD
made  ||| S:30895 E:30900 ||| VBN
using  ||| S:30900 E:30906 ||| VBG
the  ||| S:30906 E:30918 ||| DT
GENBANK  ||| S:30918 E:30926 ||| NNP
database ||| S:30926 E:30934 ||| NN
.  ||| S:30934 E:30936 ||| .
The  ||| S:30936 E:30940 ||| DT
sequences  ||| S:30940 E:30950 ||| NN
for  ||| S:30950 E:30954 ||| IN
monkey  ||| S:30954 E:30961 ||| JJ
LTBP-3  ||| S:30961 E:30968 ||| NN
and  ||| S:30968 E:30980 ||| CC
monkey  ||| S:30980 E:30987 ||| JJ
fibulin-1c  ||| S:30987 E:30998 ||| NN
have  ||| S:30998 E:31003 ||| VBP
been  ||| S:31003 E:31008 ||| VBN
submitted  ||| S:31008 E:31018 ||| VBN
to  ||| S:31018 E:31021 ||| TO
the  ||| S:31021 E:31025 ||| DT
GenBank  ||| S:31025 E:31041 ||| JJ
database  ||| S:31041 E:31050 ||| NN
under  ||| S:31050 E:31056 ||| IN
the  ||| S:31056 E:31060 ||| DT
accession  ||| S:31060 E:31070 ||| JJ
numbers  ||| S:31070 E:31078 ||| NNS
AF395658  ||| S:31078 E:31087 ||| NNP
and  ||| S:31087 E:31091 ||| CC
AF395659  ||| S:31091 E:31108 ||| NNP
respectively ||| S:31108 E:31120 ||| RB
.  ||| S:31120 E:31122 ||| .
Sequence  ||| S:31122 E:31131 ||| JJ
alignment  ||| S:31131 E:31141 ||| NN
and  ||| S:31141 E:31145 ||| CC
identity  ||| S:31145 E:31154 ||| NN
was  ||| S:31154 E:31166 ||| VBD
determined  ||| S:31166 E:31177 ||| VBN
using  ||| S:31177 E:31183 ||| VBG
the  ||| S:31183 E:31187 ||| DT
Mac  ||| S:31187 E:31191 ||| NNP
Vector  ||| S:31191 E:31198 ||| NNP
sequence  ||| S:31198 E:31207 ||| NN
analysis  ||| S:31207 E:31224 ||| NN
program ||| S:31224 E:31231 ||| NN
.  ||| S:31231 E:31241 ||| .
The  ||| S:31241 E:31245 ||| DT
calcium-binding  ||| S:31245 E:31261 ||| JJ
type  ||| S:31261 E:31266 ||| NN
II  ||| S:31266 E:31269 ||| NNP
EGF-like  ||| S:31269 E:31278 ||| NNP
modules  ||| S:31278 E:31286 ||| VBD
# ||| S:31286 E:31287 ||| #
1-8  ||| S:31287 E:31291 ||| CD
of  ||| S:31291 E:31302 ||| IN
monkey  ||| S:31302 E:31309 ||| CD
LTBP-3  ||| S:31309 E:31316 ||| CD
( ||| S:31316 E:31317 ||| -LRB-
Fig.  ||| S:31317 E:31322 ||| CD
1 ||| S:31322 E:31323 ||| CD
)  ||| S:31323 E:31325 ||| -RRB-
were  ||| S:31325 E:31330 ||| VBD
amplified  ||| S:31330 E:31340 ||| VBN
by  ||| S:31340 E:31343 ||| IN
PCR  ||| S:31343 E:31347 ||| NNP
using  ||| S:31347 E:31353 ||| VBG
primers  ||| S:31353 E:31369 ||| CD
GAD10SEQ  ||| S:31369 E:31378 ||| CD
5 ||| S:31378 E:31379 ||| CD
' ||| S:31379 E:31380 ||| POS
TACCACTACAATGGATG  ||| S:31380 E:31398 ||| NNP
and  ||| S:31398 E:31402 ||| CC
LB3priLQGSYVC  ||| S:31402 E:31424 ||| CD
5 ||| S:31424 E:31425 ||| CD
' ||| S:31425 E:31426 ||| POS
CGCGGATCCTCAACACACATAGGAGCCCTGAAG ||| S:31426 E:31459 ||| NNP
.  ||| S:31459 E:31461 ||| .
The  ||| S:31461 E:31465 ||| DT
PCR  ||| S:31465 E:31469 ||| NNP
product  ||| S:31469 E:31477 ||| NN
was  ||| S:31477 E:31489 ||| VBD
digested  ||| S:31489 E:31498 ||| VBN
with  ||| S:31498 E:31512 ||| IN
Eco  ||| S:31512 E:31516 ||| NNP
RI  ||| S:31516 E:31519 ||| NNP
and  ||| S:31519 E:31532 ||| CC
Bam  ||| S:31532 E:31536 ||| NNP
HI  ||| S:31536 E:31539 ||| NNP
and  ||| S:31539 E:31543 ||| CC
ligated  ||| S:31543 E:31551 ||| NN
into  ||| S:31551 E:31556 ||| IN
the  ||| S:31556 E:31569 ||| DT
Eco  ||| S:31569 E:31573 ||| NNP
RI  ||| S:31573 E:31576 ||| NNP
and  ||| S:31576 E:31589 ||| CC
Bam  ||| S:31589 E:31593 ||| NNP
HI  ||| S:31593 E:31596 ||| NNP
restriction  ||| S:31596 E:31608 ||| NN
sites  ||| S:31608 E:31614 ||| NNS
of  ||| S:31614 E:31617 ||| IN
pGADA424  ||| S:31617 E:31634 ||| CD
to  ||| S:31634 E:31637 ||| TO
produce  ||| S:31637 E:31645 ||| VB
construct  ||| S:31645 E:31655 ||| FW
pGAD424 ||| S:31655 E:31662 ||| FW
/ ||| S:31662 E:31663 ||| FW
LTBP-3  ||| S:31663 E:31670 ||| FW
EGF ||| S:31670 E:31673 ||| FW
# ||| S:31673 E:31674 ||| #
1-8 ||| S:31674 E:31677 ||| CD
.  ||| S:31677 E:31679 ||| .
The  ||| S:31679 E:31683 ||| DT
construct  ||| S:31683 E:31701 ||| NN
was  ||| S:31701 E:31705 ||| VBD
sequenced  ||| S:31705 E:31715 ||| VBN
as  ||| S:31715 E:31718 ||| RB
described  ||| S:31718 E:31728 ||| VBN
above  ||| S:31728 E:31734 ||| IN
using  ||| S:31734 E:31740 ||| VBG
the  ||| S:31740 E:31744 ||| DT
primers  ||| S:31744 E:31760 ||| JJ
pGAD10SEQ  ||| S:31760 E:31770 ||| NN
and  ||| S:31770 E:31774 ||| CC
pGAD10cSEQ ||| S:31774 E:31784 ||| NNP
.  ||| S:31784 E:31794 ||| .
The  ||| S:31794 E:31798 ||| DT
calcium-binding  ||| S:31798 E:31814 ||| JJ
type  ||| S:31814 E:31819 ||| NN
II  ||| S:31819 E:31822 ||| NNP
EGF-like  ||| S:31822 E:31831 ||| NNP
modules  ||| S:31831 E:31839 ||| VBD
# ||| S:31839 E:31840 ||| #
1-5  ||| S:31840 E:31844 ||| CD
( ||| S:31844 E:31845 ||| -LRB-
Fig.  ||| S:31845 E:31858 ||| CD
3 ||| S:31858 E:31859 ||| CD
)  ||| S:31859 E:31861 ||| -RRB-
of  ||| S:31861 E:31864 ||| IN
monkey  ||| S:31864 E:31871 ||| JJ
fibulin-1C  ||| S:31871 E:31882 ||| NN
were  ||| S:31882 E:31887 ||| VBD
amplified  ||| S:31887 E:31897 ||| VBN
by  ||| S:31897 E:31900 ||| IN
PCR  ||| S:31900 E:31904 ||| NNP
using  ||| S:31904 E:31910 ||| VBG
primers  ||| S:31910 E:31926 ||| CD
Fib5priYLNDRC  ||| S:31926 E:31940 ||| CD
5 ||| S:31940 E:31941 ||| CD
' ||| S:31941 E:31942 ||| POS
CGAATTCTATCTGAATGACCGCTGC  ||| S:31942 E:31968 ||| NNP
and  ||| S:31968 E:31972 ||| CC
Fib3priCAPPAE  ||| S:31972 E:31994 ||| CD
5 ||| S:31994 E:31995 ||| CD
' ||| S:31995 E:31996 ||| POS
CCGTCGACTCACTCAGCAGGTGGCGCGCA ||| S:31996 E:32025 ||| NNP
.  ||| S:32025 E:32027 ||| .
The  ||| S:32027 E:32031 ||| DT
calcium-binding  ||| S:32031 E:32047 ||| JJ
type  ||| S:32047 E:32060 ||| NN
II  ||| S:32060 E:32063 ||| NNP
EGF-like  ||| S:32063 E:32072 ||| NNP
repeats  ||| S:32072 E:32080 ||| VBZ
# ||| S:32080 E:32081 ||| #
5-9  ||| S:32081 E:32085 ||| CD
( ||| S:32085 E:32086 ||| -LRB-
Fig.  ||| S:32086 E:32091 ||| CD
3 ||| S:32091 E:32092 ||| CD
)  ||| S:32092 E:32094 ||| -RRB-
and  ||| S:32094 E:32098 ||| CC
the  ||| S:32098 E:32102 ||| DT
carboxyl  ||| S:32102 E:32111 ||| JJ
terminus  ||| S:32111 E:32128 ||| NN
of  ||| S:32128 E:32131 ||| IN
monkey  ||| S:32131 E:32138 ||| JJ
fibulin-1C  ||| S:32138 E:32149 ||| NN
were  ||| S:32149 E:32154 ||| VBD
amplified  ||| S:32154 E:32164 ||| VBN
by  ||| S:32164 E:32167 ||| IN
PCR  ||| S:32167 E:32171 ||| NNP
using  ||| S:32171 E:32177 ||| VBG
primers  ||| S:32177 E:32193 ||| CD
Fib5priCAPPAE  ||| S:32193 E:32207 ||| CD
5 ||| S:32207 E:32208 ||| CD
' ||| S:32208 E:32209 ||| POS
CGAATTCTGCGCGCCACCTGCTGA  ||| S:32209 E:32234 ||| NNP
and  ||| S:32234 E:32238 ||| CC
Fib3priFVSAEL  ||| S:32238 E:32260 ||| CD
5 ||| S:32260 E:32261 ||| CD
' ||| S:32261 E:32262 ||| POS
CCGTCGACTCAGAGCTCTGCAGACACAAA ||| S:32262 E:32291 ||| NNP
.  ||| S:32291 E:32293 ||| .
The  ||| S:32293 E:32297 ||| DT
PCR  ||| S:32297 E:32301 ||| NNP
products  ||| S:32301 E:32310 ||| NNS
were  ||| S:32310 E:32323 ||| VBD
digested  ||| S:32323 E:32332 ||| VBN
with  ||| S:32332 E:32346 ||| IN
Eco  ||| S:32346 E:32350 ||| NNP
RI  ||| S:32350 E:32353 ||| NNP
and  ||| S:32353 E:32366 ||| CC
Sal  ||| S:32366 E:32370 ||| NNP
I  ||| S:32370 E:32372 ||| NNP
and  ||| S:32372 E:32376 ||| CC
ligated  ||| S:32376 E:32384 ||| NN
into  ||| S:32384 E:32389 ||| IN
the  ||| S:32389 E:32402 ||| DT
Eco  ||| S:32402 E:32406 ||| NNP
RI  ||| S:32406 E:32409 ||| NNP
and  ||| S:32409 E:32422 ||| CC
Sal  ||| S:32422 E:32426 ||| NNP
I  ||| S:32426 E:32428 ||| NNP
restriction  ||| S:32428 E:32440 ||| NN
sites  ||| S:32440 E:32446 ||| NNS
of  ||| S:32446 E:32449 ||| IN
pGAD424  ||| S:32449 E:32457 ||| CD
to  ||| S:32457 E:32468 ||| TO
produce  ||| S:32468 E:32476 ||| VB
constructs  ||| S:32476 E:32487 ||| FW
pGAD424 ||| S:32487 E:32494 ||| FW
/ ||| S:32494 E:32495 ||| FW
Fib-1C  ||| S:32495 E:32502 ||| FW
EGF ||| S:32502 E:32505 ||| FW
# ||| S:32505 E:32506 ||| #
1-5  ||| S:32506 E:32510 ||| CD
and  ||| S:32510 E:32522 ||| CC
pGAD424 ||| S:32522 E:32529 ||| CD
/ ||| S:32529 E:32530 ||| CD
Fib-1C  ||| S:32530 E:32537 ||| CD
EGF ||| S:32537 E:32540 ||| JJ
# ||| S:32540 E:32541 ||| #
5-COOH  ||| S:32541 E:32548 ||| CD
respectively ||| S:32548 E:32560 ||| RB
.  ||| S:32560 E:32562 ||| .
The  ||| S:32562 E:32566 ||| DT
constructs  ||| S:32566 E:32577 ||| NN
were  ||| S:32577 E:32590 ||| VBD
sequenced  ||| S:32590 E:32600 ||| VBN
as  ||| S:32600 E:32603 ||| RB
described  ||| S:32603 E:32613 ||| VBN
above  ||| S:32613 E:32619 ||| IN
using  ||| S:32619 E:32625 ||| VBG
primers  ||| S:32625 E:32633 ||| JJ
pGAD10SEQ  ||| S:32633 E:32643 ||| NN
and  ||| S:32643 E:32655 ||| CC
pGAD10cSEQ ||| S:32655 E:32665 ||| NNP
.  ||| S:32665 E:32675 ||| .
A  ||| S:32675 E:32677 ||| DT
random  ||| S:32677 E:32684 ||| JJ
primed  ||| S:32684 E:32691 ||| JJ
P  ||| S:32691 E:32693 ||| NN
33labeled  ||| S:32693 E:32703 ||| CD
1.8  ||| S:32703 E:32707 ||| CD
kb  ||| S:32707 E:32710 ||| JJ
DNA  ||| S:32710 E:32714 ||| NN
probe  ||| S:32714 E:32720 ||| NN
to  ||| S:32720 E:32723 ||| TO
the  ||| S:32723 E:32735 ||| DT
region  ||| S:32735 E:32742 ||| NN
of  ||| S:32742 E:32745 ||| IN
LTBP-3  ||| S:32745 E:32752 ||| CD
gene  ||| S:32752 E:32757 ||| NN
containing  ||| S:32757 E:32768 ||| VBG
domain  ||| S:32768 E:32775 ||| NN
4  ||| S:32775 E:32777 ||| CD
was  ||| S:32777 E:32781 ||| VBD
prepared  ||| S:32781 E:32798 ||| VBN
using  ||| S:32798 E:32804 ||| VBG
the  ||| S:32804 E:32808 ||| DT
High  ||| S:32808 E:32813 ||| NNP
Prime  ||| S:32813 E:32819 ||| NNP
Labeling  ||| S:32819 E:32828 ||| NNP
Kit  ||| S:32828 E:32832 ||| NNP
from  ||| S:32832 E:32837 ||| IN
Roche  ||| S:32837 E:32843 ||| NNP
Molecular  ||| S:32843 E:32861 ||| NNP
Biochemicals ||| S:32861 E:32873 ||| NNP
.  ||| S:32873 E:32875 ||| .
Colony  ||| S:32875 E:32882 ||| NN
hybridizations  ||| S:32882 E:32897 ||| NNS
were  ||| S:32897 E:32902 ||| VBD
performed  ||| S:32902 E:32912 ||| VBN
on  ||| S:32912 E:32924 ||| IN
E.  ||| S:32924 E:32927 ||| NNP
coli  ||| S:32927 E:32932 ||| NNS
colonies  ||| S:32932 E:32941 ||| VBP
containing  ||| S:32941 E:32952 ||| VBG
the  ||| S:32952 E:32964 ||| DT
monkey  ||| S:32964 E:32971 ||| JJ
cv-1  ||| S:32971 E:32976 ||| CD
cDNA  ||| S:32976 E:32981 ||| JJ
library ||| S:32981 E:32988 ||| NN
.  ||| S:32988 E:32990 ||| .
Colony  ||| S:32990 E:32997 ||| NN
lifts  ||| S:32997 E:33003 ||| NNS
on  ||| S:33003 E:33006 ||| IN
zeta  ||| S:33006 E:33011 ||| JJ
probe  ||| S:33011 E:33025 ||| NN
membranes  ||| S:33025 E:33035 ||| NNS
( ||| S:33035 E:33036 ||| -LRB-
Bio-Rad ||| S:33036 E:33043 ||| NNP
)  ||| S:33043 E:33045 ||| -RRB-
were  ||| S:33045 E:33050 ||| VBD
performed  ||| S:33050 E:33060 ||| VBN
and  ||| S:33060 E:33064 ||| CC
the  ||| S:33064 E:33068 ||| DT
colonies  ||| S:33068 E:33077 ||| NN
were  ||| S:33077 E:33090 ||| VBD
denatured  ||| S:33090 E:33100 ||| JJ
and  ||| S:33100 E:33104 ||| CC
neutralized  ||| S:33104 E:33116 ||| VBP
as  ||| S:33116 E:33119 ||| RB
described  ||| S:33119 E:33129 ||| VBN
by  ||| S:33129 E:33132 ||| IN
Sambrook  ||| S:33132 E:33141 ||| NNP
et  ||| S:33141 E:33144 ||| FW
al.  ||| S:33144 E:33148 ||| FW
[  ||| S:33148 E:33158 ||| -LRB-
52  ||| S:33158 E:33161 ||| CD
]  ||| S:33161 E:33163 ||| -RRB-
air  ||| S:33163 E:33167 ||| NN
dried  ||| S:33167 E:33173 ||| NNS
and  ||| S:33173 E:33177 ||| CC
then  ||| S:33177 E:33182 ||| RB
UV  ||| S:33182 E:33185 ||| JJ
cross-linked  ||| S:33185 E:33198 ||| JJ
using  ||| S:33198 E:33204 ||| VBG
a  ||| S:33204 E:33206 ||| DT
Stratagene  ||| S:33206 E:33225 ||| JJ
crosslinker ||| S:33225 E:33236 ||| NN
.  ||| S:33236 E:33238 ||| .
The  ||| S:33238 E:33242 ||| DT
probe  ||| S:33242 E:33248 ||| NN
was  ||| S:33248 E:33252 ||| VBD
allowed  ||| S:33252 E:33260 ||| VBN
to  ||| S:33260 E:33263 ||| TO
hybridize  ||| S:33263 E:33273 ||| VB
to  ||| S:33273 E:33276 ||| TO
the  ||| S:33276 E:33288 ||| DT
colony  ||| S:33288 E:33295 ||| NN
DNA  ||| S:33295 E:33299 ||| NN
at  ||| S:33299 E:33302 ||| IN
42°C  ||| S:33302 E:33307 ||| CD
overnight  ||| S:33307 E:33317 ||| JJ
as  ||| S:33317 E:33320 ||| IN
described  ||| S:33320 E:33330 ||| VBN
by  ||| S:33330 E:33333 ||| IN
Sambrook  ||| S:33333 E:33342 ||| NNP
et  ||| S:33342 E:33353 ||| FW
al.  ||| S:33353 E:33357 ||| FW
[  ||| S:33357 E:33359 ||| -LRB-
52  ||| S:33359 E:33362 ||| CD
]  ||| S:33362 E:33364 ||| -RRB-
.  ||| S:33364 E:33366 ||| .
The  ||| S:33366 E:33370 ||| DT
membranes  ||| S:33370 E:33380 ||| NN
were  ||| S:33380 E:33385 ||| VBD
then  ||| S:33385 E:33390 ||| RB
rinsed  ||| S:33390 E:33397 ||| JJ
and  ||| S:33397 E:33401 ||| CC
washed  ||| S:33401 E:33416 ||| VBD
twice  ||| S:33416 E:33422 ||| RB
for  ||| S:33422 E:33426 ||| IN
5  ||| S:33426 E:33428 ||| CD
minutes  ||| S:33428 E:33436 ||| NNS
in  ||| S:33436 E:33439 ||| IN
2X  ||| S:33439 E:33442 ||| NNP
SSC ||| S:33442 E:33445 ||| NNP
/ ||| S:33445 E:33446 ||| CD
0.1 ||| S:33446 E:33449 ||| CD
%  ||| S:33449 E:33451 ||| NN
SDS  ||| S:33451 E:33455 ||| NN
at  ||| S:33455 E:33458 ||| IN
room  ||| S:33458 E:33463 ||| NN
temperature ||| S:33463 E:33474 ||| NN
,  ||| S:33474 E:33484 ||| ,
twice  ||| S:33484 E:33490 ||| RB
for  ||| S:33490 E:33494 ||| IN
15  ||| S:33494 E:33497 ||| CD
minutes  ||| S:33497 E:33505 ||| NNS
in  ||| S:33505 E:33508 ||| IN
0.1X  ||| S:33508 E:33513 ||| NNP
SSC ||| S:33513 E:33516 ||| NNP
/ ||| S:33516 E:33517 ||| CD
0.1  ||| S:33517 E:33521 ||| CD
%  ||| S:33521 E:33523 ||| NN
SDS  ||| S:33523 E:33527 ||| NN
at  ||| S:33527 E:33530 ||| IN
68°C ||| S:33530 E:33534 ||| NNP
,  ||| S:33534 E:33536 ||| ,
and  ||| S:33536 E:33548 ||| CC
once  ||| S:33548 E:33553 ||| RB
for  ||| S:33553 E:33557 ||| IN
15  ||| S:33557 E:33560 ||| CD
minutes  ||| S:33560 E:33568 ||| NNS
in  ||| S:33568 E:33571 ||| IN
0.1X  ||| S:33571 E:33576 ||| NNP
SSC ||| S:33576 E:33579 ||| NNP
/ ||| S:33579 E:33580 ||| CD
0.1 ||| S:33580 E:33583 ||| CD
%  ||| S:33583 E:33585 ||| NN
SDS  ||| S:33585 E:33589 ||| NN
at  ||| S:33589 E:33592 ||| IN
room  ||| S:33592 E:33605 ||| NN
temperature ||| S:33605 E:33616 ||| NN
.  ||| S:33616 E:33618 ||| .
The  ||| S:33618 E:33622 ||| DT
colony  ||| S:33622 E:33629 ||| NN
blots  ||| S:33629 E:33635 ||| NNS
were  ||| S:33635 E:33640 ||| VBD
then  ||| S:33640 E:33645 ||| RB
wrapped  ||| S:33645 E:33653 ||| VBN
in  ||| S:33653 E:33656 ||| IN
saran  ||| S:33656 E:33670 ||| JJ
wrap  ||| S:33670 E:33675 ||| NN
and  ||| S:33675 E:33679 ||| CC
exposed  ||| S:33679 E:33687 ||| VBN
to  ||| S:33687 E:33690 ||| TO
X-ray  ||| S:33690 E:33696 ||| NN
film  ||| S:33696 E:33701 ||| NN
at  ||| S:33701 E:33704 ||| IN
room  ||| S:33704 E:33709 ||| NN
temperature  ||| S:33709 E:33721 ||| NN
for  ||| S:33721 E:33725 ||| IN
24  ||| S:33725 E:33728 ||| CD
h  ||| S:33728 E:33738 ||| NN
at  ||| S:33738 E:33741 ||| IN
-80°C ||| S:33741 E:33746 ||| CD
.  ||| S:33746 E:33748 ||| .
The  ||| S:33748 E:33752 ||| DT
above  ||| S:33752 E:33758 ||| JJ
strategy  ||| S:33758 E:33767 ||| NN
was  ||| S:33767 E:33771 ||| VBD
used  ||| S:33771 E:33776 ||| VBN
to  ||| S:33776 E:33779 ||| TO
perform  ||| S:33779 E:33787 ||| VB
colony  ||| S:33787 E:33802 ||| NN
blot  ||| S:33802 E:33807 ||| NNS
hybridization  ||| S:33807 E:33821 ||| VBP
screening  ||| S:33821 E:33831 ||| VBG
on  ||| S:33831 E:33834 ||| IN
the  ||| S:33834 E:33838 ||| DT
monkey  ||| S:33838 E:33845 ||| JJ
cv-1  ||| S:33845 E:33850 ||| CD
cDNA  ||| S:33850 E:33863 ||| JJ
library  ||| S:33863 E:33871 ||| NN
using  ||| S:33871 E:33877 ||| VBG
a  ||| S:33877 E:33879 ||| DT
~750  ||| S:33879 E:33884 ||| JJ
bp  ||| S:33884 E:33887 ||| JJ
P  ||| S:33887 E:33889 ||| NN
33-labeled  ||| S:33889 E:33900 ||| CD
probe  ||| S:33900 E:33906 ||| NN
to  ||| S:33906 E:33909 ||| TO
a  ||| S:33909 E:33911 ||| DT
region  ||| S:33911 E:33918 ||| NN
of  ||| S:33918 E:33929 ||| IN
the  ||| S:33929 E:33933 ||| DT
fibulin-1C  ||| S:33933 E:33944 ||| JJ
gene  ||| S:33944 E:33949 ||| NN
containing  ||| S:33949 E:33960 ||| VBG
most  ||| S:33960 E:33965 ||| JJS
of  ||| S:33965 E:33968 ||| IN
the  ||| S:33968 E:33972 ||| DT
type  ||| S:33972 E:33977 ||| NN
I  ||| S:33977 E:33987 ||| PRP
anaphylatoxin  ||| S:33987 E:34001 ||| VBP
repeats  ||| S:34001 E:34009 ||| NNS
and  ||| S:34009 E:34013 ||| CC
almost  ||| S:34013 E:34020 ||| RB
all  ||| S:34020 E:34024 ||| RB
of  ||| S:34024 E:34027 ||| IN
the  ||| S:34027 E:34031 ||| DT
type  ||| S:34031 E:34036 ||| NN
II  ||| S:34036 E:34047 ||| NNP
EGF-like  ||| S:34047 E:34056 ||| JJ
repeats  ||| S:34056 E:34064 ||| NNS
( ||| S:34064 E:34065 ||| -LRB-
Fig.  ||| S:34065 E:34070 ||| CD
3 ||| S:34070 E:34071 ||| CD
) ||| S:34071 E:34072 ||| -RRB-
.  ||| S:34072 E:34089 ||| .
